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Summary 
        The task of my thesis was to study palladium(0)-catalyzed cross-coupling reactions (Suzuki 
and Heck reaction). Different types of bis(triflates) and dibromides of different substrates 
(thioxanthons, indenones, indoles, naphthaquinones) were studied. 
     1,3- Dihydroxythioxanthones and 1,4-dihydroxythioxanthones as substrates were synthesized 
in the laboratory from available chemicals and known procedures. 
    The palladium(0)-catalyzed Suzuki-Miyaura cross-coupling reaction of bis(triflates) of 1,3-
dihydroxythioxanthones afforded 1,3-diarylthioxanthones. The reactions proceeded with very 
good yield and excellent site-selectivity. The first attack takes place at carbon atom C-3. In 
general, the site-selectivity of palladium(0)-catalyzed reactions is controlled by electronic and 
steric effects. The oxidative addition of palladium usually occurs first at the most electron 
deficient and sterically less hindered position. The regioselectivity of the formation of mono-
adducts for bis(triflates) of 1,3-dihydroxythioxanthone is due to the fact that carbon atom C-3 is 
sterically less hindered than carbon atom C-1. Therefore, the first attack occurred at this position. 


    The Suzuki-Miyaura cross-coupling reactions of bis(triflates) of 1,4-dihydroxythioxanthones 
afforded 1,4-diarylthioxanthones. The reaction again proceeded with excellent site-selectivity in 
favour of carbon atom C-1 which is more electron-deficient than carbon atom C-4. The attack at 
carbon atom C-4 is hindered by the lone pairs of the sulfur atom. Therefore, the first attack takes 
place at position 1. 
    Various 1,3- and 1,4-diarylthioxanthones with different electron-donating and withdrawing 
groups were prepared in high yields and excellent site-selectivity. Pd(PPh3)4 was used as an 
optimal catalyst for the synthesis (5 mol% per cross-coupling reaction). 
    2,3,5-Tribromoinden-1-one was prepared from commercially available 5-bromoinden-1-one. 
The Suzuki-Miyaura reaction of this substrate was studied also in my thesis. The site-selective 
Suzuki-Miyaura cross-coupling reaction of 2,3,5-tribromoinden-1-one with one equivalent of 
different arylboronic acids, having both electron-donating and withdrawing groups, afforded 3-
aryl-2,5-dibromo-1H-inden-1-one in high yields and excellent site-selectivity. Pd(PPh3)4 (3 
mol%) was used for this coupling reaction as a catalyst. The first attack occurred at carbon atom 
C-3. 
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    The palladium(0)-catalyzed Suzuki-Miyaura cross-coupling reactions to give di- and 
triarylinden-1-ones proceeded with high yields and very good site-selectivity. The second attack 
takes place in favour of carbon atom C-2 of tribromominden-1-one.  The site-selectivity can be 
explained by the fact that carbon atom C-3 is considerablly more electron-deficient than 
positions 2 and 5. Carbon atom C-2 is sterically more hindered than C-5 and electronically less 
deficient.  
	

   The site-selectivity in favour of position 5 might be explained by chelation of the catalyst to 
the carbonyl oxygen atom which may enhance the rate in favour of position 2.  
     The Suzuki-Miyaura cross-coupling reaction of 2,3,6-tribromo-1-methyl-1H-indole with 
different arylboronic acids, both electron-donating and withdrawing groups, were studied also in 
my thesis.  
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    2-Aryl-3,6-dibromo-1-methyl-1H-indoles were synthesized in high yields and excellent site-
selectivity for both electron-donating and withdrawing groups of the arylboronic acids used. 
Pd(PPh3)4 (3 mol%), a solvent mixture of toluene/1,4-dioxane (4:1), and K3PO4(1.5 equiv.) as the 
base were most suitable conditions for this reaction. Both symmetrical and unsymmetrical di- 
and triaryl-1-methyl-1H-indoles were prepared in this project in high yields and very good site-
selectivities for both electron-donating and withdrawing groups. 
   The first attack occurred at carbon atom C-2 and the site-selectivity of 2,3,6-tribromo-1-
methyl-1H-indole was explained by the fact that position 2 is considerably more electron-
deficient than positions 3 and 6. Carbon atom C-6 is sterically less-hindered than C-3, therefore 
the second attack occurred at C-6. The synthesis of 2,3,6-triaryl-1-methyl-1H-indoles, containing 
different aryl groups, was proceeded as a one-pot synthesis with sequential addition of the 
reagents. Other products were synthesized after isolation of the product of the first coupling 
reaction from the first step and its reaction with a second boronic acid in a second cross-coupling 
reaction. 
  The synthesis of functionalized anthraquinones by domino twofold 6-electrocyclization 
reactions of 2,3-dibromonaphthaquinone was studied also in my thesis. The Heck reaction of 2,3-
dibromonaphthaquinone with different types of alkenes (acrylate and styrene), having both 
electron-donating and withdrawing groups, afforded substituted anthraquinones. The temperature 
played an important effect in this reaction. The yields significantly decreased when the 
temperature was increased. A clean reaction was observed when the reaction was carried out at 
90°C. Pd(OAc)2 (5 mol%) and Buchwald ligand XPhos (10 mol%) were used for the reaction. 
The products, which are not readily available by other methods, were formed in only one step 
under relatively mild conditions.  



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1.     Introduction
        1.1   General Introduction
     Carbon-carbon bond forming reactions played an enormously decisive and important role in 
shaping chemical synthesis of organic compounds. Classical reactions, for example aldol and 
Grignard-type reactions, the Diels-Alder, Wittig and related reactions, allow chemists to 
construct increasingly complex carbon frameworks and thus enabled the synthesis of a myriad of 
organic compounds. 
     During the second half of the 20th century, transition metals started to play an important role 
in organic chemistry and this has led to the development of a large number of transition metal-
catalyzed reactions for creating organic molecules. Transition metals have a unique ability to 
activate various organic compounds and through this activation they can catalyze the formation 
of new bonds. In 2005, the Nobel Prize in chemistry was awarded to metal-catalyzed reactions 
for the formation of carbon-carbon double bonds. In 2010, the Nobel Prize in chemistry is 
awarded to the formation of carbon-carbon single bonds through palladium-catalyzed cross-
coupling reactions1. 
1.2   Characteristic Features of Palladium-Catalyzed Reactions 
    There are several features which make reactions involving palladium-catalysts and reagents 
particularly useful and versatile among many transition metals used for organic synthesis. Most 
importantly, Pd catalysts offer an abundance of possibilities of carbon-carbon bond formation. 
No other transition metal can offer such versatile methods for carbon-carbon bond formations as 
Pd. Tolerance of Pd-catalysts and reagents to many functional groups, such as carbonyl and 
hydroxyl groups, is the second important feature. Pd-catalyzed cross-coupling reactions can be 
carried out without protection of these functional groups. However, reactions involving Pd 
should be carried out carefully as Pd(0)-reagents and catalysts are sensitive to oxygen and 
moisture. It is sufficient to apply precautions to avoid oxidation of coordinated phosphines and 
Pd(0). 2
     Palladium is a noble and expensive metal. The toxicity of Pd has posed no serious problems 
so far. Numbers of industrial processes, particularly for the production of fine chemicals based 


on Pd-catalyzed reactions, have been developed and are currently being operated and reflect the 
advantages of using Pd catalysts commercially 3. 
1.3   Palladium-Catalyzed Cross-Coupling Reactions 
   Based on transition-metal catalysis, the newly acquired ability to form carbon-carbon bonds 
between functionalized and sensitive substrates provided new opportunities, particularly in total 
synthesis, but also in medicinal and process chemistry as well as in chemical biology and 
nanotechnology. Various types of palladium-catalyzed cross-coupling reactions are known in 
organic synthesis, such as Heck, Stille, Suzuki, Sonogashira, Tsuji-Trost, and the Negishi 
reactions (Figure 1). The increasing popularity of these reactions in synthesis is seen in every 
issue of modern scientific journals dedicated to organic synthesis or organometallic chemistry 
and catalysis4. 
Figure 1: Types of palladium-catalyzed cross-coupling reactions (picture taken from 
Angew.Chem. Ind. Ed. 2005, 44, 4442). 


    With regard to the application in industry, the shown coupling reactions offer the opportunity 
of shorter and more selective routes for a number of fine chemicals as compared to traditional 
stoichiometric organic transformations. Thus, it is not surprising that, since the early 1990s, more 
and more palladium-catalyzed reactions are transferred from academic protocols to industrial 
scale. Therefore, during the last decade, the development of new catalysts which are more 
productive and more active continues to be a major goal of organometallic chemistry and 
homogeneous catalysis5.
1.4   Fundamental Reactions of Palladium Compounds 
    The reaction mechanism and the synthetic applications of Pd-catalyzed cross-coupling 
reactions proceed according to the following major steps6,7(Figure 2). 
1.  Oxidative Addition: The ‘oxidative’ addition is the addition of a molecule X-Y to Pd(0) with 
cleavage of its covalent bond, forming two new bonds. Since the two previously non-bonding 
electrons of Pd are involved in bonding, the Pd increases its formal oxidation state by two units, 
namely, Pd(0) is oxidized to Pd(II). 

2. Insertion: The term ‘insertion’ is somewhat misleading. The insertion should be understood 
as the migration of the adjacent ligand from the Pd to the Pd-bound unsaturated ligand. The 
reaction below is called ‘insertion’ of an alkene to a (Ar-Pd-X) bond mainly by inorganic 
chemists. Some organic chemists prefer to use the term ‘carbo-palladation’ of alkenes. 
3. Transmetallation: Organometallic compounds M-R and hydrides M-H of main group 
metals (M= Mg, Zn, B, Al, Sn, Si, Hg) react with Pd complexes (Ar-Pd-X) formed by 
oxidative addition, and the organic group or hydride is transferred to Pd by substituting X 
with R or H. In other words, alkylation of Pd or hydride formation takes place and this 
process is called transmetallation.  


4. Reductive Elimination: it is a uni-molecular decomposition pathway, and the reverse of 
oxidative addition. Reductive elimination (or reductive coupling) involves loss of two 
ligands of cis configuration from the Pd center, and their combination gives rise to a single 
elimination product as it has been shown below. By reductive elimination, both the 
coordination number and the formal oxidation state of Pd(II) are reduced by two units to 
generate Pd(0), and hence the reaction is named ‘reductive’ elimination. The regenerated 
Pd(0) species undergo oxidative addition again. In this way, a catalytic cycle is completed 
by a reductive elimination step8. 
  
Figure 2: General mechanism for palladium-catalyzed cross-coupling reactions (picture taken 
from Molecules, 2011, 16, 951-969). 

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1.5   Palladium-Catalyzed Suzuki-Miyaura Cross-Coupling Reaction 
     The  Suzuki-Miyaura cross-coupling reaction represents  an  extremely  useful method  for 
the  synthesis  of biaryls  and  is widely  applied  in  organic chemistry. The reaction involves, 
for example, the palladium-catalyzed cross-coupling between organoboron compounds and aryl 
halides. The scope of the reaction is not restricted to aryl derivatives, but includes also alkyl, 
alkenyl and alkynyl compounds. The reaction also works well with triflates (the OH group is 
converted into OTf by triflic anhydride); thus, phenolic compounds can be arylated by this 
method. Boronic esters, boranes or boronic acids can be used 9. Since its discovery, the Suzuki-
Miyaura cross-coupling reaction has seen significant advancement and became one of the most 
powerful carbon-carbon bond forming methods in organic synthesis. The Suzuki reaction 
represents one of the, if not the most, widely used methods for aryl-aryl bond formation in 
modern organic synthesis. Biaryl systems have a lot of advantages in many scientific and 
economic fields, from natural products to ligands for asymmetric catalysis, pharmaceutical 
compounds, and nanomaterials. Extensive research efforts have recently been extended to 
develop further the utility and efficiency of the Suzuki reaction within this context10. 
     The reaction has important advantages including functional group compatibility, low toxicity 
of reagents and intermediates, easy availability of boron derivatives, high thermal stability and 
tolerance toward oxygen and aqueous solvents11.  
     Recently, organic chemists have turned their work to the application of this reaction for the 
synthesis of more complex molecules, by using successive Suzuki-Miyaura cross-coupling 
reactions with substrates containing two or more possible reactive sites12. 
      The mechanism usually involves three steps (Figure 3). In the first step of the reaction, the 
oxidative addition of organic halides or triflates to the Pd(0) complex to form an organo-
palladium halide (R1-Pd (II)-X) takes place. This step is then followed by transmetallation with a 
boronic acid derivative to give a diorgano-palladium complex (R1-Pd-R2). In the final step of the 
reaction, this complex undergoes a reductive elimination resulting in the formation of a carbon-
carbon bond and regeneration of the catalyst13. 
     Many factors are affecting both the oxidative addition and transmetallation steps and then 
affect the rate of Suzuki reactions. For example, the reactivity of the reacting substrates has an 
important role to play on the oxidative addition step. Generally, the reactivity of various 
substrates in Suzuki reactions is observed in the following order, Ar-I > Ar-Br > Ar-OTf > Ar-
Cl.  The base supports the transmetallation step of the Suzuki reaction. Different types of bases 

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are used in this reaction, e.g. potassium carbonate, potassium phosphate and cesium carbonate, 
which enhances the rate of the transmetalation by increasing the nucleophilicity of the organo-
boran compound by formation of an organo-borate containing a tetravalent boron atom14. 
Figure 3: Catalytic cycle of the Suzuki reaction 
     The Suzuki-Miyaura cross-coupling reaction is the only one among metal-catalyzed cross-
coupling reactions which can be run in biphasic (organic/ aqueous) or aqueous environments in 
addition to organic solvents15. 
      Organo-boron derivatives can tolerate a broad range of functional groups, such as organic 
halides, carbonyls, etc. The electronegativity of boron is about 2.0 which is close to the value of 
carbon of 2.5 and is higher than the electronegativities of lithium, magnesium, or most of the 
transition metals which range from 0.86 to 1.75. Therefore, the boronic compounds are air-stable 
and also water tolerant. The starting materials and borate by-products are not toxic16. 
In organic synthesis, two kinds of palladium compounds, namely Pd(II) salts and Pd(0) 
complexes are used. Pd(II) compounds are mainly used as oxidizing reagents, or as catalysts for 
some reactions. Pd(0) complexes are often used as catalysts. Pd(II) compounds such as PdCl2 and 
Pd(OAc)2 are stable and commercially available. They can be used in two ways: as unique 
stoichiometric oxidizing agents and as precursors of Pd(0) complexes. Pd(OAc)2 is commercially 
available, stable and soluble in organic solvents. Commercially available Pd(OAc)2, 


PdCl2(PPh3)2, Pd(PPh3)4, Pd2(dba)3 are generally used as precursors of Pd(0) catalysts with or 
without addition of phosphine ligands. Pd(PPh3)4 is a light-sensitive, air unstable, yellowish 
green catalyst and a coordinatively saturated Pd(0) complex which is widely used as a catalyst 
for palladium-catalyzed cross-coupling reactions17.
      As these catalysts serve as a source of electrons in the reaction; the electron-rich ligands are 
often the key for a successful reaction. Sterically hindered and electron-rich phosphines serve the 
purpose in a best way. Many chemists all over the world are trying to synthesize most useful 
ligands which can be employed to achieve the best results in the field of palladium-catalyzed 
chemistry. Buchwald and co-workers18 recently have developed electron-rich, bulky biphenyl 
phosphine ligands, such as S-Phos, X-Phos, and others.  
     Langer and coworkers extensively studied site-selective Suzuki-Miyaura cross-coupling 
reactions of poly-halogenated hetero-aromatic and aromatic compounds or their triflates. In this 
context, regioselective Suzuki-Miyaura cross-coupling reactions of  2,3-dibromo-1H-inden-1-
one (a), 2,3-dibromobenzofuran (b), 2,3-dibromo-1-methyl-1H-indole (c), 2,3,4-
tribromothiophene (d), 2,3,5-tribromothiophene (e), 3,4,5-tribromo-1-methyl-1H-pyrazole (f), 
perchloropyrimidine (g) and perbromofuran (h) were reported (Figure 4) 19a-h. 
Figure 4: Site-selective Suzuki cross-coupling reactions of various halides studied in 
Langer’s group 
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    Site-selective Suzuki-Miyaura cross-coupling reactions of bis(triflate) substrates and 
subsequently the site-selectivity of the reaction were studied as well (Figure 5). The use of aryl 
triflates instead of aryl halides is particularly important in organic synthesis because it can 
provide a way of forming a carbon-carbon bond at a phenolic site, which is often useful when 
appropriate halides are unavailable.20
     Langer’s group also reported the regioselective synthesis by Suzuki-Miyaura cross-coupling  
reactions of different hydroxylated substrates, e. g. (3,4-dihydroxyphenyl)(phenyl)methanone (i) 
2-((4-hydroxyphenyl)sulfonyl)phenol (j) 1,2-dihydroxyanthracene-9,10-dione (k) phenyl 1,4-
dihydroxy-2-naphthoate (l) 7,8-dihydroxy-2-phenyl-4H-chromen-4-one (m), 1,2,3,4-tetrahydro-
9,10-dihydroxyanthracen-1-one (n) 5,10-dihydroxy-11H-benzo[b]fluoren-11-one (o).21a-g  
All mentioned substrates proceeded with very good yields and excellent site-selectivity.   
       
Figure 5: Site-selective Suzuki cross-coupling reactions of dihydroxylated substrates studied in 
Langer’s group 
      In general, complex compounds can be prepared by successive Suzuki-Miyaura cross- 
coupling reactions of substrates containing one, two or more possible reactive sites. The 
regioselectivity can be explained by electronic and steric parameters. The first attack usually 
occurs at the more electrons deficient and sterically less hindered position22.


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1.6   Palladium-Catalyzed Heck Cross-Coupling Reaction 
     The Mizoroki–Heck reaction is the palladium-catalyzed C-C coupling reaction between aryl 
halides or vinyl halides with activated alkenes in the presence of Pd(0) catalyst and a base. Pd(II) 
acetate or Pd(II) chloride in combination with different ligands, such as triphenyl 
phosphine(PPh3), S-Phos, X-Phos, tricyclohexylphosphine (PCy3) were used as catalysts to give 
the corresponding substituted alkenes23. 
     In general, the reaction proceeds with high stereo- and regioselectivity. The reaction was 
discovered independently by Heck and Mizoroki in the early 1970s. After further development in 
the 1980s and 1990s, the synthesis community benefited enormously from the Heck reaction, 
especially for the synthesis of pharmaceuticals and agrochemicals24. The intramolecular Heck 
reaction has been well-established as a powerful tool for the construction of complex polycyclic 
ring systems in the context of natural product synthesis. 
     In Heck reactions, the reactivity depends on the substituted olefins: more substituted olefins 
resulted in a slower reaction. However, electron-poor olefins provided higher yields (electron- 
withdrawing groups such as ester, ether, carboxylic acid, nitriles, located at the olefin). The type 
of leaving group also plays an important role. The reactivity order is I > Br > Cl. 
     The generally accepted reaction mechanism is shown in Figure 6. The reaction begins with 
the oxidative addition of the aryl-X compound (X = I, Br, Cl, OTf, OTs, etc) to an active ligated 
Pd(0) center to form the respective Pd(II) species.
     Subsequent coordination and then insertion of the alkene at the Pd(II) center generates an 
alkyl palladium complex. After rotation of the carbon–carbon bond, hydride elimination takes 
place and the substituted alkene is released as the terminal product. Finally, the active Pd(0) 
catalyst is regenerated with base.  
     Besides the typical intermolecular reactions of aryl halides with ethylene, styrenes, acrylates, 
enol ethers, etc., intramolecular variants exist, which form unsaturated carba- or heterocycles.
Furthermore, the Heck reaction has proven to be very useful as part of novel domino reactions25. 
                   


Figure 6:  general reaction mechanism of Heck cross-coupling reaction (picture taken from 
Angew.Chem. Int. Ed. 2010, 49, 9047-9050). 
    The combination of the Heck cross-coupling reaction with electrocyclization reactions 
provides a convenient access to a variety of carbacyclic frameworks. Pioneering work in this 
field was reported by de Meijere and co-workers. Benzene derivatives have been prepared by 
double Heck reactions of aliphatic 1,2-dibromoalkenes to give hexatrienes and subsequent 
thermal-6π-electrocyclization of the latter. The electrocyclization can proceed smoothly, if the 
central double bond of the triene system is not involved in a stable aromatic 6π-system26.
Langer’s group later studied the application of this concept to various halogenated compounds, 
e.g. twofold Heck cross coupling reactions of 2,3-dibromoindenone (a) 2,3dibromo-N-
methylindole (b) 2,3-dibromobenzothiophene(c), 2,3-dibromofuran (d) 2,3dibromothiophene (e) 
2,3-dibromobenzofuran (f) (Figure 7) 27a-e. 
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Figure 7: Heck reaction of vicinal dibromide studied in Langer’s Group 
    In conclusion, the Pd(0)-catalyzed Heck cross-coupling reaction of dibrominated substrates 
can provide a cyclization and aromatization by a subsequent electrocyclization. The synthesis of 
the products following this type of reaction can be achieved in only one-step under relatively 
mild conditions.  

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2.   Synthesis of Functionalized Dihydroxy-9H-thioxanthen-9-ones.
2.1 General Introduction:  
    The first part of my work was concerned to the synthesis of functionalized thioxanthones 
based on site-selective Suzuki-Miyaura cross-coupling reactions. In the literature, it has been 
reported that thioxanthones show a variety of properties. These types of compounds have 
considerable pharmacological relevance and occur in various natural products28. Thioxanthone 
derivatives have been studied extensively owing to their medicinal properties, such as 
antihistaminic, antiparasitic, neuroleptic, and antitumor activities29-33. Lucanthone and 
hycanthone, a metabolite, represent bioactive natural products with thioxanthone core structure34.
A series of hycanthone derivatives have been recently reported to display high levels of in vivo 
activity against murine pancreatic adenocarcinoma35-37. Thioxanthone-dioxide is also known to 
exhibit significant pharmacological activities, including antitumor, cytotoxic and monoamine 
oxidase (MAO) inhibitory activity38. A number of plants such as cartoxylum cochinchinense 
(Lour.), contain thioxanthone derived natural products and have been used as traditional 
medicines to treat fever, coughing, diarrhoea, itching, ulcers and abdominal complaints39. The 
thioxanthone class of drugs are effective in the systematic treatment of psychoses; they are most 
appropriately used in the therapy of schizophrenia, organic psychoses and other idiopathic 
psychotic illness. These drugs have other clinically useful properties including anti-emetic, anti-
nausea, anti-histamine and the ability to potentiate the analgesics sedatives and general 
anaesthetic action40.  Thioxanthones are also important in the field of material sciences. Various 
derivatives of thioxanthones are used as activators in the photo polymerization of ethylene-
derived unsaturated monomers (particularly acrylate derivatives)41. Moreover, alkyl-, alkoxy- 
and hydroxy-substituted thioxanthones are particularly useful as heat and ultraviolet stabilizers 
of polyolefins42. 
    Several methods were used for the synthesis of thioxanthones39,43. A rather general procedure 
is based on the condensation of substituted potassium 2-chlorobenzoates with thiophenols or on 
the condensation of substituted thiosalicylic acids with benzene derivatives to give 2-
phenylmercaptobenzoic acids which are subsequently cyclized by reaction with sulphuric acid, 
44,45, AlCl330,33 or polyphosphoric acid (PPA)32. However, these classical methods have some 
disadvantages, such as low yields, long reaction times, use of large amounts of concentrated 
sulphuric acid, and lack of regiochemical control in the ring closure step. Moreover, some of 
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these methods require several synthetic steps, because the starting materials are not readily 
available, and are limited to activated benzoic acids and benzene derivatives containing electron-
withdrawing groups. 
     1,3-Dihydroxy-9H-thioxanthen-9-one was prepared, following a known procedure,46 by AlCl3
mediated reaction of thiosalicylic acid with 1,3,5-trihydroxybenzene.  
     1,4-Dihydroxy-9H-thioxanthen-9-one was synthesized by cyclization of 2-[(2,5-di- 
hydroxyphenyl)sulfanyl]benzoic acid. The latter was prepared from benzoquinone and 
thiosalicylic acid in acetic acid or other solvents (such as diethyl ether or ethanol) at room 
temperature and the reaction occurs as a  1,4-addition of the nucleophile at the conjugated 
bond system of the quinone with participation of one carbonyl group (which is typical of 
quinones), followed by rearrangement of the adduct to  produce dihydroxy-substituted 
biphenyl sulfide 47. 

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2.2 Site-Selective Suzuki–Miyaura Cross-Coupling Reactions of the 
Bis(triflates) of 1,3-Dihydroxy-9H-thioxanthen-9-one. 
Results and discussion:
     1,3-Dihydroxy-9H-thioxanthen-9-one 1 was prepared following a known procedure 46. The 
hydroxyl group can be transformed to triflates by treatment with triflic anhydride in the presence 
of pyridine as a base. The triflic anhydride was added at -78oC and the mixture was allowed to 
warm to room temperature. Based on the above mentioned procedure, compound 1 was 
converted to the bis(triflate) 2 which was isolated as a yellow solid in 80% yield (Scheme1). 
Scheme 1: Synthesis of 2. Reagents and conditions: i, CH2Cl2, 1 (1.0 equiv.), Et3N (4.0 equiv.), 
Tf2O (2.4 equiv.), -78°C  20°C, 8 h.
    The Suzuki–Miyaura cross-coupling reaction of 2 with arylboronic acids 3a–g (2.4 equiv.) 
afforded the 1,3-diarylthioxanthones 4a–g (Scheme 2, Table 1). The structures of all products 
were confirmed by spectroscopic methods. Very good yields were obtained both for reactions of 
electron-rich and poor arylboronic acids. The best yields were obtained when the reactions were 
carried out using Pd(PPh3)4 (10 mol%) as catalyst, K3PO4 (3.0 equiv.) as base and when the 
reaction was carried out using 1,4-dioxane as a solvent at 90°C for 8 h. 

Scheme 2: Synthesis of 4a-g. Reagents and conditions: i, 2 (1.0 equiv.), 3a-g (2.4 equiv.), 
Pd(PPh3)4 (10 mol%), K3PO4 (3.0 equiv.), 1,4-dioxane, 90°C, 8 h. 
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Table 1: Synthesis of 4a-g
    

                                                                        a Yields of isolated products.  
                              
    The Suzuki–Miyaura reaction of 2 with arylboronic acids 3b,c,d,f,g,h,i,j (1.1 equiv.) resulted 
in the formation of the 3-aryl-1-(trifluorosulfonyloxy)-thioxanthones 5a-h in a good yields and 
excellent site-selectivity (Scheme 3, Table 2).
Scheme 3: Synthesis of 5a-h and of 6a-c. Reagents and conditions: i, 2 (1.0 equiv.), 
3b,c,d,f,g,h,i,j (1.1 equiv.), Pd(PPh3)4 (5 mol%), K3PO4 
 !"#$%ii, 5b,c,f 
(1.0 equiv.), 3a,h,k (1.1 equiv.), Pd(PPh3)4 (5 mol%), K3PO4 (1.5 equiv.), 1,4-dioxane, 90°C, 6 h 
  3   4       Ar 4(%)a
  a   a   2-(MeO)C6H4   90 
  b   b   4-EtC6H4   81 
  c   c   4-tBuC6H4   86 
  d   d 3,5-Me2C6H3   77 
  e   e   4-MeC6H4   84 
  f   f   4-ClC6H4   70 
  g   g   3-(CF3)C6H4   75 

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Table 2: Synthesis of 5a-g and 6a-c 
                        a Yields of isolated products. 
     It was proved to be important to carry out the reaction at 60 instead of 90°C in order to induce 
a good site-selectivity and to avoid double attack. Good yields were again obtained both for 
reactions of electron rich and poor arylboronic acids. The structure of compound 5b (Figure 7) 
and 5c (Figure 8) were independently confirmed by X-ray crystal structure analysis. The 
thioxanthone moiety is slightly twisted out of plane. The structures of all products were 
confirmed by spectroscopic methods.  
Figure 7: Molecular structure of compound 5b
  5   6            Ar1   %(5)a             Ar2   %(6)a
  a    4-(MeO)C6H4      87   
  b  a   4-EtC6H4      84    2-(MeO)C6H4      82 
  c  b   4-tBuC6H4      75    4-(MeO)C6H4      79 
  d    3,5-Me2C6H3      82 
  e        C6H5      71 
  f  c   4-ClC6H4      78    3,4-(MeO)2C6H3       71 
  g    3-(CF3)C6H4      81 
  h    4-FC6H4      80   


Figure 8: Molecular structure of compound 5c 
    Compounds 6a-c were synthesized by two steps. After isolation of the products of the mono-
adducts 5b,c,f from the first step, the second arylboronic acids 3a,h,k were added for the second 
cross-coupling reaction which afforded 1,3-diarylthioxanthones 6a-c in 71-82% yields (Scheme 
3, Table 2). It is important to carry out the first coupling reaction at 60°C for 8 h using THF as a 
suitable solvent for this step to improve the yield and site-selectivity. The second coupling cross-
coupling step was done at 90°C for 6 h using 1,4-dioxane as a solvent. Very good yields are 
again obtained to prepare the unsymmetrical 1,3-diarylthioxanthones 6a-c with both electron-
donating and withdrawing groups. 
     The structure of compound 6b was independently confirmed by X-ray crystal structure 
analysis (Figure 9). The structures of all products were confirmed by spectroscopic methods. 
Figure 9: Molecular structure of compound 6b
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    Products 5a, 5f were selected for optimization studies (Table 3). Thioxanthone 5a is derived 
from an electron-rich arylboronic acid, while 5f is derived from an electron-poor arylboronic 
acid. During the optimization we have found that the best yields were obtained when the 
reactions were carried out at 60°C.  
Table 3: Optimization table for synthesis of 5a, 5f at 60°C for 8 h
                 a (1.5equiv.) per (0.197 mmol) of 2. b (5ml) per (0.197 mmole) of  2.    
          c (5mol%) per (0.197 mmole) of 2.  (d ,e) Yield of isolated product. 
    Higher temperatures led to the formation of significant amounts of bis-arylated products. In 
addition, it is important to use exactly 1.1 equiv. of the arylboronic acids per cross-coupling 
reaction. The use of 1,4-dioxane as the solvent gave the best results in the case of the synthesis of 
1,3-diarylthioxanthones  4. It was observed that employment of THF was advantageous in the 
case of monoarylated products 5. The employment of potassium phosphate gave better yields 
than the use of an aqueous solution of potassium carbonate, The use of Pd(PPh3)4 gave higher 
yields than Pd(PPh3)2Cl2. 
     The sequential addition of two different arylboronic acids to 2 allowed for the direct synthesis 
of 1,3-diarylthioxanthone 6d in only one step in 75% yield (Scheme 4, Table 4). Based on my 
findings related to the synthesis of monoarylated products 5, the first step of the one-pot reaction 
was carried out at 60°C while the second step was carried out at 90°C. One portion of the 
catalyst (5 mol%) was added at the start of the reaction. 
Entry        Base(a) Solvent(b)   Catalyst(c) % (5a)d  % (5f)e
   1 K2CO3 (1 mL, 2 M) dioxane [Pd(PPh)3Cl2]     35     24 
   2 K2CO3 (1 mL, 2 M) THF [Pd(PPh)3Cl2]     41     32 
   3   K2CO3 (1 mL, 2 M) dioxane [Pd(PPh3)4]     46     37 
   4  K2CO3 (1 mL, 2 M) THF [Pd(PPh3)4]     41     33 
   5 K3PO4 (1.5 equiv.) dioxane [Pd(PPh)3Cl2]     55     47 
   6 K3PO4 (1.5 equiv.) THF [Pd(PPh)3Cl2]     66     50 
   7 K3PO4 (1.5 equiv.) dioxane [Pd(PPh3)4]     63     57 
   8 K3PO4 (1.5 equiv.) THF [Pd(PPh3)4]     87     78 

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Scheme 4: Synthesis of 6d. Reagents and conditions: i, 1) 2 (1.0 equiv.), 3l (1.1 equiv.), 
Pd(PPh3)4 (5 mol%), K3PO4 (1.5 equiv.), 1,4-dioxane, 60" $%3h (1.1 equiv.), 90°C, 6 h. 
Table 4: Synthesis of 6d 



                                             a Yields of isolated products 
    The Suzuki-Miyaura cross-coupling reactions of the bis(triflates) of 1,3-
dihydroxyanthraquinone proceeds by initial attack at position 1 (next to the carbonyl group) 
which can be explained by the fact that position 1 is electronically more deficient than positions 
2 and 3. In addition, a chelation of the catalyst by the carbonyl group might play a role. In 
contrast, the Suzuki–Miyaura reactions of 2 proceed by initial attack at position 3. The different 
site-selectivity is surprising. Obviously, the regiodirecting effect of the carbonyl group of this 
compound seems to be less pronounced than in case of the bis(triflates) of 1,2- and 1,3-
dihydroxyanthraquinone. Therefore, the sterically less hindered position 3 was attacked first 
(Figure 10).  
  3   6         Ar1          Ar2  %(6)a
 l , h   d   2-MeC6H4   4-(MeO)C6H4    75 


              
Figure 10: Possible explanation for the site-selectivity of the reactions of bis (triflate) 2 
2.3 Conclusion
             An efficient synthesis of different arylated thioxanthones by Suzuki-Miyaura cross-coupling 
reactions of the bis(triflate) of 1,3-dihydroxythioxanthone was studied and reported. The 
reactions were achieved with very good yields and excellent site-selectivity. The first attack 
appeared at carbon atom C-3, while the second one was at C-1. The steric effect played an 
important effect in this case and directed the selectivity in favour of carbon atom C-3. 
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2.4 Site-Selective Suzuki–Miyaura Cross-Coupling Reactions of the 
Bis(triflates) of 1,4-Dihydroxy-9H-thioxanthen-9-one. 
Results and discussion:
    Palladium-catalyzed Suzuki cross-coupling reactions of the bis(triflate) of 1,4-dihydroxy-9H-
thioxanthen-9-one, which has been synthesized by a known procedure,47 was studied. 1,4-
Dihydroxy-9H-thioxanthen-9-one 7 was transformed into its bis(triflate) 8 in 87% yield (Scheme 
5) by treatment with triflic anhydride in the presence of a mixture of Et3N and pyridine (1:2). 
The triflic anhydride was added at -78oC under an argon atmosphere and the reaction mixture 
was allowed to warm to room temperature and stirred for further 8 h. The best yields were 
obtained when a mixture of base in this reaction was used. 
Scheme 5: Synthesis of 8, Reagents and conditions: i, CH2Cl2, 7 (1.0 equiv.), Et3N/pyridine 
(Mix.) 1:2(4.0 equiv.), Tf2O (2.4 equiv.), -78°C  20°C, 8 h. 
   The Suzuki-Miyaura reaction of 8 with (2.4 equiv.) of arylboronic acids 3b,c,e,h,i,j resulted in  
1,4-diarylthioxanthones 9a-f in (80-92%) yields (Scheme 6, Table 5). The reactions were carried 
out nearly at the same conditions as reported for the synthesis of products 4. 
Scheme 6:Synthesis of 9a-f. Reagents and conditions: i, 8 (1.0 equiv.), 3b,c,e,h,i,j (2.4 equiv.), 
Pd(PPh3)4 (10 mol%), K3PO4 (3.0 equiv.), THF, 90°C, 8 h. 
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Table 5: Synthesis of 9a-f
                                                                    a Yields of isolated products. 
    The best yields were obtained when the reactions were carried out using Pd(PPh3)4 (10 mol %) 
as catalyst, K3PO4 (3.0 equiv.) as base and when the reaction was carried out using THF as a 
solvent at 90°C for 8 h. The structures of all products were confirmed by spectroscopic methods. 
Very good yields were obtained in both reactions for electron-rich and poor arylboronic acids. 
    1-Aryl-4-(trifluorosulfonyloxy)-thioxanthones 10a-i were synthesized by Suzuki cross-
coupling reaction of 8 with arylboronic acids 3b,c,e,f,h,i,j,l.m (1.1 equiv.). Different arylboronic 
acids with both electron-donating and withdrawing group and sterically hindered arylboronic 
acid (2-MeC6H4) were used for the synthesis. The reactions were achieved in high yields (76-
90%) and excellent site-selectivity (Scheme 7, Table 6). The best conditions for the synthesis of 
mono-adducts were found when the reaction was carried out at 65°C for 8 h using Pd(PPh3)4 (5 
mol% per cross-coupling reaction) as catalyst, K3PO4 (1.5 equiv.) as base and when the reaction 
was carried out using THF as a solvent. 
 3 9         Ar  9 (%)a
 b  a   4-EtC6H4    80 
 c  b   tBuC6H4    83 
 e  c  4-MeC6H4    84 
 h  d  4-(MeO)C6H4    92 
 i  e       C6H5    91 
 j  f    4-FC6H4    82 


Scheme 7:Synthesis of 10a-i. Reagents and conditions: i, 8 (1.0 equiv.), 3b,c,e,f,h,i,j,l,m (1.1 
equiv.), Pd(PPh3)4 (5 mol%), K3PO4 (1.5 equiv.), THF, 65°C, 8 h. 
Table 6: Synthesis of 10a-i
  3  10         Ar 10 (%)a
   b   a   4-EtC6H4   90 
   c   b   4-tBuC6H4   76 
   e   c   4-MeC6H4   87 
   f   d   4-ClC6H4    84 
   h   e  4-(MeO)C6H4   81 
   i   f      C6H5     88 
   j   g    4-FC6H4   82 
   l   h    2-MeC6H4   76 
  m    i    3-MeC6H4   79 
                                                                     a Yields of isolated products. 
    The structure of compound 10a (Figure 11) was independently confirmed by X-ray crystal 
structure analysis. The aryl groups and the thioxanthone moiety are only slightly twisted out of 
plane. The heterocyclic moiety is twisted out of plane. The structures of all products were 
confirmed by spectroscopic methods. 
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Figure 11: Molecular structure of compound 10a
    Products 10e, 10d were selected for optimization studies (Table 7). Thioxanthone 10e is 
derived from an electron-rich arylboronic acid, while 10d is derived from an electron-poor 
arylboronic acid.  
Table 7: Optimization table for synthesis of 10e, 10d at 65Co for 8 h
Entry Base(a) Solvent(b)  Catalyst(c) %(10e)d %(10d)e
  1 K2CO3  Dioxane [Pd(PPh)3Cl2]    33    22 
  2 K2CO3  THF [Pd(PPh)3Cl2]    44    39 
  3 K2CO3  Dioxane [Pd(PPh3)4]    41    40 
  4 K2CO3  THF [Pd(PPh3)4]    42    33 
  5 K3PO4  Dioxane [Pd(PPh)3Cl2]    51    48 
  6 K3PO4  THF [Pd(PPh)3Cl2]    56    50 
  7 K3PO4  Dioxane [Pd(PPh3)4]    60    52 
  8 K3PO4  THF [Pd(PPh3)4]    81    84 
                                      a (1.5eq) per (0.197mmole) of 8. b (5ml) per (0.197mmol) of 8.  
                       c (5mol%) per (0.197 mmol) of 8.  (d ,e) Yield of isolated product. 
   It was observed that the employment of THF as a solvent was advantageous in the case of the 
synthesis of mono-adducts 10. Also, potassium phosphate gave better yields than the use of an 

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aqueous solution of potassium carbonate. The use of Pd(PPh3)4 (5 mol% per cross-coupling 
reaction) gave higher yields than Pd(PPh3)2Cl2. 
   The structure of compound 10e was unambiguously confirmed by 2D-NMR techniques (Figure 
12).  
Figure 12: NOESY experiment of compound 10e 
    In the NOESY spectrum, an interaction was observed between the aromatic protons attached 
to the carbon atom C-2 of thioxanthone ring to the aromatic protons of the attached boronic acid 
ring attached to carbon atoms C-2' and C-6'. This confirmed that the first attack of boronic acid 
takes place at carbon atom C-1 of the bis(triflate). These correlations are not observed, if the 
boronic acid is attached to carbon atom C-4 of the bis(triflate).
    The one-pot reaction of 8 with two different arylboronic acids allowed for the synthesis of 1,4-
diarylthioxanthones 11a-d in only one step and in very good yields (84-90%) (Scheme 8, Table 
8).  
Scheme 8: Synthesis of 11a-d. Reagents and conditions: i, 1) 8 (1.0 equiv.), 3h,j,h,h (1.1 
equiv.), Pd(PPh3)4 (5 mol%), K3PO4 (1.5 equiv. "#$%3e,h,c,n (1.1 equiv.), 90°C, 
6 h. 
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    Based on our findings related to the synthesis of mono-aryl products 5, the first step of the 
one-pot reaction was carried out at 65°C and the second step was carried out at 90°C. One 
portion of the catalyst (5 mol%) was added at the start of the reaction. 
Table 8: Synthesis of 11a-d
                                      a Yields of isolated products.
     The reaction of bis(triflate) 8 proceeds by initial attack at the sterically more hindered 
position 1. This might be explained as follows: carbon atom C-1 is the most electron-deficient 
position, but it is sterically more hindered than positions 4 and 3. In case of compound 2, the first 
attack occurs at the sterically less hindered position 3. The attack to carbon atom C-4 of 
thioxanthone 8 is hindered by the lone pairs of the sulfur atom. Therefore, the attack occurs at 
position 1.      
Figure 12: Possible explanation for the site-selectivity of the reactions of bis(triflates) 2  and 8 
  3   11         Ar1           Ar2 %(11)a
h , e   a  4-(OMe)C6H4  4-MeC6H4   90 
 j , h   b  4-FC6H4  4-(OMe)C6H4   88 
h , c   c  4-(OMe)C6H4  4-tBuC6H4   84 
h , n   d  4-(OMe)C6H4  3-ClC6H4   89 
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2.5 Conclusion   
              The synthesis of various arylated thioxanthones by Pd(0)-catalyzed Suzuki cross-coupling 
reactions of the bis(triflates) of 1,3- and 1,4-dihydroxy-9H-thioxanthen-9-one were studied and 
reported. The first attack of the Suzuki reactions of 2 proceeded in favour of carbon atom C-3, 
while for compound 8, the Suzuki reactions preceded in favour of carbon atom C-1. Electronic 
and steric effects were the responsible reasons of the site-selective Suzuki reaction in 1,3- and 
1,4-dihydroxy-9H-thioxanthen-9-one.    
	
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3.   Site-Selective Synthesis of Arylated-1H-inden-1-ones by Suzuki-Miyaura 
Cross-Coupling Reactions of 2,3,5-Tribromo-1H-inden-1-one. 
3.1 General Introduction    
     Arylated indenones represent a pharmacologically important molecular entity 48 For example, 
2,3-diarylindenones have been studied as ligands for the estrogen receptor 48a. 3-Arylindenone-2-
carboxylic acid derivatives have been studied as selective inhibitors of fibroblast growth factor 
receptor-1 tyrosine kinase48d. Indenones also occur in several biologically relevant natural 
products, such as euplectin containing both a benzofuran and an inden-1-one substructure49. 
Other examples include neo-lignans isolated from the fruits of Virola sebifera50. Pauciflorol F is 
a 2,3-diarylindanone which has been prepared by palladium catalyzed Larock cyclization, 
hydrogenation and subsequent epimerization51. 2,3-Diarylindenones are available by classic 
methods which include, for example, intramolecular Friedel-Crafts acylations,52a reactions of 
phthalides or 1H-indene-1,3(2H)-diones with Grignard reagents,52b,c and synthetic 
transformations of dibenzoylmethane,52d benzophenone derivatives,52e or diphenyl acetylene52f. 
Transition metal-catalyzed syntheses of 2,3-diarylinden-1-ones include the Larock cyclization51 
and related processes53.
     Reactions of functionalized indenones, such as hydrogenations, reactions of the carbonyl group 
or conjugate additions, have been widely studied. We were interested in palladium-catalyzed 
cross-coupling reactions of halogenated inden-1-ones. While reactions of 2,3-dibromo-1H-inden-
1-one with amines, Grignard reagents, and CH-acidic compounds were reported nearly a century 
ago,54 transition metal-catalyzed reactions of this molecule were unknown until our recent 
report55 in this field. Site-selective palladium catalyzed reactions of dibromofuranones, which are 
closely related to 2,3-dibromoindenones, have been previously reported by Bellina and 
coworkers56.
   In general, site-selective palladium(0)-catalyzed cross-coupling reactions of polyhalogenated 
heterocycles are of considerable current interest in organic chemistry because they allow a facile 
assembly of complex heterocycles in only one step57,58.  
     I have studied what are, to the best of my knowledge, the first site-selective Suzuki-Miyaura 
cross-coupling reactions of 2,3,5-tribromoinden-1-one. These reactions provide a convenient 
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approach to various arylated inden-1-ones. Interestingly, my starting material, 2,3,5-tribromo-
1H-inden-1-one, represents a new compound which has, to the best of our knowledge, not been 
synthesized or studied before. 
Results and Discussion:
    2,3,5-Tribromo-1H-inden-1-one 13 was prepared in 62% yield by reaction of commercially 
available 5-bromoindan-1-one with NBS in the presence of AIBN (Scheme 9). While 2,3-
dibromoinden-1-one is known,59 the synthesis of 13 has, to the best of our knowledge, not been 
previously reported.
Scheme 9: Synthesis of 13. Conditions: i, 12 (1.0 equiv.), NBS (3.5 equiv.), AIBN (10 mol %), 
benzene, reflux, 7 h. 
        The Suzuki-Miyaura cross-coupling reaction of 13 with 3.3 equiv. of arylboronic acids 
3i,b,c,o,n,j,g afforded the 2,3,5-triaryl-1H-inden-1-ones 14a-g in (76-88%) yields (Scheme 10, 
Table 9). The best yields were obtained using 3.3 equiv. of the arylboronic acid, Pd(PPh3)4 (5 
mol %) as catalyst, K2CO3 (2 M, 1 mL) as base and 1,4-dioxane as solvent at 70°C for  6 h. 
Compounds 14 could be prepared in equally good yields using Pd(PPh3)2Cl2 as the catalyst. 
Similar conditions were used for the Suzuki reaction of 2,3-dibromoinden-1-one55. Different 
types of arylboronic acids were used in this reaction. The reactions were successful for both 
electron-rich and electron-poor arylboronic acids. The highest yield was obtained using 3b as 
electron-rich boronic acid (88%). 

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Scheme 10: Synthesis of 14a-g. Conditions: i, ArB(OH)2 3i,b,c,o,n,j,g (3.3 equiv.), Pd(PPh3)4 (5 
mol%), K2CO3 (2 M, 1 mL), 1,4-dioxane, 70°C, 6 h. 
       Table 9: Synthesis of 2,3,5-triaryl-indenone 14a-g 
  3  14         Ar %(14) a
   i   a        C6H5    83 
   b   b    4-EtC6H4    88 
   c   c   4-tBuC6H4    85 
   o   d  3-(MeO)C6H4    76 
   n   e   3-ClC6H4    79 
   j   f    4-FC6H4    81 
   g   g    3-(CF3)C6H4    78 
                                                 a Yields of isolated products. 
    Pd(0)-catalyzed Suzuki-Miyaura cross-coupling reactions of 13 with (1.0 equiv.) of 
arylboronic acids 3i,c,n,g,p,e,h afforded the 3-aryl-2,5-dibromo-1H-inden-1-ones 15a-g in (78-
92%) yields and with excellent site-selectivity (Scheme 11, Table 10). The first attack occurred 
at carbon atom C-3. The yields dropped when more than exactly (1.0 equiv.) of the boronic acids 
were used. The reactions were carried out using Pd(PPh3)4 (3 mol % per cross-coupling reaction) 
as the catalyst. In case of 15c, Pd(PPh3)2Cl2 (3 mol%) was employed as well. K3PO4 (1.5 equiv.) 
was used instead of K2CO3 to achieve the best conditions for site-selectivity in the reaction.


Scheme 11: Synthesis of 15a-g. Conditions: i, ArB(OH)2 3i,c,n,g,p,e,h (1.0 equiv.), Pd(PPh3)4 
OR Pd(PPh3)2Cl2 (3 mol %), K3PO4 (1.5 equiv.), 1,4-dioxane, 45°C, 9 h. 
    It is important to carry out the reactions at 45 instead of 70°C for this coupling. Significant 
amounts of side-products, derived from multifold coupling, were formed when the temperature 
was too high. The reactions could be successfully carried out with both electron-rich and poor 
arylboronic acids. The highest yield was obtained using 3h as boronic acid among the other types 
used for the reaction which afforded 15g in (92%) yield and excellent site-selectivity. 
Table 10: Synthesis of 2,5-dibromo-3-aryl-indenone 15a-g 
 3  15         Ar % (15) a
  i   a       C6H5    83 
  c   b   4-tBuC6H4    86 
  n   c   3-ClC6H4    82b
  g   d   3-(CF3)C6H4    80 
  p   e   4-(OCF3)C6H4    78 
  e   f   4-MeC6H4    86 
  h   g   4-(MeO)C6H4    92 
                                   a Yields of isolated products,b Pd(PPh3)2Cl2 was used. 
   The structures of all products were confirmed by spectroscopic methods. The structure of 15d
was independently confirmed by X-ray crystal structure analysis 60 (Figure 13).The aryl group 
and the indenone moiety is twisted out of plane. 

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Figure 13: Molecular structure of compound 15d
     2,3-Diaryl-5-bromo-1H-inden-1-one 16a-g was prepared by reaction of 13 with (2.0 equiv.) 
of arylboronic acids 3b,c,o,j,g,h,f in (75-88%) yields (Scheme 12, Table 11). The best yields 
were obtained using exactly (2.0 equiv.) of the arylboronic acids, Pd(PPh3)4 (5 mol %) as 
catalyst, K3PO4 (3.0 equiv.) as base with 1,4-dioxane at 60°C for 6 h. The reactions were 
successful for both electron-rich and poor arylboronic acids (Table 11) and the structures of all 
products were confirmed by spectroscopic methods. 
Scheme 12: Synthesis of 16a-g. Conditions: i, ArB(OH)2 3b,c,o,j,g,h,f (2.0 equiv.), Pd(PPh3)4 (5 
mol %), K3PO4 (3.0 equiv.), 1,4-dioxane, 60°C, 6 h. 


Table 11: Synthesis of 5-bromo-2,3-diaryl-indenone 16a-g 
  3   16        Ar % (16) a
  b    a 4-EtC6H4     88 
  c    b 4-tBuC6H4     83 
  o    c 3-(MeO)C6H4     75 
  j    d 4-FC6H4     78 
  g    e 3-(CF3)C6H4     77 
  h    f 4-(MeO)C6H4     85 
  f    g 4-ClC6H4     87 
                                          a Yields of isolated products. 
       
     The structure of 16g was independently confirmed by X-ray crystal structure analysis (Figure 
14). The aryl groups and the indenone moiety are twisted out of plane.     
Figure 14: Molecular structure of compound 16g

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   The one-pot synthesis reaction of 13 with two different arylboronic acids, which were 
sequentially added, afforded the unsymmetrical 2,3-diaryl-5-bromo-1H-inden-1-ones 17a-c
containing two different aryl groups (Scheme 13, Table 12). To achieve a good site-selectivity in 
favour of position 3 of the substrate, it was proved that the first coupling step should carried out 
at 45°C for 9 h and the second step at 60°C for 6 h. 
  
Scheme 13: Synthesis of 17a-c. Conditions:1) Ar1B(OH)2 3b,f,f (1.0 equiv.), Pd(PPh3)4 (5 
mol%), K3PO4 (3.0 equiv.), 1,4-dioxane, 45°C'$% 2) Ar2B(OH)2 3h,b,h (1.0 equiv.), 60°C, 6 h. 
Table 12: Synthesis of 17a-c 
       
                                             a Yields of isolated products. 
   The one-pot reaction was carried out in one step without isolating the first cross-coupling 
product. The second boronic acids 3h,b,h was added after a period of 9 h for the first coupling 
reaction (which was done at 45°C) to ensure full conversion of the starting material of the first 
coupling product. The reaction was carried out in very good yields (79-82%) and excellent site-
selectivity. 
   The synthesis of the 2,3,5 triaryl-1H-inden-1-ones containing two different arylboronic acids 
were studied also and afforded 18a-c. The reaction of 15g with (2.2 equiv.) of 3c afforded 18a in 
(78%) yield (Scheme 14, Table). The one-pot reaction of 13 with (1.0 equiv.) of 3f and with (2.2 
  3   17       Ar1          Ar2 % (17)a
b , h      a  4-EtC6H4  4-(MeO)C6H4    80 
f , b    b  4-ClC6H4  4-EtC6H4    79 
f , h      c  4-ClC6H4  4-(MeO)C6H4    82 

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equiv.) of 3b afforded 18b in (81%) yield. Compound 18c was prepared in very good overall 
yield (84%) (Scheme 14, Table 13).  
   During the synthesis of 18a-c as a one-pot reaction (sequential addition), the temperature and 
the stoichiometry again played an important role. 
Scheme 14: Synthesis of 18a-c. Conditions: i, Ar1B(OH)2 3f,f (1.0 equiv.), Pd(PPh3)4 (5 mol%), 
K3PO4 (4.5 equiv.), 1,4-dioxane, 45°C, 9 h, : ii, Ar2B (OH)2 3b,h (2.2 equiv.), 60°C, 6 h, : iii, 
Ar2B(OH)2 3c (2.2 equiv.), Pd(PPh3)4 (5 mol%), K2CO3 (2 M, 1 mL), 1,4-dioxane, 70°C, 6 h. 
Table 13: Synthesis of 18a-c
   3  18         Ar1         Ar2 % (18)a
h , c  a  4-(MeO)C6H4  4-tBuC6H4   78b
f , b  b  4-ClC6H4  4-EtC6H4   81c
f , h    c  4-ClC6H4  4-(MeO)C6H4   84c
                            a Yields of isolated products, b Yields based on 15g, c Overall yield based on 13.

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      The reaction of 16d with (1.1 equiv.) of 3o afforded 19a in (88%) yield (Scheme 15, Table 
14). The one-pot synthesis reaction (sequential addition) of 13 with (2.2 equiv.) of 3q and with 
(1.1 equiv.) of 3h afforded 19b in (86 %) yield.  
Scheme 15: Synthesis of 19a,b. Conditions: i, Ar1B(OH)2 3q (2.0 equiv.), Pd(PPh3)4 (5 mol%), 
K3PO4 (4.5 equiv.), 1,4-dioxane, 60°C, 6 h: ii, Ar2B(OH)2 3h (1.1 equiv.), 70°C, 6 h: iii, 16d (1.0 
equiv.), Ar2B(OH)2 3o (1.1 equiv.), Pd(PPh3)4 (3 mol%), K2CO3 (2 M, 1 mL), 1,4-dioxane, 70°C, 
6 h. 
Table 14: Synthesis of 19a, 19b 
  3  19       Ar1         Ar2  %(19)a
j , o   a 4-FC6H4 3-(MeO)C6H4     88b
q , h   b 4-(CF3)C6H4 4-(MeO)C6H4     86c
                                                    a Yields of isolated products, b Yield based on 16d, 
                                   c Overall yield for one-pot synthesis based on 13. 
     During the optimization of the one-pot synthesis of compounds 19a, 19b, the temperature was 
60°C for the first cross-coupling step and was then increased to 70°C for the second step. The 
stoichiometry (2.0 equiv. for the first step and 1.1 equiv. for the second step) proved to be 
important. The structure of 19b was independently confirmed by X-ray crystal structure analysis 
60 (Figure 15).  Two of the three aryl groups of 19b are twisted out of plane.


  
Figure 15: Molecular structure of compound 19b
    The development of a site-selective one-pot process, which sequentially introduces three 
different aryl groups in one step, failed. However, the synthesis of such molecules can be 
realized by reaction of 2,3-diaryl-5-bromoinden-1-ones 17a-c with arylboronic acids. 
    The order of the reactivity of the three different positions of 2,3,5-tribromoinden-1-one is    C-
3 > C-2 > C-5. The site-selectivity can be explained by the fact that carbon atom C-3 is 
considerable more electron-deficient than positions 2 and 5. The second attack occurred at 
carbon atom C-2 which is sterically more hindered than position 5 and electronically less 
deficient.  
     This result was surprising because it does not follow the rule suggested by Handy and Zhang 
for the prediction of the site-selectivity of palladium-catalyzed reactions of polyhalogenated 
substrates. For the prediction of the selectivity, the 1H NMR spectrum of the non-halogenated 
parent compounds is studied which reflects the electronic situation of the different positions. 
According to the rule of the authors, the first attack should occur at that position which has the 
higher chemical shift value of the respective proton. In case of the 1H NMR spectrum of inden-1-
one, which is the parent molecule of 2,3,5-tribromoinden-1-one 13, the chemical shift of proton 
5-H is significantly shifted downfield with regard to proton 2-H which is the most up-field 
resonating proton of the molecule. In contrast, proton 3-H resonates most downfield of all 
protons of inden-1-one. Therefore, the rule of Handy and Zhang correctly predicts the selectivity 
in favour of position 3, but not the selectivity in favour of position 2 (with respect to position 5). 
The selectivity in favour of position 5 might be explained by chelation of the catalyst to the 
carbonyl oxygen atom which may enhance the rate in favour of position 2 (Figure 16). 
	

Figure 16: Possible explanation for the site-selectivity of the reactions of 13
   
                                        
3.2 Conclusion   
                I have studied the site-selective Suzuki-Miyaura cross-coupling reactions of 2,3,5-tribromo-
1H-inden-1-one, a novel brominated indenone derivative, which provide a convenient and site-
selective approach to various arylated inden-1-ones in good yields. The order of the selectivity is 
C-3 > C-2 > C-5. Carbon atom C-3 is the most electron deficient position; thus, the first attack 
takes place there. The selectivity in favor of position C-2 can be explained by chelation of the 
catalyst to the neighboring carbonyl group. 
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4.    Synthesis of Arylated 1-Methyl-1H-indoles by Suzuki-Miyaura Cross-
Coupling Reactions of 2,3,6-Tribromo-1-methyl-1H-indole. 
4.1 General Introduction        
     Alkaloids are groups of natural products containing nitrogen in a cyclic system and occur 
naturally in plants and other living organisms. These types of compounds nearly always contain 
their nitrogen as part of a heterocyclic system with few exceptions and are often complex in 
structure and usually show specific pharmacological activity. For example, some alkaloids show 
antifungal activity such as the aporphine alkaloid liriodenine which displays a broad activity 
spectrum against fungi, such as the yeast Candila albicans, Trichophyton mentagrophytes, and 
has high activity against phytopathogenic fungi61. 
    Many reviews have been written on indole and its derivatives62,63. A wide variety of naturally 
occurring, biologically active brominated indole alkaloids have been isolated from marine 
invertebrates, including bryozoans, coelenterates, sponges and tunicates. 2,3,6-Tribromo-1-
methyl-1H-indole has been isolated from red alga Laurencia brongniartii which possess anti-
bacterial and anti-fungal properties. In addition, the central importance of the indole derivatives 
in living organisms has inspired chemists to design and synthesize indole-containing 
compounds64. Arylated indoles are of considerable pharmacological relevance, due to their anti-
inflammatory, anti-arthritic and anti-pyretic properties65. For example 2,3-bis(4-
methoxyphenyl)indole ((indoxole() has been shown to possess a stronger anti-inflammatory 
activity than common drugs, such as aspirin and indomethacin66 . Based on these findings, novel 
COX-2 inhibitors for the treatment of arthritic pain have recently been developed 67. 
    Many methods for the synthesis of N-methylarylindoles, for example the Fisher indole 
synthesis, is the best known and most widely used method. The Ullman-type coupling 
methodology, involving the combination of an indole with an aryl halide in the presence of base 
and a copper catalyst at high temperatures, is an important alternative. Methods that operate 
under milder conditions and utilize aryl bismuth and aryl lead reagents have been developed. 
While all of these methods are useful in their own right, each of them suffers from one or more 
limitations including a lack of generality, the use stoichiometric quantities of toxic reagents, or 
the need to employ harsh reaction conditions68.
     In recent years, a number of site-selective palladium(0)-catalyzed cross-coupling reactions of 
polyhalogenated heterocycles have been developed 69. The site-selectivity of these reactions is 

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generally influenced by electronic and steric parameters. Recently, Langer and coworkers 
reported the synthesis of different aryl-substituted compounds using polyhalogenated substrates 
and also reported the site-selective Suzuki-Miyaura cross-coupling reactions of 2,3-dibromo-1-
methyl-1H-indole19a-h. 
    A number of Suzuki-Miyaura reactions of mono-halogenated indoles have been reported70.
Ohta et al. studied the site-selective Suzuki-Miyaura reactions of N-TBDS-3,6-dibromoindole71.
The first attack occurred at carbon atom C-6. Gribble and Liu reported the synthesis of 
symmetrical N-phenylsulfonyl-2,3-diarylindoles by twofold Suzuki-Miyaura reactions of 2,3-
dihalo-N-(phenylsulfonyl)indoles72. The reactions were carried out using Pd(OAc)2/P(o-Tol)3
and K2CO3 in acetone/H2O (2:1) or DMF (70°C).  
    The Suzuki-Miyaura reactions of N-sulfonyl- and N-acyl-2,3,4,5-tetrabromopyrrole and of 
unprotected 2,3,4,5-tetrabromopyrrole gave unsatisfactory results (with regard to yield and site-
selectivity). In contrast, the reactions of N-methyl-2,3,4,5-tetrabromopyrrole proceeded in good 
yields and with excellent site-selectivity. The synthesis of 2,3,6-triaryl-1-methyl-1H-indoles by 
Suzuki-Miyaura cross-coupling reactions have, to the best of our knowledge, not been reported 
before. The reactions indeed proceed in very good yields and excellent site-selectivity. 
Results and Discussion: 
   2,3,6-Tribromo-1-methyl-1H-indole 21 was prepared in (70%) yield using a known procedure, 
27b from commercially available 1-methyl-1H-indole 20 with NBS (3.4 equiv.) (Scheme16). 
Scheme 16:Bromination of 1-methyl-1H-indole 20, Reagents and conditions: i, THF, NBS (3.4 
equiv.), -78°C  20°C, 14 h.
     The Pd(0)-catalyzed Suzuki-Miyaura cross-coupling reaction of 2,3,6-tribromo-1-methyl-1H-
indole 21 with (3.4 equiv.) of arylboronic acids 3h,c,b,e,f,n,j,q,g afforded the 2,3,6-triaryl-1-
methyl-1H-indole 22a-i in (78-87%) yields (Scheme 17, Table 15). The best yields were 

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obtained using Pd(PPh3)4 (5 mol%) as a catalyst, K2CO3 (2 M, 1 mL) as base and 1,4-dioxane at 
110°C for 8 h. 

Scheme 17:Synthesis of 22a-i. Reagents and conditions: i, 21 (1.0 equiv.), 3h,c,b,e,f,n,j,q,g
(3.4 equiv.), Pd(PPh3)4 (5 mol%), K2CO3 (2 M, 1 mL), 1,4-dioxane, 110°C, 8 h. 
Table 15: Synthesis of 2,3,6-triaryl-1-methyl-1H-indole 22a-i
                                       
    
                                             a Yields of isolated products. 
    Different types of arylboronic acid having both electron-donating and withdrawing groups 
were used in the reaction (Table 15). The structures of all products were confirmed by 
spectroscopic methods. 
     Products 22c, 22g were selected for optimization studies (Table 16). Compound 22c is 
derived from an electron-rich arylboronic acid, while 22g is derived from an electron-poor 
arylboronic acid. The best yields were obtained when the reactions were carried out at 110°C for 
8 h. the use of 1,4-dioxane as solvent gave the best results; the employment of an aqueous 
  3   22          Ar % (22) a
  h   a   4-(MeO)C6H4       87 
  c   b   4-tBuC6H4       85 
  b   c   4-EtC6H4       82 
  e   d   4-MeC6H4       87 
  f   e   4-ClC6H4       85 
  n   f   3-ClC6H4       80 
  j   g   4-FC6H4       84 
  q   h   4-(CF3)C6H4       82 
  g  i   3-(CF3)C6H4       78 

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solution of potassium carbonate gave better yields than the use of potassium phosphate as base. 
The use of Pd(PPh3)4 (5 mol%) gave higher yields than Pd(PPh)3Cl2 or Pd(OAc)2 (3 mol%), 
(Cy)3P or SPhos (6 mol%) as a catalyst. 
Table 16: Optimization table for synthesis of 22c, 22g
                         a Yields of isolated products.,all reactions were carried out in dioxane(110°C, 8h). 
     2,6-Diaryl-3-bromo-1-methyl-1H-indoles 23a-e was prepared by reaction of 21 with 
arylboronic acids 3h,b,e,f,j (2.1 equiv.) The reaction was carried out in good yields (73-83%) 
and excellent site-selectivity (Scheme 18, Table 17). The first attack occurred at carbon atom C-2 
and C-6, while position 3 remained free. The reactions were best carried out at 90°C using 
exactly (2.1 equiv.) of the boronic acid and (5 mol%) of Pd(PPh3)4 as a catalyst. Both electron 
donating and withdrawing groups were examined in this reaction. K3PO4 (3.0 equiv.) was used 
as a suitable base in this case instead of K2CO3. 
Scheme 18: Synthesis of 23a-e. Reagents and conditions: i, 21(1.0 equiv.), 3h,b,e,f,j (2.1 
equiv.), Pd(PPh3)4 (5 mol%), K3PO4 (3.0 equiv.), 1,4-dioxane, 90°C, 8 h. 
Entry                         Conditions %(22c)a %(22g)a
  1 Pd(PPh)3Cl2 (5mol%),aq. K2CO3 (2 M)                             55     48 
  2 Pd(PPh)3Cl2 (5mol%), K3PO4 (4.5 equiv.)     52     40 
  3 Pd(PPh3)4 (5mol%),aq. K2CO3 (2 M)     82     84 
  4 Pd(PPh3)4 (5mol%), K3PO4 (4.5 equiv.)     65     53 
  5 Pd(OAc)2(3mol%), SPhos (6mol%),aq.K2CO3 (2 M)     75     71 
  6 Pd(OAc)2(3mol%), (Cy)3P (6mol%),aq.K2CO3 (2 M)     63     52 
  7 Pd(OAc)2 (3mol%), (Cy)3P (6mol%), K3PO4 (4.5 
equiv.) 
    53     48 

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Table 17: Synthesis of 23a-e
  
                                                                       a Yields of isolated products. 
   The structures of compound 23a (Figure 17) and compound 23b (Figure 18) were 
independently confirmed by X-ray crystal structure analysis. Both aryl groups and the indole 
moiety are twisted out of plane.
Figure 17:  Molecular structure of compound 23a
        
         Figure 18: Molecular structure of compound 23b
  3   23        Ar %(23)a
   h   a 4-(MeO)C6H4     83 
   b   b 4-EtC6H4     79 
   e   c 4-MeC6H4     73 
   f   d 4-ClC6H4     80 
   j   e 4-FC6H4     83 


    The Suzuki-Miyaura cross-coupling reaction of 21 with arylboronic acids 3c,b,e,f (1.1 equiv.) 
afforded the 2-aryl-3,6-dibromo-1-methyl-1H-indole 24a-d in (77-84%) yields and with a very 
good site-selectivity (Scheme 19, Table 18).  
Scheme 19:Synthesis of 24a-d. Reagents and conditions: i, 21(1.0 equiv.), 3c,b,e,f (1.1 equiv.), 
Pd(PPh3)4 (3 mol%), K3PO4 (1.5 equiv.), toluene/1,4-dioxane (4:1), 65°C, 8h. 
     The reactions were carried out using Pd(PPh3)4 (3 mol%) as the suitable catalyst. It is 
important to carry out the reactions at 65°C instead of 90°C.  
Table 18: Synthesis of 24a-d
                                                                   a Yields of isolated products. 
      Compounds 24a, 24d were selected for optimization studies (Table 19). 24a is derived from 
an electron-rich arylboronic acid, while 24d is derived from an electron-poor arylboronic acid. 
During the optimization, we have found that the best yields were obtained when the reactions 
were carried out at 65°C. Significant amounts of side-products, derived from multi-fold 
coupling, were formed when the temperature was higher than 65°C. A solvent mixture of
toluene/1,4-dioxane (4:1), K3PO4 (1.5 equiv.) as base, and Pd(PPh3)4 (3 mol%) as a catalyst were 
used. The structures of all products were confirmed by spectroscopic methods.  
  3   24        Ar % (24)a
  c   a  4-tBuC6H4     84 
  b   b  4-EtC6H4     83 
  e   c  4- MeC6H4     77 
  f   d  4-ClC6H4     79 

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Table 19: Optimization table for the synthesis of 24a, 24d
Entry     solvent       base         ligand Temp.°C   % (24a)a   % (24d)a
  1 dioxane 2 M K2CO3 (PPh3)4Pd 70 °C  mixture mixture 
  2 dioxane 2 M K2CO3 Cy3P, Pd(OAc)2 70 °C mixture mixture 
  3 dioxane 2 M K2CO3 SPhos, Pd(OAc)2 70 °C mixture mixture 
  4 dioxane 2 M K2CO3 (PPh3)2PdCl2 70 °C mixture mixture 
  5 dioxane 1.5eq. K3PO4 (PPh3)4Pd 65 °C mixture mixture 
  6 dioxane 1.5eq. K3PO4 Cy3P, Pd(OAc)2 65 °C mixture mixture 
  7 toluene 2 M K2CO3 (PPh3)4Pd 65°C No 
reaction 
No reaction 
  8 toluene 2 M K2CO3 (PPh3)4Pd 70 °C No 
reaction 
No reaction 
  9 dioxane/ toluene 
(1:1) 
2 M K2CO3 (PPh3)4Pd 65 °C mixture mixture 
 10 dioxane/ toluene 
(4:1) 
1.5eq. K3PO4 (PPh3)4Pd 65 °C 30% 25% 
 11 dioxane/ toluene 
(1:4) 
1.5eq. K3PO4 (PPh3)4Pd 65 °C 84a% 79a% 
                    a Yields of isolated products. 
  
    The structure of compound 24b was independently confirmed by 2D-NMR experiments. In 
the HMBC spectrum, the aromatic proton of the attached boronic acid at C-2' showed a strong 
coupling with C-2 of the indole ring. The same is true also with the proton at C-6'.This 
confirmed that the first attack of boronic acid 3b occurred at carbon atom C-2 of the 
tribromoindole. 

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Figure 19: 2D-NMR correlations of the compound 24b
    Unsymmetrical 2,3,6-triaryl-1-methyl-1H-indoles 25a-d were prepared by site-selective 
Suzuki cross-coupling reactions. A one-pot synthesis was carried out for product 25a. The first 
cross-coupling reaction happened by reaction of 21 with (1.1 equiv.) of 3j at 65°C )#$%K3PO4
(1.5 equiv.) as a base, a mixture of solvents toluene/ 1,4-dioxane (4:1), and Pd(PPh3)4 (5 mol%) 
as catalyst were used. Then, 3c was added (2.1 equiv.) for the second cross-coupling reaction 
which afforded product 25a in good yield (74%) containing two different aryl groups. Based on 
our finding for the synthesis of 24a-d, compounds 25b-d was synthesized in two steps. After 
isolating the first product of the first cross-coupling step, the second boronic acid was added for 
the second catalysed cross-coupling reaction. 
    Products 25b-d were isolated in good yields (72-82%) (Scheme 20, Table 20). To achieve a 
good site-selectivity in favour of position 2 of the substrate, it is important that the first step is
carried out at 65°C for 8 h and the second step at 90°C for the period of 8 h. In both steps 
Pd(PPh3)4 was used as a catalyst. Both electron-donating and withdrawing groups were examined 
for the synthesis of compounds 25a-d. 
Scheme 20:Synthesis of 25a-d. Reagents and conditions: i, 1) Ar1B(OH)2 3j,c,f,c (1.1 equiv.) , 
Pd(PPh3)4 (5 mol%), K3PO4 (1.5 equiv.), toluene/1,4-dioxane (4:1), 65°C, 8 h, 2) Ar2B(OH)2
3c,h,h,a (2.1 equiv.), K2CO3 (2 M, 1 mL), 1,4-dioxane, 90°C, 8h. 

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Table 20: Synthesis of 25a-d 
                                                  a Yields of isolated products, b,d Yields based on 24a,24d
                               c Yields based on 21 as one-pot reaction. 
    The order of reactivity of the three different positions of 2,3,6-tribromo-1-methyl-1H-indole is 
C-2 > C-6 > C3. The first attack was happened at carbon atom C-2. The site-selectivity can be 
explained by the fact that carbon atom C-2 is considerable more electron-deficient than positions 
3 and 6. The second attack occurred at position 6 which is sterically less hindered than position 3 
and electronically less deficient than position 2. Carbon atom C-3 is more hindered and more 
electron-deficient than C-6. 
Figure 20: Possible explanation for the site-selectivity of the reactions of 21
  3 25            Ar1          Ar1  %(25)a
j , c   a  4-FC6H4 4-tBuC6H4    74c
c , h   b  4-tBuC6H4 4-(OMe)C6H4    81b
f , h   c  4-ClC6H4 4-(OMe)C6H4    82d
c , a   d  4-tBuC6H4 2-(OMe)C6H4    72b
	

4.2 Conclusion  
             Pd(0)-catalyzed site-selective Suzuki-Miyaura cross-coupling reactions of 2,3,6-tribromo-1-
methyl-1H-indole afforded various arylated indoles in high yield and excellent site-selectivity. 
The site-selectivity can be explained according to electronic and steric reasons. The order of the 
selectivity is C-2 > C-6 > C-3. Carbon atom C-2 is the most electron-deficient and it was the first 
position attacked. 
. 
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5. Synthesis of Functionalized Anthraquinones by Domino Twofold Heck-6π-
Electrocyclization Reactions of 2,3-Dibromonaphthaquinone. 
5.1   General Introduction  
     Anthraquinones or anthracene-9,10-diones are essential chemical constituents of fungi, 
lichens and higher plants which possess a broad spectrum of biological activities including 
antibacterial, anti-inflammatory, and antiviral properties73a,b. For example, the anthracyclines 
constitute an important class of antitumor agents and antibiotics, which include several 
prominent compounds such as daunorubicin, adriamycin and aclarubicin74. 
      Most naturally occurring anthracyclines are isolated in O-glycosylated form, but some of 
them, such as saintopin, are found as aglycons70. Simple hydroxylated anthraquinones (such as 
chrysophanic acid, vismiaquinone, anthragallol, questin, and several others) are also widely 
distributed in nature76a,b. While most of them are found as aglycons, some derivatives, such as 
pulmatin, occur in O-glycosylated form77. 
Anthraquinone derivatives show a very good antitumor activity against cancer cells78. On the 
other hand, anthraquinones are widely used as antihelminthic as well as inhibitor agents79. Many 
applications of aryl-substituted anthraquinones exist in material sciences, due to their redox, UV 
and luminescence properties80a-d. They have been also used as stabilizers of light-modulating 
fluids. Anthraquinones provide the basis of several natural dyes as well81. 
     Current methods for the synthesis of anthraquinones are based on regioselective annulation 
reactions, such as Diels-Alder cycloadditions of naphthaquinones, reactions of lithiated species 
with suitable electrophiles, and Friedel-Craft condensations82. 
     Palladium-catalyzed coupling reactions of Heck type is the most versatile method for C-C 
bond formation83. Application of the Heck reaction in the synthesis of natural and non-natural 
products is well reviewed by de Meijere and Meyer84. Extensive methodological refinements 
over the last decade, particularly with regard to solvents, catalysts and additives, have greatly 
improved the synthetic efficiacy of these reactions, as a result of which they are now finding 
almost routine use in complex organic synthesis. Polyhalogenated molecules represent 
interesting substrates in Pd(0)-catalyzed cross-coupling reactions69. In this chapter, I show my 
results related to the synthesis of functionalized anthraquinones by domino85 twofold Heck-6π-
electrocyclization reactions of 2,3-dibromonaphthoquinone. 
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
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Results and Discussion:
     Different types of acrylates and styrenes 27a-j with both electron-donating and withdrawing 
groups were used in this study. The Heck reaction of 2,3-dibromonaphthoquinone 26 with 27a
(2.5 equiv.) afforded 28a in 76% yield (Scheme 21, Table 21). The formation of 28a can be 
explained by twofold Heck reaction (intermediate A) and subsequent 6π-electrocyclization to 
give intermediate B. Dehydrogenation of the latter afforded 28a. The best yields were obtained 
when the reactions were carried out using Pd(OAc)2 (5 mol%) and the biaryl mono-phosphine 
ligand XPhos (10 mol%), which was recently developed by Buchwald and co-workers 18 (Figure 
21).  
  
Scheme 21: Synthesis of 28a-j and 29a-j. Conditions: i, method 1) Pd(OAc)2 (5 mol%), XPhos 
(10 mol%), NEt3 (8.0 equiv.), DMF, 90°#$% method 2) ii, Pd(OAc)2 (5 mol%), XPhos (10 
mol%), NEt3 (8.0 equiv.), DMF, 110°C, 8 h. 
   The reaction was carried out in DMF at 90°C for 8 hours (method 1). The temperature played 
an important role in these reactions. The yields significantly decreased when the temperature was 
increased. A clean reaction was observed when it was carried out at 90°C.  
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    Compound 29a was isolated as a separable mixture in 44% yield following method 2 (110°C). 
Decomposition was observed when the reaction was carried out at temperatures higher than 
120°C. The formation of 29a, which contains only one alkyl group, can be explained by the fact 
that thermal conditions have an effect on the electrocyclization providing intermediate B.  
  
Figure 21: Biaryl mono-phosphine ligands developed by Buchwald and co-workers 
Table 21: Synthesis of 28a-j and 29a-j 
28,29              27         Method 1, 
     Yield of 28(%)a
       Method 2, 
Yields of 28and 29(%)a
   a      4-ClC6H4          76         Traces+44 
   b      3-ClC6H4          71            _b
   c      4-tBuC6H4          80            _b
   d      4-MeC6H4          78            _b
   e      4-FC6H4          72            _b
   f      4-tBuOC6H4          _b       Traces+59 
   g      CO2Et          79          25+37 
   h      CO2tBu          82          30+60 
   i     CO2iOctadecyl           _b       Traces+46 
   j     CO2EtMeO           _b        Traces+71 
                                     a Yields of isolated products. b Experiment was not carried out. 
   The Heck reaction of 2,3-dibromonaphthoquinone 26 with styrenes 27b-e afforded 28b-e in 
(71-80%) yields (method 1). When we have applied the reactions using method 2, compound 29f
was isolated in (59%) yield as a separable mixture; 27f was used as alkene for this reaction 
	
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(Scheme 1, Table 1). All products were confirmed by spectroscopic methods. The structure of 
compound 28c was confirmed independently by X-ray crystallography (Figure 22). 
           Figure 22: Molecular structure of compound 28c
                                                                                                                              
    The Pd(OAc)2 catalyzed reaction of 26 with acrylates 27g, 27h afforded anthraquinones 28g 
(79%), 28h (82%) following method 1. At higher temperature (110°C) and using method 2, a 
separable mixture of 28g,h and 29g,h was obtained, respectively (Scheme 21, Table 21). Educt 
27j afforded 29j in 71% yield. The product distribution was again dependent on the reaction 
temperature. All products have been confirmed by spectroscopic methods. 
    Compound 28g was used for the optimization of the conditions for this project (Table 22). We 
have found that di-substituted anthraquinones 28 were generally formed in good yields when the 
reaction was carried out at 90°C, while mono-substituted anthraquinones 29 were predominantly 
formed at 110°C as a separable mixture with 28. Pd(OAc)2 (5mol%) and XPhos (10 mol%) was 
used as an efficient catalyst for such type of reactions. The choice of the solvent also played an 
important role. No conversion was observed for non-polar solvents such as toluene. The 
successful employment of DMF can be explained by its polarity and high boiling point. 
	

Table 22: Optimization table for synthesis of 28g 
                   
                            
                         a Yields of isolated products,all reactions were carried out in DMF and NEt3 as a base, 
                 b Yield of isolated by-product 29g  
    
5.2 Conclusion   
               An efficient synthesis of functionalized anthraquinones by domino ‘twofold Heck-6π-
electrocyclization’ reactions of 2,3-dibromonaphthoquinone was studied. The products, which 
are not readily available by other methods, were formed in only one step under relatively mild 
conditions. The temperature played an important role during the optimization of the reaction 
conditions. 
Entry                  Catalyst Temp.°C (28g)a % 
   1 Pd(OAc)2 (5 mol%), P(Cy)3 (10 mol%)     90   40 
   2 Pd(PPh3)2Cl2 (5 mol%)     90   25 
   3 Pd(PPh3)4 (5 mol%)     90   30 
   4 Pd(OAc)2 (5 mol%), XPhos (10 mol%)     120  25+37b
   5 Pd(OAc)2 (5 mol%), XPhos (10 mol%)      90   79 
	
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6. Abstract 
     Due to the importance and wide-range applications of carbon-carbon bond forming reactions 
in organic synthesis, palladium(0)-catalyzed Suzuki cross-coupling reactions of 1,3- and 1,4- 
dihydroxy-9H-thioxanthen-9-one, 2,3,5-tribromoinden-1-one, 2,3,6-tribromo-1-methyl-1H-
indole and Heck reactions of 2,3-dibromonaphthaquinone were studied in my thesis. The Pd(0)-
catalyzed Suzuki cross-coupling reaction of the bis(triflates) of 1,3-dihydroxythioxanthones 
afforded 1,3-diarylthioxanthones in high yields and excellent site-selectivity. The site-selectivity 
was explained by steric-hindered effect, while electronic effect was responsible for the site-
selective Suzuki cross-coupling reaction of the bis(triflates) of 1,4-dihydroxythioxanthones. A 
wide scope of symmetrical and unsymmetrical aryl indenones and indoles from brominated 
substrates were synthesized using Pd(0)-catalyzed Suzuki cross-coupling reactions. Electronic 
and steric parameters again played an important role for the site-selectivity. An efficient 
synthesis of substituted anthraquinones by domino twofold Heck-6-electrocyclization reactions 
of 2,3-dibromonaphthaquinone was studied. The products were formed in only one step under 
relatively mild conditions. The temperature played an important effect during the optimization. 
In German
     Aufgrund der großen Bedeutung und breiten Anwendbarkeit von C-C-Knüpfungsreaktionen 
in der organischen Synthese wurden in meiner Dissertation Palladium(0)-katalysierte Suzuki-
Kreuzkupplungsreaktionen an 1,3- und 1,4-Dihydroxy-9H-thioxanthen-9-on, 2,3,5-
Tribrominden-1-on, 2,3,6-Tribrom-1-methyl-1H-indol sowie Heck-Reaktionen an 2,3-
Dibromnaphthochinon in großem Umfang untersucht. Die Palladium(0)-katalysierte Suzuki-
Kreuzkupplung an Bis(triflaten) von 1,3-Dihydroxythioxanthonen ergab 1,3-Diarylthioxanthone 
in hohen Ausbeuten und mit hoher Regioselektivität. Die Regioselektivität lässt sich in diesem 
Fall durch sterische Hinderung erklären, während sie bei Bis(triflaten) von 1,4-
Dihydroxythioxanthonen von elektronischen Effekten gesteuert wird.  
Darüber hinaus wurden mittels Palladium(0)-katalysierter Suzuki-Kreuzkupplungsreaktionen in 
großem Umfang symmetrisch und unsymmetrisch substituierte Arylindenone und -indole 
ausgehend von bromierten Ausgangsstoffen dargestellt. Auch hier spielten sterische und 
elektronische Einflüsse eine große Rolle hinsichtlich der Regioselektivität. 
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Außerdem wurde eine effiziente Synthese von substituierten Anthrachinonen durch eine 
zweifache Heck-6 / Electrocyclisierungsreaktion ausgehend von 2,3-Dibromnaphthochinon 
erschlossen. Die Produkte wurden in nur einem Schritt unter relativ milden Bedingungen 
gebildet. Dabei spielte die Temperatur eine entscheidende Rolle. 
	
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7.     Experimental Section 
7.1   General: Equipment, Chemicals and Work Technique 
     Reactions were carried out under inert atmosphere (Argon 4.6) in order to simultaneously 
exclude oxygen and water when appropriate. Pressure tubes were used to avoid condenser. 
Solvents for reactions were dried and distilled by standard methods or purchased from Merck, 
Aldrich, Acros Organics, and others whenever exclusion of water was desired. Solvents for 
liquid chromatography and extraction were always distilled prior to use and partly reused after 
fractional distillation (n-heptane, ethyl acetate).  
1H NMR Spectroscopy: 	+,!	+*-!!	+*-!!% = 0.00 ppm for 
./0.$12/3% 4 5 ! 660 ) 7.)3-d6;  = 7.26 ppm for (CDCl3% ! 660 )
DMSO-d; Characterization of the signal fragmentations: s = singlet, d = doublet, dd = double of 
doublet, t = triplet, q = quartet, m = multiplet, br = broadly. Spectra were evaluated according to 
first order rule. All coupling constants are indicated as (J). 
13C NMR Spectroscopy: 	+,!
 '8%	+,*-!!
98	+,
ARX 500, (125 MHz) Ref: 29.84 ± 0.01 ppm and 206.26 ± 0.13 ppm for (CD3)2CO. d = 128.00 
ppm for benzene-d6;  = 77.00 ppm for CDCl3. The multiplicity of the carbon atoms was 
determined by the DEPT 135 and APT technique (APT = Attached Proton Test) and quoted as 
CH3, CH2, CH and C for primary, secondary, tertiary and quaternary carbon atoms. 
Characterization of the signal fragmentations: quart = quartet the multiplicity of the signals was 
determined by the DEPT recording technology and/or the APT recording technology.
Mass Spectroscopy: AMD MS40, AMD 402 (AMD Intectra), Varian MAT CH 7, MAT 731. 
High Resolution mass spectroscopy: 33:/3');//3%	+<*
AMD 402 (AMD Intectra). 
	
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Infrared Spectroscopy (IR)  
Nicolet 205 FT-IR, Nicolet Protége 460 FT-IR. Peaks are given the following assignments: w = 
weak, m = medium, s = strong. 
  
Elemental Analysis  
LECO CHNS-932, Thermoquest Flash EA 1112. 
  
Melting Points  
Micro heating table HMK 67/1825 Kuestner (Büchi Apparatus), Leitz Labolux 12 Pol with 
heating table Mettler FP 90. Melting points are uncorrected. 
  
X-ray Structures 
Bruker X8Apex diffractometer with CCD camera (Mo K= radiation and graphite 
monochromator, > = 0.71073 Å). 
  
Column Chromatography: Chromatography was performed over Merck silica gel 60 (0,063 -
0,200 mm, 70 - 230 mesh) as normal and/or over mesh silica gel 60 (0,040 - 0,063 mm, 200 -400 
mesh) as Flash Chromatography. All solvent were distilled before use. 
Thin Layer Chromatography (TLC):  Merck DC finished foils silica gel 60 F 254 on 
aluminum foil and Macherey finished foils Alugram ® Sil G/UV254. Detection under UV light 
with 254 nm and/or 366 nm without dipping reagent, as well as with anisaldehyde sulfuric acid 
reagent (1 mL anisaldehyde consisting in 100 mL stock solution of 85% methanol, 14% acetic 
acid and 1% sulfuric acid). 
		
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7.2   General Procedures
Site-Selective Suzuki–Miyaura Reactions of the Bis(triflate) of 1,3-Dihydroxythioxanthone 
Synthesis of 9-oxo-9H-thioxanthene-1,3-diyl bis(trifluoro-methanesulfonate) (2): To a 
solution of 1 (0.34g, 1.39 mmol) in CH2Cl2(20 mL) was added 
Et3N (0.77 mL, 5.56 mmol), at 20°C under an argon atmosphere. 
After stirring for 10 min at -78°C, Tf2O (0.56 mL, 3.34 mmol) was 
added. The mixture was allowed to warm to 20°C and stirred for further 8 h. The reaction 
mixture was filtered and the filtrate was concentrated in vacuo. The residue was 
chromatographed without work up (flash silica gel, heptanes-EtOAc) and 2 was isolated as  a 
yellow solid (0.57 g, 80%), Mp.149-150°C. 1H NMR (300 MHz, CDCl3):  = 7.11(d, 1H, 
J = 2.37 Hz, ArH), 7.45-7.51(m, 3H, ArH), 7.58-7.65 (m, 1H, ArH), 8.50 (dd, 1H, J = 1.02, 
8.50 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):  = -72.3, -73.2. 13C NMR (62.9 MHz, CDCl3): 
 = 114.7 (CH), 118.6 (q, JF,C = 321.3 Hz, CF3), 118.7 (q, JF,C = 320.9 Hz, CF3), 118.9, 125.4, 
127.7 (CH), 129.9 (C), 130.3, 133.3 (CH), 134.3, 142.7, 149.9, 150.8 (C), 177.8 (CO). IR (KBr): 
v = 3081, 3030, 2958, 2923, 2851, 1728 (w), 1602, 1599, 1590 (m), 1554, 1465 (w), 1426 (s), 
1399 (m), 1317, 1295 (w), 1246 (m), 1198 (s), 1150 (m), 1133, 1099 (s), 1080 (m), 1033 (w), 
989, 929, 904, 884, 819, 807, 798 (m), 768 (w), 751, 714 (m), 684, 666, 655, 635 (w), 590, 569, 
542, 530 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 508 ([M+H]+, 100), 347 (28), 283 (62), 255 
(19). HRMS (EI, 70 eV): calcd for C15H6F6O7S3 [M]+,!9'9%)34,!9' #'!
General Procedure for Suzuki–Miyaura cross-coupling Reactions: A THF solution (4-5 mL), 
K3PO4 (1.5 equiv. per cross-coupling), Pd(PPh3)4 (5 mol% per cross-coupling) and arylboronic 
acid 3 (1.1 equiv. per cross-coupling) was stirred at 60-90°C for 8 h. After cooling to 20°C, 
distilled H2O was added. The organic and the aqueous layers were separated and the latter was 
extracted with CH2Cl2. The combined organic layers were dried (Na2SO4), filtered and the 
filtrate was concentrated in vacuo. The residue was purified by column chromatography (flash 
silica gel, heptanes-EtOAc). 
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Synthesis of 1,3-diarylthioxanthones 4a-g: 
1,3-Bis(2-methoxyphenyl)-9H-thioxanthen-9-one (4a): Starting with 2 (100 mg, 0.197 mmol), 
2-methoxyphenylboronic acid 3a (72 mg, 0.47 mmol), Pd (PPh3)4
(23 mg, 10  mol %), K3PO4 (125 mg, 0.59 mmol) and 1,4-dioxane (5 
mL), 4a was isolated as a light 1)?2)4
90:'!@%reaction 
temperature: 90°C for 8 h. Mp.163-165°C. 1H NMR (300 MHz, 
CDCl3):  = 3.72 (s, 3H, OCH3), 3.76 (s, 3H, OCH3), 6.87 (dd, 1H, 
J = 0.71, 8.19 Hz, ArH), 6.93 (d, 1H, J = 8.04 Hz, ArH), 6.97-7.02 (m, 2H, ArH), 7.19-7.36 (m, 
6H, ArH), 7.46 (d, 2H, J = 1.79 Hz, ArH), 7.68 (d, 1H, J = 1.77 Hz, ArH), 8.23 (dt, 1H, J = 0.96, 
8.01 Hz, ArH). 13C NMR (75.5 MHz, CDCl3):  = 55.5 (OCH3), 55.7 (OCH3), 110.3, 111.4, 
120.7, 121.0, 125.3, 125.9, 126.1 (CH), 127.0 (C), 128.4, 129.1, 129.4, 129.8, 130.9, 131.5 (CH), 
131.6 (C), 131.8 (CH), 132.7, 136.2, 137.1, 141.2, 141.5, 156.1, 156.3 (C), 181.0 (CO). IR 
(KBr): v = 3377, 3056, 2997, 2930, 2833, 2247 (w), 1640, 1587 (s), 1536 (w), 1492, 1460, 1434 
(s), 1485 (m), 1299, 1270 (m), 1238 (s), 1178, 1157, 1117 (m), 1074, 1057, 1047 (w), 1022 (s), 
963 (w), 924 (m), 906, 877, 851(w), 834 (m), 807, 785, 771 (w), 746, 736, 722 (s), 678, 666 (m), 
645, 615, 574, 552 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) = 423 ([M-H]+, 100), 394 (29), 377 
(39). HRMS (EI, 70 eV): calcd for C27H20O3S [M]+: 99%)34,9
1,3-Bis(4-ethylphenyl)-9H-thioxanthen-9-one (4b): Starting with 2 (100 mg, 0.197 mmol),                
4-ethylphenylboronic acid 3b (70 mg, 0.47 mmol), Pd(PPh3)4
(23 mg, 10 mol%), K3PO4 (125 mg, 0.59 mmol) and 1,4-dioxane 
(5 mL), 4b was isolated as a light 1)? 2)4 
 90:#@%
reaction temperature: 90°C for 8 h. Mp.179-181°C. 1H NMR 
(300 MHz, CDCl3):  =1.18 (t, 3H, J = 7.59 Hz, CH3), 1.21 (t, 
3H,  J = 7.59 Hz, CH3), 2.60 (q, 2H, J = 7.59 Hz, CH2), 2.67 (q, 
2H, J = 7.59 Hz, CH2), 7.17-7.22 (m, 6H, ArH), 7.26-7.32 (m, 1H, ArH), 7.40 (d, 1H, J = 1.86 
Hz, ArH), 7.40-7.46 (m, 2H, ArH), 7.50 (d, 2H, J = 8.25 Hz, ArH), 7.64 (d, 1H, J = 1.86 Hz, 
ArH), 8.26 (dd, 1H, J = 0.75, 8.49 Hz, ArH). 13C NMR (75.5 MHz, CDCl3):  = 15.3 (CH3), 15.5 
(CH3), 28.6 (CH2), 28.7 (CH2), 122.9, 125.2 (CH), 125.9 (C), 126.1, 127.3, 127.4, 127.9, 128.6, 
129.4, 129.8 (CH), 131.6 (C), 131.8 (CH), 135.9, 136.0, 138.9, 140.9, 142.6, 143.4, 145.1, 140.8 
(C), 180.7 (CO). IR (KBr): v = 3050, 3022, 2961, 2927, 2891, 2871, 2853 (w), 1644 (s), 1612 
(w), 1588 (s), 1556, 1537 (w), 1510 (m), 1469, 1455 (w), 1432 (m), 1380, 1316 (w), 1298 (s), 
1286 (m), 1231, 1184, 1162 (w), 1152, 1115, 1074 (m), 1051 (w), 1031 (m), 1017, 966 (w), 924 
	
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(m), 892, 875(w), 833 (m), 821 (s), 770 (w), 749, 720 (s), 672 (m), 659, 651, 640, 615, 591, 574, 
566 (w), 553 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 420 ([M]+, 53), 419 ([M-H]+, 100), 404 
(11). HRMS (EI, 70 eV): calcd for C29H23OS [M-H]+: ' %)34,'9'
1,3-Bis(4-(tert-butyl)phenyl)-9H-thioxanthen-9-one (4c): Starting with 2 (100 mg, 0.197 
mmol), 4-tert-butylphenylboronic acid 3c (84 mg, 0.47 mmol), 
Pd(PPh3)4 (23 mg, 10 mol%), K3PO4 (125 mg, 0.59 mmol) and
1,4-dioxane (5 mL), 4c was isolated as a light yellow solid (80 
0:# @%reaction temperature: 90°C for 8 h. Mp.123-125°C. 1H 
NMR (300 MHz, CDCl3):   = 1.28 (s, 9H, 3CH3), 1.33 (s, 9H, 
3CH3), 7.20 (d, 2H, 8.49 Hz, ArH), 7.28-7.33 (m, 1H, ArH), 
7.35-7.40 (m, 3H, ArH), 7.42-7.48 (m, 4H, ArH), 7.54 (d, 2H, J 
= 8.6 Hz, ArH), 7.66 (d, 1H, J = 1.89 Hz, ArH), 8.27 (d, 1H, J = 7.80 Hz, ArH). 13C NMR 
(62.9 MHz, CDCl3):  = 30.3 (CH3), 30.5 (CH3), 33.4, 33.5 (C), 121.9, 123.8, 124.2, 124.9, 
125.1 (CH), 125.6 (C), 126.0, 126.7, 128.6, 128.8 (CH), 130.6 (C), 130.7 (CH), 134.7, 134.9, 
137.9, 139.5, 142.3, 145.7, 148.3, 151.0 (C), 179.7 (CO). IR (KBr): v = 3389, 3051, 3030, 2952, 
2901, 2865 (w), 1638 (s), 1611 (w), 1588 (s), 1556, 1537 (w), 1511 (m), 1475 (w), 1461, 1434 
(m), 1416 (w), 1381, 1360 (m), 1317 (w), 1299 (s), 1267 (m), 1231, 1201 (w), 1157,1109 (m), 
1175,  1144, 1032, 1014, 961 (w), 924 (m), 890, 867 (w), 822,754 (s), 746 (m), 719 (s), 697, 
671, 671, 656, 646, 613 (w), 581 (s), 563, 549, 541 (w) cm−1. GC-MS (EI, 70 eV): m/z 
(%) = 476 ([M]+, 64), 475 ([M-H]+, 100), 462 (15), 461 (46). HRMS (ESI): calcd for C33H33OS 
[M+H]+: 999!%)34,99!
1,3-Bis(3,5-dimethylphenyl)-9H-thioxanthen-9-one (4d): Starting with 2 (100 mg, 0.197 
mmol), 3,5-dimethylphenylboronic acid 3d (71 mg, 0.47 mmol), 
Pd(PPh3)4 (23 mg, 10 mol%), K3PO4 (125 mg, 0.59 mmol) and 1,4-
dioxane (5 mL), 4d was isolated as a light yellow solid (64 mg, 
99@%reaction temperature: 90°C for 8 h. Mp.159-161°C. 1H NMR 
(300 MHz, CDCl3):   = 2.31 (s, 6H, 2CH3), 2.32 (s, 6H, 2CH3), 
6.88 (brs, 2H, ArH), 6.98 (d, 2H, J = 6.39 Hz, ArH), 7.22 (brs, 2H, 
ArH), 7.30-7.36 (m, 1H, ArH), 7.40 (d, 1H, J = 1.83 Hz, ArH), 7.48-7.49 (m, 2H, ArH ), 7.66 (d, 
1H, J = 1.86 Hz, ArH), 8.27 (d, 1H, J = 7.80 Hz, ArH). 13C NMR (62.9 MHz, CDCl3):  = 20.3 
(CH3), 20.5 (CH3), 122.1 (CH), 124.1 (C), 124.2, 124.7 (CH), 125.0 (C), 125.1, 127.6, 128.3, 
	

128.7, 129.3, 130.6, 130.7 (CH), 134.9, 136.2, 137.6, 137.7, 138.0, 142.5, 142.6, 145.8 (C), 
179.7 (CO). IR (KBr): v = 3269, 3004, 2914, 2854, 2729 (w), 1640 (s), 1601 (m), 1587 (s), 1540 
(m), 1503, 1494, 1468 (w), 1432 (m), 1398 (w), 1382, 1373 (m), 1332, 1315 (w), 1300 (s), 1279 
(m), 1245, 1204, 1185, 1168 (w), 1150 (m), 1137, 1117, 1100, 1080 (w), 1034 (m), 1011, 966, 
940 (w), 912, 889, 875 (m), 842 (s), 813, 806 (m), 769 (w), 752, 744, 719 (s), 703, 697, 692, 
672, 651, 643 (m), 603 (w), 591 (m), 569, 540 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) = 420 
([M]+, 54), 419 ([M-H]+, 100), 405 (39). HRMS (ESI): calcd for C29H25OS [M+H]+:  !%
found: 421.16300. 
1,3-Di-p-tolyl-9H-thioxanthen-9-one (4e): Starting with 2 (100 mg, 0.197 mmol),                        
4-methylphenylboronic acid 3e (64 mg, 0.47 mmol), Pd(PPh3)4
(23 mg, 10 mol%), K3PO4 (125 mg, 0.59 mmol) and 1,4-dioxane 
(5 mL), 4e was isolated as a :$. 1)? 2)4 
 0: #@%
reaction temperature: 90°C for 8 h. Mp.175-177°C. 1H NMR 
(300 MHz, CDCl3):   = 2.31(s, 3H, CH3), 2.36 (s, 3H, CH3), 
7.15-7.19 (m, 6H, ArH), 7.27-7.32 (m, 1H, ArH), 7.39 (d, 1H, 
J =1.89 Hz, ArH), 7.44 (d, 1H, J =1.17 Hz, ArH), 7.48 (d, 3H, J = 8.25 Hz, ArH ), 7.63 (d, 1H, 
J =1.89 Hz, ArH), 8.27 (dd, 1H, J = 0.78, 8.61 Hz, ArH). 13C NMR (75.5 MHz, CDCl3):  = 20.2 
(CH3), 20.4 (CH3), 121.9, 124.2 (CH), 124.9 (C), 125.1, 126.2, 126.8, 127.6, 128.2, 128.7, 128.8 
(CH), 130.5 (C), 130.7 (CH), 134.7, 134.9, 135.3, 137.8, 137.9, 139.7, 142.3, 145.7 (C), 179.7 
(CO). IR (KBr): v = 3044, 3022, 2952, 2919, 2857 (w), 1631 (s), 1613 (w), 1588 (s), 1556, 1537 
(w), 1511 (m), 1462 (w), 1433 (m), 1415, 1380, 1316, 1192 (w), 1256 (m), 1116, 1107, 1075 
(m), 1044 (w), 1031 (m), 1017 (w), 983, 961, 945 (w), 923 (s), 888, 877, 848, 837 (w), 811, 803 
(s), 787 (m), 768 (w), 757, 748 (s), 725, 717, 675 (m), 659, 649, 631, 612, 586 (w), 568, 536 (m) 
cm−1. GC-MS (EI, 70 eV): m/z (%) = 392 ([M]+, 49), 391 ([M-H]+, 100). HRMS (ESI): calcd for 
C27H21OS [M+H]+: '!#!%)34,'!'!
1,3-Bis(4-chlorophenyl)-9H-thioxanthen-9-one (4f): Starting with 2 (100 mg, 0.197 mmol), 4-
chloro phenylboronic acid 3f (73 mg, 0.47 mmol), Pd(PPh3)4 (23 
mg, 10 mol%), K3PO4 (125 mg, 0.59 mmol) and 1,4-dioxane (5 
mL), 4f was isolated as a :$.1)?2)4
 !0:9!@%reaction 
temperature: 90°C for 8 h. Mp.230-231°C. 1H NMR (300 MHz, 
CDCl3):  = 7.19 (d, 2H, J = 3.72 Hz, ArH), 7.31-7.39 (m, 6H, 










ArH), 7.46-7.54 (m, 4H, ArH), 7.66 (d, 1H, J = 1.66 Hz, ArH), 8.27 (d, 1H, J = 7.88 Hz, ArH). 
13C NMR (75.5 MHz, CDCl3):  = 122.6, 124.3 (CH), 125.1 (C), 125.4, 127.1, 127.6, 127.9, 
128.2, 128.3, 129.7 (CH), 130.2 (C), 131.1 (CH), 131.9, 134.2, 134.8, 135.9, 138.4, 140.8,  
141.3, 144.6 (C), 179.4 (CO). IR (KBr): v = 3064, 3041, 2920, 2851 (w), 1640, 1589 (s), 1537 
(w), 1490 (s), 1470 (w), 1434 (m), 1414, 1397, 1375 (w), 1317, 1298 (m), 1284, 1263, 1234, 
1186 (w), 1158 (m), 1107 (w), 1090 (s), 1076 (m), 1032, 1031 (w), 1012 (s), 926 (m), 892, 873, 
844 (w), 832 (m), 816, 806, 747 (s), 727, 713 (m), 693 (w), 680, 651 (m), 643, 626, 602 (w),  
567, 553 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 433 ([M+H]+, 44), 432 ([M]+, 27), 431 ([M-
H]+, 56), 199 (100), 181 (49), 165 (16). HRMS (EI, 70 eV): calcd for C25H14Cl2OS [M]+: 
! '%)34,!
                     
1,3-Bis(3-(trifluoromethyl)phenyl)-9H-thioxanthen-9-one (4g): Starting with 2 (100 mg, 
0.197 mmol), 3-(trifluoromethyl)phenylboronic acid 3g (89 mg, 
0.47 mmol), Pd(PPh3)4 (23 mg, 10 mol%), K3PO4 (125 mg, 0.59 
mmol) and 1,4-dioxane (5 mL), 4g was isolated as a light yellow 
2)4 
9 0: 9@% /7.on temperature: 90°C for 8 h. 
Mp.167-169°C. 1H NMR (300 MHz, CDCl3):  = 7.32-7.38 (m, 
2H, ArH), 7.42-7.54 (m, 6H, ArH), 7.56-7.62 (m, 1H, ArH), 7.58-7.59 (m, 1H, ArH), 7.73 (d, 
1H, J = 1.90 Hz, ArH), 7.77 (d, 1H, J = 7.68  Hz, ArH), 7.83 (brs, 1H, ArH), 8.22-8.26 (m, 1H, 
ArH). 19F NMR (282.4 MHz, CDCl3):  = -62.6, -62.3. 13C NMR (62.9 MHz, CDCl3):  = 122.7 
(q, JF,C = 3.7 Hz, CH), 122.9 (q, JF,C = 272.5 Hz, CF3), 123.2 (q, JF,C = 272.5 Hz, CF3),123.2 (q, 
JF,C = 3.9 Hz, CH), 123.3 (CH), 123.6 (q, JF,C = 3.9 Hz, CH), 124.4 (CH), 124.5 (q, JF,C = 
3.9 Hz, CH), 125.4 (C), 125.6, 127.2, 128.0, 128.6, 128.7 (CH), 129.5 (q, JF,C = 32.2 Hz, C-CF3), 
129.7 (CH), 130.1 (C), 130.3 (CH), 130.9 (q, JF,C = 32.5 Hz, C-CF3), 131.2 (CH), 134.7, 138.3, 
138.7, 141.2, 142.9, 144.4 (C), 179.3 (CO). IR (KBr): v = 3270, 3063, 2959, 2852 (w), 1641 (s), 
1615 (w), 1588 (s), 1547, 1496, 1486, 1462, 1455 (w), 1435 (m), 1380 (w), 1326, 1304 (s), 1268, 
1251, 1226 (m), 1195 (w), 1174 (m), 1154, 1112, 1095, 1069, 1052 (s), 1033, 1000, 961, 928, 
897, 887, 871, 859 (m), 797, 755 (s), 748 (m), 720, 698 (m), 686, 672, 654 (s), 627, 611, 562, 
542 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 500 ([M]+, 45), 499 ([M-H]+, 100), 356 (19), 277 
(07), 240 (08). HRMS (EI, 70 eV): calcd for C27H13F6OS [M-H]+, ''!##% )34,
499.058160. 



Synthesis of 3-Aryl-1-(trifluorosulfonyloxy)-thioxanthones 5a-h: 
3-(4-Methoxyphenyl)-9-oxo-9H-thioxanthen-1-yl trifluoromethanesulfonate (5a): Starting 
with 2 (100 mg, 0.197 mmol), 4-methoxyphenylboronic acid 
3h (33 mg, 0.22 mmol), Pd(PPh3)4 (11 mg, 5 mol%), K3PO4
(63 mg, 0.29 mmol) and THF (5 mL), 5a was isolated as a light
1)?2)4
#!0:#9@%/7.)3.06/., !")#$
Mp.186-188°C. 1H NMR (300 MHz, CDCl3):  = 3.81 (s, 3H, OCH3), 6.96 (d, 2H, J = 8.85 Hz, 
ArH), 7.33 (d, 1H, J = 1.10 Hz, ArH), 7.41-7.58 (m, 5H, ArH), 7.64 (d, 1H, J = 1.74 Hz, ArH), 
8.53 (dd, 1H, J = 1.10, 8.2 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):  = -73.4. 13C NMR 
(75.5 MHz, CDCl3):  = 55.5 (OCH3), 114.9 (CH), 118.9 (q, JF,C = 321.3 Hz, CF3), 119.1 (CH), 
120.3 (C), 123.4, 125.4, 126.9, 128.5 (CH), 129.2 (C), 130.1 (CH), 130.2 (C), 132.6 (CH), 135.3, 
141.0, 145.4, 150.4, 161.0 (C), 178.5 (CO). IR (KBr): v = 3082, 3063, 2841, 1651 (w), 1635, 
1594 (s), 1558 (w), 1523 (m), 1471, 1460 (w), 1435 (m), 1425 (s), 1404 (w), 1389 (m), 1328, 
1317, 1307 (w), 1286, 1256, 1242, 1219 (m), 1191 (s),1135, 1126, 1111(m), 1060 (w), 1030 (m), 
1007 (w), 958, 904, 889, 881 (m), 848 (w), 832 (s), 811, 799 (m), 782, 759 (w), 745 (s), 725 (w), 
712, 661, 653, 637 (m), 595 (s), 582, 567, 527 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 466 
([M]+, 100), 334 (13), 305 (44), 262 (17). HRMS (EI, 70 eV): calcd for C21H13F3O5S2 [M]+: 
  !!%)34,  !'
3-(4-Ethylphenyl)-9-oxo-9H-thioxanthen-1-yl trifluoromethanesulfonate  (5b): Starting with 
2 (100 mg, 0.197 mmol), 4-ethylphenylboronic acid 3b (32 mg, 
0.22 mmol), Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 0.29 
mmol) and THF (5 mL), 5b was isolated as a yellow solid (77 
mg, #@% reaction temperature: 60°C for 8 h. Mp.158-160°C 
(CH2Cl2/EtOH 1:1). 1H NMR (300 MHz, CDCl3):  = 1.21 (t, 3H, J =7.59 Hz, CH3), 2.65 (q, 2H, 
J =7.59 Hz, CH2), 7.27 (d, 2H, J = 8.32 Hz, ArH), 7.35 (d, 1H, J = 0.96 Hz, ArH), 7.38-7.44 (m, 
2H, ArH), 7.46 (d, 2H, J = 8.32 Hz, ArH), 7.50-7.56 (m, 1H, ArH), 7.66 (d, 1H, J = 1.74 Hz, 
ArH), 8.52 (dd, 1H, J = 1.05, 8.13 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):  = -73.4. 13C 
NMR (62.9 MHz, CDCl3):  = 14.4 (CH3), 27.6 (CH2), 117.4 (q, JF,C = 321.1 Hz, CF3), 118.4 
(CH), 120.4 (C), 122.9, 124.4, 125.9, 126.1, 127.9, 129.0 (CH), 129.1 (C), 131.6 (CH), 133.5, 
134.3, 139.9, 144.8, 145.3, 149.3 (C), 177.5 (CO). IR (KBr): v = 3052, 2960, 2929, 2871 (w), 
1641, 1602, 1589 (s), 1524 (m), 1454, 1444 (w), 1422 (s), 1386, 1316, 1303, 1240 (m), 1221, 
1186 (s), 1157 (w), 1134, 1123 (s), 1110 (m), 1080, 1060, 1033, 1018 (w), 955,  899 (s), 862 



(w), 839 (m), 811, 798 (s), 759 (w), 745 (s), 714 (m), 666, 659, 637 (w), 595, 577, 569 (s), 531 
(w) cm−1. GC-MS (EI, 70 eV): m/z (%) = 464 ([M]+, 100), 332 (14), 303 (39), 275 (17), 260 
(19). HRMS (EI, 70 eV): calcd for C22H15F3O4S2 [M]+, !#%)34, !'!
3-(4-(Tert-butyl)phenyl)-9-oxo-9H-thioxanthen-1-yl trifluoromethanesulfonate (5c): Starting 
with 2 (100 mg, 0.197 mmol), 4-tert-butyl phenylboronic acid 3c
(39 mg, 0.22 mmol), Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 
0.29 mmol) and THF (5 mL), 5c was isolated as a yellow solid 

90:9@%reaction temperature: 60°C for 8 h. Mp.170-172°C 
(CH2Cl2/EtOH 1:1). 1H NMR (300 MHz, CDCl3):  = 1.30 (s, 9H, 
3CH3), 7.36 (d, 1H, J = 0.90 Hz, ArH), 7.38-7.46 (m, 2H, ArH), 7.48-7.57 (m, 5H, ArH), 7.68 
(d, 1H, J = 1.68 Hz, ArH), 8.52 (dd, 1H, J =1.08, 8.10 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):
 = -73.4. 13C NMR (75.5 MHz, CDCl3):  = 31.2 (CH3), 31.9 (C), 118.9 (q, JF,C = 321.0 Hz, 
CF3), 119.5 (CH), 120.7 (C), 124.0, 125.4, 126.4, 126.9, 130.1 (CH), 130.2 (C), 132.7 (CH), 
134.1, 135.3, 141.0, 145.8, 150.4, 153.2 (C), 178.6 (CO). IR (KBr): v = 3087, 3050, 3022, 2966, 
2920, 2872, 2854 (w), 1630, 1602, 1589 (s), 1524 (m), 1480 (w), 1465, 1437 (m), 1424 (s), 1384 
(m), 1362, 1325 (w), 1305 (m), 1278 (w), 1241 (m), 1217, 1193 (s), 1171 (m), 1131, 1105 (s), 
1078, 1059, 1035, 1024, 1014 (w), 958, 903 (s), 890 (m), 829 (s), 810 (m), 801 (s), 760 (m), 753 
(s), 712 (m), 666, 658, 651, 637 (w), 588 (s), 568, 537, 529 (w) cm−1. GC-MS (EI, 70 eV): m/z 
(%) = 493 ([M+H]+, 17), 492 ([M]+, 59), 478 (28), 477 (100), 316 (36). HRMS (EI, 70 eV): 
calcd for C24H19F3O4S2 [M]+,'! 9%)34,'!  
3-(3,5-Dimethylphenyl)-9-oxo-9H-thioxanthen-1-yl trifluoromethanesulfonate (5d): Starting 
with 2 (100 mg, 0.197 mmol), 3,5-dimethylphenylboronic acid 3d
(33 mg, 0.22 mmol), Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 
0.29 mmol) and THF (5 mL), 5d was isolated as a yellow solid (75 
0: #@% reaction temperature: 60°C for 8 h. Mp.221-223°C. 1H 
NMR (300 MHz, CDCl3):  = 2.34 (s, 6H, 2CH3), 7.04 (brs, 1H, 
ArH), 7.14 (brs, 2H, ArH), 7.35 (d, 1H, J = 0.96 Hz, ArH), 7.39-7.48 (m, 2H, ArH), 7.52-7.58 
(m, 1H, ArH), 7.67 (d, 1H, J =1.71 Hz, ArH), 8.53 (dd, 1H, J =1.02, 7.68 Hz, ArH). 19F NMR 
(282.4 MHz, CDCl3):  = -73.4. 13C NMR (75.5 MHz, CDCl3):  = 20.4 (CH3), 117.9 (q, JF,C = 
321.1 Hz, CF3), 118.7 (CH), 119.7 (C), 123.3, 124.0, 124.4, 125.9, 129.1 (CH), 129.2 (C), 130.3, 
131.6 (CH), 134.3, 136.0, 138.1, 139.9, 145.2, 149.2 (C), 177.6 (CO). IR (KBr): v = 3152, 3115, 

 

 



3059, 2951, 2917, 2849 (w), 1631, 1601, 1588 (s), 1555 (w), 1534 (m), 1503, 1483 (w), 1427 (s), 
1408 (w), 1375, 1302 , 1248 (m), 1217, 1197, 1186, 1130 (s), 1081 (m) , 1031, 1004 (w), 964, 
911 (m), 894, 888 (s), 871 (m), 842, 813, 803 (s), 760 (w), 727 (w), 715, 686, 660 (m), 630 (w), 
609 (m), 589 (s), 568 (m), 545, 537 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) = 464 ([M]+, 100), 
303 (46), 275 (27). HRMS (EI, 70 eV): calcd for C22H15F3O4S2 [M]+,  !#% )34,
464.03623. 
9-Oxo-3-phenyl-9H-thioxanthen-1-yl trifluoromethanesulfonate (5e): Starting with 2 (100 
mg, 0.197 mmol), phenylboronic acid 3i (26 mg, 0.22 mmol), 
Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 0.29 mmol) and THF (5 
mL), 5e was isolated as a 1)? 2)4 
  0: 9@% reaction 
temperature: 60°C for 8 h. Mp.163-165°C. 1H NMR (300 MHz, 
CDCl3):  = 7.36 (d, 1H, J = 0.87 Hz, ArH), 7.39-7.47 (m, 5H, ArH), 7.50-7.56 (m, 3H, ArH), 
7.67 (d, 1H, J = 1.68 Hz, ArH), 8.50 (dd, 1H, J = 1.11, 8.16 Hz, ArH). 19F NMR (282.4 MHz, 
CDCl3):  = -73.3. 13C NMR (75.5 MHz, CDCl3):  = 118.9 (q, JF,C = 321.0 Hz, CF3), 119.6 
(CH), 120.9 (C), 124.3, 125.4, 127.0, 127.2, 129.4, 129.7, 130.0 (CH), 130.1 (C), 132.7 (CH), 
135.3, 137.0, 141.1, 145.8, 150.4 (C), 178.5 (CO). IR (KBr): v = 3083, 3062, 3023, 2917, 2848 
(w), 1635, 1606, 1588 (s), 1531 (m), 1506, 1463, 1448 (w), 1423 (s), 1404 (w), 1388 (m), 1345, 
1321 (w), 1306 (m), 1277 (w), 1242, 1218 (m), 1189 (s), 1169, 1157 (m), 1135, 1124, 1109 (s), 
1081, 1032 (m), 999 (w), 956, 902, 876 (s), 843 (w), 810, 802, 761, 748 (s), 716, 684, 673, 666 
(m), 622 (w), 637 (w), 597, 585 (s), 568 (m), 530 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) = 436 
([M]+, 100), 275 (49), 247 (48), 245 (16). HRMS (ESI): calcd for C20H12F3O4S2 [M+H]+: 
9!!%)34,9!#!
3-(4-Chlorophenyl)-9-oxo-9H-thioxanthen-1-yl trifluoromethanesulfonate (5f): Starting with 
2 (100 mg, 0.197 mmol), 4-chlorophenylboronic acid 3f (34 mg, 
0.22 mmol), Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 0.29 
mmol) and THF (5 mL), 5f was isolated as a yellow solid (72 
0: 9#@% reaction temperature: 60°C for 8 h. Mp.133-135°C. 
1H NMR (300 MHz, CDCl3):  = 7.34 (d, 1H, J = 0.80 Hz, ArH), 
7.42-7.51 (m, 6H, ArH), 7.57 (d, 1H, J = 8.25 Hz, ArH), 7.67 (d, 1H, J = 1.67 Hz, ArH), 8.45 
(dd, 1H, J = 1.01, 7.95 Hz, ArH). 19F NMR (282.4 MHz,CDCl3):  = -73.3. 13C NMR 
(75.5 MHz, CDCl3):  = 118.7 (q, JF,C = 321.1 Hz, CF3), 119.5 (CH), 121.1 (C), 124.2, 125.4, 
127.1, 128.5 (CH), 129.6 (C), 129.7, 130.2, 132.8 (CH), 135.2, 135.5, 136.1, 141.2, 144.5, 150.4 



(C), 178.5 (CO). IR (KBr): v = 3087, 3060, 3023, 2956, 2918, 2849 (w), 1714, 1673, 1668 (w), 
1639, 1606, 1590 (s), 1531 (w), 1503 (m), 1463, 1456 (w), 1426 (s), 1380 (m), 1319 (w), 1303 
(m), 1276, 1262 (w), 1242 (m), 1219, 1190 (s), 1167, 1159 (w), 1135, 1126 (s), 1112 (w), 1090 
(s), 1049, 1033 (w), 1010 (m), 955 (s), 928 (w), 902, 890 (s), 845 (w), 832 (m), 811, 799 (s), 760 
(m), 748 (s), 717, 712 (m), 692 (w), 666, 659, 654, 630 (m), 595, 586 (s), 567 (m), 558, 537 (w) 
cm−1. GC-MS (EI, 70 eV): m/z (%) = 470 ([M+H]+, 100), 338 (11), 311 (19), 310 (12), 309 (47), 
281 (41), 274 (12), 245 (22). HRMS (ESI): calcd for C20H11F3ClO4S2 [M+H]+, 9!'9!%
found: 470.97450. 
9-Oxo-3-(3-(trifluoromethyl)phenyl)-9H-thioxanthen-1-yl trifluoromethanesulfonate (5g):            
Starting with 2 (100 mg, 0.197 mmol), 3-
(trifluoromethyl)phenylboronic acid 3g (41 mg, 0.22 mmol), 
Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 0.29 mmol) and THF 
(5 mL), 5g ?/22)/.4/2/1)?2)4
#!0:#@%reaction 
temperature: 60°C for 8 h. Mp.176-177°C. 1H NMR (300 MHz, CDCl3):  = 7.35 (d, 1H, 
J = 1.14 Hz, ArH), 7.40-7.48 (m, 2H, ArH), 7.54-7.62 (m, 2H, ArH), 7.67-7.74 (m, 3H, ArH), 
7.77 (brs, 1H, ArH), 8.52 (dd, 1H, J = 1.11, 8.16 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):  = -
73.3, -62.7. 13C NMR (62.9 MHz, CDCl3):  = 118.9 (q, JF,C = 323.9 Hz, CF3), 119.7 (CH), 
121.4 (C), 123.7 (q, JF,C = 272.5 Hz, CF3), 124.0 (q, JF,C = 3.79 Hz, CH), 124.6, 125.4 (CH), 
126.3 (q, JF,C = 3.66 Hz, CH), 127.2, 130.0 (CH), 130.1 (C), 130.2, 130.6 (CH), 131.9 (q, JF,C = 
32.5 Hz, C-CF3), 132.9 (CH), 135.1, 137.9, 141.4, 144.2, 150.4 (C), 178.4 (CO). IR (KBr): v = 
3083, 3062, 3023, 2918, 2851 (w), 1630, 1609, 1589 (s), 1537, 1502, 1461 (w), 1424 (s), 1386 
(m), 1336 (s), 1303, 1267, 1240, 1224 (m), 1204 (s), 1166 (m), 1123 (s), 1078, 1066 (m), 1033, 
1000 (w), 963 (s), 906, 877 (m), 814, 801 (s), 777 (w), 761, 750 (m), 734 (w), 717, 661 (m), 685 
(s), 566, 657, 647, 633, 623 (w), 595 (s), 568 (m), 533 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) = 
503 ([M]+, 46), 375 (42),  311 (100), 283 (15), 242 (27), 214 (16), 186 (29), 158 (13). HRMS 
(EI, 70 eV): calcd for C21H10F6O4S2 [M]+,!'''%)34,!''#
3-(4-Fluorophenyl)-9-oxo-9H-thioxanthen-1-yl trifluoromethanesulfonate (5h): Starting with 
2 (100 mg, 0.197 mmol), 4-flourophenylboronic acid 3j (30 mg, 
0.22 mmol), Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 0.29 
mmol) and THF (5 mL), 5h was isolated as a yellow solid (71 mg, 
#!@% reaction temperature: 60°C for 8 h. Mp.179-181°C. 1H 



NMR (300 MHz, CDCl3):  = 7.13 (t, 2H, J = 8.52 Hz ArH), 7.30 (d, 1H, J = 1.02 Hz, ArH), 
7.38-7.45 (m, 2H, ArH), 7.49-7.58 (m, 3H, ArH), 7.63 (d, 1H, J = 1.74 Hz, ArH), 8.50 (dd, 1H, 
J = 0.90, 7.80 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):  = -111.1, -73.3. 13C NMR (75.5 MHz, 
CDCl3):  = 116.5 (d, JF,C = 21.9 Hz, CH), 118.9 (q, JF,C = 321.2 Hz, CF3), 119.5 (CH), 120.9 
(C), 124.1, 125.4, 127.0 (CH), 129.1 (d, JF,C = 8.46 Hz, CH), 130.1, 132.8 (CH), 133.1, 133.2, 
135.2, 141.2, 144.7, 150.4 (C), 163.8 (d, JF,C = 250.9 Hz, C-F), 178.8 (CO). IR (KBr): v = 3070, 
2953, 2921, 2851 (w), 1637(m), 1591 (s), 1531 (w), 1514 (m), 1488, 1435 (w),  1421 (s), 1383 
(m), 1321 (w), 1302 (m), 1281 (w), 1241(m), 1207, 1191 (s), 1163 (m), 1137, 1116 (s), 1079 (m) 
, 1034, 1014, 993 (w), 957, 903 (s), 876 (m), 854 (w), 838, 810, 792, 754, 741 (s), 715, 665, 659 
(m), 636 (w), 590 (s), 569 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 454 ([M]+, 100), 294 (10), 
293 (49), 265 (52), 263 (14). HRMS (ESI): calcd for C20H11F4O4S2 [M+H]+,!!'!%)34,
455.00300. 
Synthesis of unsymmetrical diarylthioxanthones 6a-d: 
General procedure (A) for Suzuki cross-coupling reactions: The reaction was carried out in a 
pressure tube. To a THF suspension (4-5 mL) of 1,3-bis(triflates) 2 (100 mg, 0.197 mmol), 
Pd(PPh3)4 (5 mol%) and of the Ar1B(OH)2 (1.1 equiv.), K3PO4 (1.5 equiv.) was added. The 
mixture was heated at the indicated temperature (60°C) under Argon atmosphere for the 
indicated period of time (8 h) and cooled to room temperature, then diluted with water and 
extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were dried (Na2SO4), filtered 
and the filtrate was concentrated in vacuo. The residue was purified by flash chromatography 
silica gel (EtOAc/ heptanes). Then to a 1,4-dioxane (4-5 mL) suspension of products 5 (b,c,f),
Pd(PPh3)4 (5 mol%) and of the Ar2B(OH)2 (1.1 equiv.), K3PO4 (1.5 equiv.) was added. The 
reaction mixture was further heated at (90°C) for (6 h). The reaction mixture was again cooled to 
room temperature and diluted with water and extracted with CH2Cl2 (3 x 25 mL). The combined 
organic layers were dried (Na2SO4), filtered and the filtrate was concentrated in vacuo. The 
residue was purified by flash chromatography (silica gel, EtOAc/ heptanes). 
General procedure (B) for Suzuki cross-coupling reactions: The reaction was carried out in a 
pressure tube. To a THF suspension (4-5 mL) of 1,3-bis(triflates) 2 (100 mg, 0.197 mmol), 
Pd(PPh3)4 (5 mol%) and of the Ar1B(OH)2 (1.1 equiv.), K3PO4 (1.5 equiv.) was added. The 
mixture was heated at the indicated temperature (60°C) under Argon atmosphere for the 
indicated period of time (8 h) and cooled to room temperature, then Ar2B(OH)2 (1.1 equiv.) was 

	

added, the reaction mixture was further heated at (90°C) for (6 h). The reaction mixture was 
again cooled to room temperature and diluted with water and extracted with CH2Cl2 (3 x 25 mL). 
The combined organic layers were dried (Na2SO4), filtered and the filtrate was concentrated in
vacuo. The residue was purified by flash chromatography (silica gel, EtOAc/ heptanes). 
3-(4-Ethylphenyl)-1-(2-methoxyphenyl)-9H-thioxanthen-9-one (6a): Starting with 5b (77 mg, 
0.166 mmol), 2-methoxyphenylboronic acid 3a (28 mg, 0.182 
mmol), (10 mg, 5 mol%) K3PO4 (53 mg, 0.25 mmol) and 1,4-
dioxane (5 mL), following the general procedure A, 6a was isolated 
as a 1)?2)4
90:#@%reaction temperature: 90°C for 6 h. 
Mp.185-187°C. 1H NMR (300 MHz, CDCl3):   = 1.20 (t, 3H, 
J = 7.59 Hz CH3), 2.63 (s, 2H, J =7.59 Hz, CH2), 3.58 (s, 3H, 
OCH3), 6.88 (dd, 1H, J = 0.66, 8.19 Hz, ArH), 7.02 (td, 1H, J = 1.02, 7.44 Hz, ArH), 7.23 (d, 
3H, J = 7.68 Hz, ArH), 7.28-7.35 (m, 2H, ArH), 7.42 (d, 1H, J = 1.86 Hz, ArH), 7.46-7.48 (m, 
2H, ArH), 7.53 (d, 2H, J = 8.25 Hz, ArH), 7.66 (d, 1H, J = 1.86 Hz, ArH), 8.23 (dt, 1H, J = 0.96, 
8.10 Hz, ArH). 13C NMR (62.9 MHz, CDCl3):  = 15.5 (CH3), 28.6 (CH2), 55.5 (OCH3), 110.3, 
120.7, 123.2, 125.3,  126.1 (CH), 127.0 (C), 127.3, 128.5, 128.9, 129.1, 129.4, 131.4, 131.5 
(CH), 132.7, 136.0, 136.2, 138.0, 142.2, 143.7, 144.9, 156.0 (C), 180.9 (CO). IR (KBr): v = 
3272, 3109, 3061, 3012, 2964, 2865, 2238, 1922, 1899 (w), 1643, 1589 (s), 1538, 1514, 1494, 
1461, 1452, 1435 (m), 1385 (w), 1301 (s), 1278 (m), 1241 (s), 1228, 1189, 1180 (w), 1156, 
1117, 1074, 1052 (m), 1032 (w), 1020 (s), 964, 938 (w), 925 (m), 896, 871, 838 (w), 826 (s), 
802(m), 769 (w), 751, 741, 719 (s), 677, 660 (m), 647, 636, 629, 623, 593, 577, 552 (w), 536 (m) 
cm−1.GC-MS (EI, 70 eV): m/z (%) = 422 ([M]+, 4), 391 ([M]+, 100), 376 (65). HRMS (EI, 
70 eV): calcd for C28H22O2S [M]+: !%)34, 
3-(4-(Tert-butyl)phenyl)-1-(4-methoxyphenyl)-9H-thioxanthen-9-one (6b): Starting with 5c 
(73 mg, 0.148 mmol), 4-methoxyphenylboronic acid 3h (25 mg, 
0.163 mmol), Pd(PPh3)4 (9 mg, 5 mol%), K3PO4 (47 mg, 0.22 
mmol) and 1,4-dioxane (5 mL), following the general procedure 
A, 6b was isolated as a 1)? 2)4 
 0: 9'@% reaction 
temperature: 90°C for 6 h. Mp.178-180°C (CH2Cl2/EtOH 1:1). 1H 
NMR (300 MHz, CDCl3):   = 1.28 (s, 9H, 3CH3), 3.79 (s, 3H, 
OCH3), 6.89 (d, 2H, J = 8.70 Hz, ArH), 7.19 (d, 2H, J = 8.70 Hz, 







ArH), 7.29-7.34 (m, 1H, ArH), 7.40-7.48 (m, 5H, ArH), 7.54 (d, 2H, J = 8.52 Hz, ArH), 7.65 (d, 
1H, J = 1.83 Hz, ArH), 8.27 (dd, 1H, J = 0.75, 8.52 Hz, ArH). 13C NMR (62.9 MHz, CDCl3): 
 = 31.3 (CH3), 34.7 (C), 55.2 (OCH3), 113.4, 122.9, 125.2 (CH), 125.9 (C), 126.0, 126.2, 127.0, 
129.1, 129.4, 129.7 (CH), 131.6 (C), 131.7 (CH), 135.7, 135.8, 136.0, 139.0, 143.0, 146.0, 152.0, 
158.6 (C), 180.9 (CO). IR (KBr): v = 3092, 3051, 3005, 2950, 2902, 2865, 2830 (w), 1642 (s), 
1607 (m), 1587 (s), 1557, 1537 (w), 1507 (s), 1460, 1432 (m), 1415, 1379, 1359, 1316 (w), 1297 
(s), 1279 (m), 1238 (s), 1176 (m), 1163 (w), 1152, 1111, 1074, 1028 (m), 1015, 961 (w), 923 
(m), 891, 867 (w), 818 (s), 769 (w), 754 (s), 730, 722 (m), 709 (w), 675 (m), 653, 633, 611 (w), 
573, 542 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 450 ([M]+, 77), 449 ([M-H]+, 100). HRMS 
(ESI): calcd for C30H27O2S [M+H]+: 9 !%)34,9!
3-(4-Chlorophenyl)-1-(3,4-dimethoxyphenyl)-9H-thioxanthen-9-one (6c): Starting with 5f (72 
mg, 0.153 mmol), 3,4-dimethoxyphenylboronic acid 3k (31 mg, 
0.168 mmol), Pd(PPh3)4 (9 mg, 5 mol%), K3PO4 (49 mg, 0.23 
mmol) and 1,4-dioxane (5 mL), following the general procedure A, 
6c was isolated as a 1)? 2)4 
! 0: 9@% /7.)3
temperature: 90°C for 6 h. Mp.168-170°C. 1H NMR (300 MHz, 
CDCl3):  = 3.79 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 6.77 (d, 1H, 
J = 1.86 Hz, ArH), 6.81 (dd, 1H, J = 1.92, 8.16 Hz, ArH), 6.88 (d, 1H, J = 8.16 Hz, ArH), 7.32-
7.39 (m, 4H, ArH), 7.48-7.55 (m, 4H, ArH), 7.62 (d, 1H, J = 1.9 Hz, ArH), 8.25 (dd, 1H, J = 
0.84, 8.70 Hz, ArH). 13C NMR (62.9 MHz, CDCl3):  = 54.8, 54.9 (OCH3), 109.7, 110.7, 119.1, 
122.0, 124.3, 125.4, 127.6, 128.1, 128.3, 128.6 (CH), 130.7 (C), 130.9 (CH), 134.0, 134.7, 134.8, 
136.1, 138.1, 141.1, 145.5, 147.2, 147.5 (C), 179.8 (CO). IR (KBr): v = 3052, 2989, 2957, 2925, 
2850, 2829, 2247 (w), 1643 (s), 1609 (w), 1589 (m), 1537(w), 1513, 1491, 1469, 1462, 1454, 
1434, 1417 (m), 1401, 1372, 1331 (w), 1296 (m), 1281 (w), 1257, 1240, 1216, 1185, 1170, 1153, 
1136, 1122, 1102, 1092, 1077, 1056 (m), 1027, 1013 (s), 952, 932 (w), 909, 894, 875, 863 (m), 
841 (w), 825 (m), 816 (s), 804, 789, 761 (m), 747, 721 (s), 683, 662, 652, 646, 629, 618, 600, 
583, 541 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 458 ([M]+, 100), 457 ([M-H]+, 74), 443 (24), 
371 (17), 214 (14). HRMS (EI, 70 eV): calcd for C27H19ClO3S [M]+: #!99'% )34,
458.074006. 



1-(4-Methoxyphenyl)-3-(o-tolyl)-9H-thioxanthen-9-one (6d): Starting with 2 (100 mg, 0.197 
mmol), 2-methylphenylboronic acid 3l (29 mg, 0.22 mmol), 4-
methoxyphenylboronic acid 3h (34 mg, 0.22 mmol), Pd(PPh3)4 (23 
mg, 10 mol%), K3PO4 (125 mg, 0.59 mmol) and 1,4-dioxane (5 mL), 
following the general procedure B, 6d was isolated as a yellow solid 

 !0:9@%reaction temperature: at 60°C for 8 h, at 90°C for 6 h. 
Mp.168-170°C. 1H NMR (300 MHz, CDCl3):  = 2.37 (s, 3H, CH3), 
3.77 (s, 3H, OCH3), 6.88 (d, 2H, J = 8.73 Hz, ArH), 7.17-7.23 (m, 7H, ArH), 7.31-7.36 (m, 1H, 
ArH), 7.42 (d, 1H, J =1.74 Hz, ArH), 7.47-7.52 (m, 2H, ArH), 8.28 (dd, 1H, J = 0.84, 8.64 Hz, 
ArH). 13C NMR (75.5 MHz, CDCl3):  = 20.4 (CH3), 55.2 (OCH3), 113.4, 125.2, 125.4 (CH), 
125.9 (C), 126.1, 126.3, 128.3, 129.2, 129.5, 129.7, 130.7 (CH), 131.7 (C), 131.8, 131.9 (CH), 
135.3, 135.5, 135.9, 138.4, 139.6, 144.8, 145.6, 158.6 (C), 181.2 (CO). IR (KBr): v = 3399, 
3057, 2950, 2928, 2861, 2834 (w), 1641 (s), 1607 (m), 1588 (s), 1536(w), 1508 (s), 1489, 1461 
(w), 1435 (m), 1409, 1384, 1316 (w), 1295 (m), 1241 (s), 1175, 1156 (m), 1115, 1077, 1053 (w), 
1032 (m), 962 (w), 923 (m), 879, 894(w), 826 (s), 808, 786, 769 (w), 755, 723 (s), 680, 667 (m), 
643, 613 (w), 573 (m), 556, 536 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) = 408 ([M]+, 70), 407 
([M-H]+, 100). HRMS (EI, 70 eV): calcd for C27H20O2S [M]+: !#9#%)34,!# 
Site-Selective Suzuki-Miyaura Cross-Coupling Reactions of the Bis(triflate) of 1,4-
Dihydroxythioxanthone
 Synthesis of 9-oxo-9H-thioxanthene-1,4-diyl bis(trifluoromethanesulfonate) (8): To a 
solution of 7 (0.40 g, 1.63 mmol) in CH2Cl2 (20 mL) was added a 
mixture base from Et3N and pyridine 1:2 (0.34 mL, 2.46 mmol of Et3N 
and 0.40 mL, 4.10 mmol of pyridine), at 20 °C under an argon 
atmosphere. After stirring for 10 min at -78°C, Tf2O (0.66 mL, 
3.91mmol) was added. The mixture was allowed to warm to 20°C and stirred for further 8 h. The 
reaction mixture was filtered and the filtrate was concentrated in vacuo. The residue was 
chromatographed without work up (flash silica gel, heptanes-EtOAc) and 8 was isolated as a 
yellow solid (0.72 g, 86.7%), Mp.140-142°C. 1H NMR (300 MHz, CDCl3):  = 7.29 (d, 1H, J = 
8.91 Hz, ArH), 7.48-7.58 (m, 2H, ArH), 7.62-7.67 (m, 2H, ArH), 8.50 (dd, 1H, J = 1.41, 
8.10 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):  = -73.2, -73.9. 13C NMR (62.9 MHz, CDCl3): 
 = 118.5, 118.7 (q, JF,C  = 317.6, 321.0 Hz, CF3), 120.9 (CH), 124.2 (C), 124.8, 126.1, 128.0 
(CH), 129.5 (C), 130.2 (CH), 133.2 (C), 133.5 (CH), 135.2, 143.4, 148.7 (C), 178.0 (CO). IR 



(KBr): v = 3080, 2961, 2904 (w), 1649, 1592 (w), 1429 (m), 1412, 1388, 1318, 1302 (w), 1257 
(s), 1236, 1216, 1199 (m), 1078, 1010 (s), 907, 882, 850 (m), 789, 758  (s), 740 (m), 691, 673, 
660, 646, 620, 607 (w), 589 (m), 569, 529 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) = 508 
([M+H]+, 43), 375 (40), 311 (100), 311 (100), 283 (14), 242 (27). HRMS (EI, 70 eV): calcd for 
C15H6F6O7S3 [M]+,!9'9%)34,!9'9''
General procedure for Suzuki–Miyaura cross-coupling reactions: A THF solution (4-5 mL), 
K3PO4 (1.5 equiv. per cross-coupling), Pd(PPh3)4 (5 mol% per cross-coupling) and arylboronic 
acid 3 (1.1 equiv. per cross-coupling) was stirred at 65-90°C for 8 h. After cooling to 20°C, 
distilled H2O was added. The organic and the aqueous layers were separated and the latter was 
extracted with CH2Cl2. The combined organic layers were dried (Na2SO4), filtered and the 
filtrate was concentrated in vacuo. The residue was purified by column chromatography (flash 
silica gel, heptanes-EtOAc). 
Synthesis of 1,4-diarylthioxanthones 9a-f : 
1,4-Bis(4-ethylphenyl)-9H-thioxanthen-9-one (9a): Starting with 8 (100 mg, 0.197 mmol), 4-
ethylphenylboronic acid 3b (71 mg, 0.47 mmol), Pd(PPh3)4 (23 mg, 10 
mol%), K3PO4 (125 mg, 0.59 mmol) and THF (5 mL), 9a was isolated as a
1)? 2)4  
   0: #!@% reaction temperature: 90°C for 8 h. Mp.130-
132°C. 1H NMR (300 MHz, CDCl3):  = 1.25-1.31 (m, 6H, 2CH3), 2.64-2.75 
(m, 4H, 2CH2), 7.12-7.18 (m, 2H, ArH), 7.21-7.31 (m, 5H, ArH ), 7.33-7.47 
(m, 6H,  ArH), 8.19 (dd, 1H, J = 1.20, 8.19 Hz, ArH). 13C NMR (75.5 MHz, 
CDCl3):  = 14.2, 14.4 (2CH3), 27.6, 27.7 (2CH2), 124.5, 125.1 (CH), 125.9 
(C), 126.5, 126.9, 127.1, 128.2, 128.6, 128.8 (CH), 130.2 (C), 130.6, 131.0 
(CH), 134.8, 135.4, 136.5, 137.7, 139.7, 141.4, 143.7, 143.8 (C), 181.2 (CO) . IR (KBr): v = 
3270, 3053, 3024, 2961, 2929, 2872 (w), 1730 (m), 1642 (s), 1610 (w), 1589 (m), 1547, 1511, 
1494, 1474, 1462 (w), 1433 (s), 1408, 1377, 1358 (w), 1304, 1273, 1250, 1215 (m), 1184, 1160, 
1137, 1115 (w), 1080, 1072 (m), 1045, 1027 (w), 1013 (m), 970, 934, 886 (w), 822,757, 734 (s), 
717, 690 (m), 651 (w), 640 (m), 612, 602 (w), 534 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 420 
([M]+, 61), 419 ([M-H]+, 100), 404 (12), 391 (13). HRMS (EI, 70 eV): calcd for C29H23OS [M-
H]+,' %)34,'9


1,4-Bis(4-(tert-butyl)phenyl)-9H-thioxanthen-9-one (9b): Starting with 8 (100 mg, 0.197 
mmol), 4-tert-butylphenylboronic acid 3c (84 mg, 0.47 mmol), Pd(PPh3)4 (23 
mg, 10 mol%), K3PO4 (125 mg, 0.59 mmol) and THF (5 mL), 9b was isolated 
as a 1)?2)4
9#0:#@%reaction temperature: 90°C for 8 h. Mp.108-
110°C. 1H NMR (300 MHz, CDCl3):  = 1.33 (s, 9H, 3CH3), 1.35 (s, 9H, 
3CH3), 7.20-7.31 (m, 3H, ArH), 7.35-7.45 (m, 8H, ArH), 7.47 (d, 2H, J = 
8.29 Hz, ArH), 8.20 (dd, 1H, J = 1.17, 9.57 Hz, ArH). 13C NMR (75.5 MHz, 
CDCl3):  =  30.4, 30.5 (CH3), 33.5, 33.8 (C), 123.9, 124.4, 124.6, 125.0, 
126.6 (CH), 127.1 (C), 128.1, 128.2, 128.9 (CH), 130.2 (C), 130.6, 131.0 
(CH), 134.6, 135.4, 136.4, 137.6, 139.4, 143.7, 148.2, 150.5 (C), 181.2 (CO. 
IR (KBr): v = 3025, 2959, 2902, 2866, 2712, 2257, 1909, 1726 (w), 1638 (s), 1614 (w), 1589 
(m), 1563, 1543 (w), 1509, 1461 (m), 1433 (s), 1392, 1360 (w), 1308 (m), 1289 (w), 1267, 1256 
(m), 1237 (w), 1212, 1203 (m), 1168, 1161, 1138 (w), 1112 (m), 1105, 1080, 1047, 1025 (w), 
1014 (m), 973, 961, 935 (w), 917, 905, 847 (m), 835 (w), 821 (s), 801, 759, 748 (m), 724 (s), 
700, 687, 666 (w), 648 (m), 625, 611, 604, 590 (w), 568 (s) cm−1. GC-MS (EI, 70 eV): m/z (%) = 
476 ([M]+, 81), 475 ([M-H]+, 100), 461 (51), 419 (14). HRMS (EI, 70 eV): calcd for C33H31OS
[M-H]+,9!'!%)34,9!#99
1,4-Di-p-tolyl-9H-thioxanthen-9-one (9c): Starting with 8 (100 mg, 0.197 mmol), 4-
methylphenylboronic acid 3e (64 mg, 0.47 mmol), Pd(PPh3)4 (23 mg, 10 
mol%), K3PO4 (125 mg, 0.59 mmol) and THF (5 mL), 9c was isolated as a
1)? 2)4 
  0: #@% reaction temperature: 90°C for 8 h. Mp.160-
162°C. 1H NMR (300 MHz, CDCl3):  = 2.35 (s, 3H, CH3), 2.39 (s, 3H, CH3), 
7.14-7.15 (m, 4H, ArH), 7.21-7.32 (m, 6H, ArH), 7.34-7.41 (m, 3H, ArH), 
8.18 (dd, 1H, J =1.18, 7.93 Hz, ArH). 13C NMR (75.5 MHz, CDCl3):  = 20.3, 
20.4 (2CH3), 124.4, 125.1, 126.8 (CH), 127.1 (C), 127.7, 128.1, 128.4, 128.5, 
128.7 (CH), 130.2 (C), 130.6, 130.9 (CH), 134.6, 135.2, 135.4, 136.5, 137.4, 
137.7, 139.6, 143.8 (C), 181.1 (CO). IR (KBr): v = 3271, 3027, 2961, 2914, 2859, 2726, 2253 
(w), 1642 (s), 1615 (w), 1589 (s), 1574, 1557, 1494, 1547 (w), 1512 (m), 1463 (w), 1434 (s) , 
1378, 1358 (w), 1305 (s), 1285 (w), 1250, 1234, 1204 (m) , 1183, 1159, 1139 (w), 1107 (m) , 
1080, 1070, 1045, 1033 (w), 1016 (m), 971, 956, 934, 917, 896, 864, 848, 838 (w), 805 (s), 773 
(w), 758, 736, 728 (s), 688, 661, 650 (w), 642 (m), 627, 621, 613, 601, 585 (w), 556 (m), 544 


(w), 530 (s) cm−1. GC-MS (EI, 70 eV): m/z (%) = 392 ([M]+, 56), 391 ([M-H]+, 100). HRMS 
(EI, 70 eV): calcd for C27H19OS [M-H]+,'%)34,'!'
1,4-Bis(4-methoxyphenyl)-9H-thioxanthen-9-one (9d): Starting with 8 (100 mg, 0.197 mmol),             
4-methoxyphenylboronic acid 3h (72 mg, 0.47 mmol), Pd(PPh3)4 (23 mg, 10   
mol%), K3PO4 (125 mg, 0.59 mmol) and THF (5 mL), 9d was isolated as a
1)? 2)4 
99 0: '@% reaction temperature: 90°C for 8 h. Mp.193-
194°C. 1H NMR (300 MHz, CDCl3):  = 3.83 (s, 3H, OCH3), 3.84 (s, 3H, 
OCH3), 6.89 (d, 2H, J = 8.66 Hz, ArH), 6.98 (d, 2H, J = 8.66 Hz, ArH), 7.16-
7.25 (m, 3H, ArH), 7.28-7.49 (m, 6H, ArH), 8.19 (dd, 1H, J = 1.02, 8.01 Hz, 
ArH). 13C NMR (75.5 MHz, CDCl3):  = 55.2, 55.4 (2OCH3), 113.5, 114.0, 
125.5, 126.2 (CH), 128.1(C), 129.1, 129.2, 129.8 (CH), 130.8 (C), 130.9 
(CH), 131.3 (C), 131.7, 132.1(CH), 135.8, 136.4, 137.8, 138.4, 144.4, 158.5, 159.8 (C), 182.4 
(CO) . IR (KBr): v = 3061, 3031, 3004, 2952, 2921, 2852, 2834, 2537, 2350, 2285, 2252, 2052, 
1907 (w), 1634, 1606, 1589 (s), 1575 (m), 1556, 1547 (w), 1509 (s), 1462 (m), 1432 (s), 1409, 
1377, 1358 (w), 1310, 1302, 1287 (m), 1239 (s), 1193 (m), 1174 (s), 1117 (w), 1105 (m), 1081, 
1049  (w), 1026 (s), 1008, 965, 935, 927, 918, 903, 877, 864, 832 (w), 815 (s), 788, 773 (w),  
759, 724 (s), 689 (w), 662, 651, 644 (m), 629, 609, 594 (w), 569 (m), 542 (s) cm−1. GC-MS (EI, 
70 eV): m/z (%) = 425 ([M+H]+, 51), 424 ([M]+, 99), 423 ([M-H]+, 100), 380 (11). HRMS (EI, 
70 eV): calcd for C27H20O3S [M]+: 4299%)34,
1,4-Diphenyl-9H-thioxanthen-9-one (9e): Starting with 8 (100 mg, 0.197 mmol), 
phenylboronic acid 3i (57 mg, 0.47 mmol), Pd(PPh3)4 (23 mg, 10 mol%), 
K3PO4 (125 mg, 0.59 mmol) and THF (5 mL), 9e was isolated as a yellow 
solid (65 0:'@% reaction temperature: 90°C for 8 h. Mp.193-195°C. 1H 
NMR (300 MHz, CDCl3):  = 7.27 (t, 4H, J = 7.50 Hz, ArH), 7.31-7.36 (m, 
4H, ArH), 7.38-7.47 (m, 7H, ArH), 8.18 (dd, 1H, J = 1.05, 8.04 Hz, ArH). 13C 
NMR (75.5 MHz, CDCl3):  = 124.5, 125.2, 125.5, 126.8, 126.9 (CH), 127.0 
(C), 127.6, 127.7, 128.2, 128.6, 128.7 (CH), 130.1 (C), 130.7, 130.9 (CH), 135.3, 136.5, 137.5, 
137.9, 142.5, 144.0 (C), 180.9 (CO). IR (KBr): v = 3269, 3077, 3055, 3045, 3023, 2917, 2849 
(w), 1638 (s), 1622 (m), 1589 (s), 1574 (w), 1548 (m) , 1519, 1514 (w) , 1491 (m), 1462 (w), 
1441 (m), 1429 (s), 1358 (w), 1313, 1306 (s), 1286, 1251, 1235 (m), 1177 (w), 1163, 1115, 
1076, 1069, 1049 (m), 1033 (w), 1022 (m), 1001, 975, 961 (w), 934 (m), 908, 875, 717, 690, 852 


(w), 838, 823 (m), 811, 767 (w), 752, 730, 692 (s), 652, 638, 619, 609, 604 (m), 548 (w), 530 (s) 
cm−1. GC-MS (EI, 70 eV): m/z (%) = 364 ([M]+, 50), 363 (([M-H]+, 100). HRMS (EI, 70 eV): 
calcd for C25H15OS [M-H]+, !##%)34, !#9
1,4-Bis(4-fluorophenyl)-9H-thioxanthen-9-one (9f): Starting with 8 (100 mg, 0.197 mmol),                 
4-flourophenylboronic acid 3j (66 mg, 0.47 mmol), Pd(PPh3)4 (23 mg, 10 
mol%), K3PO4 (125 mg, 0.59 mmol) and THF (5 mL), 9f was isolated as a
1)? 2)4 
  0: #@% /7.)3 .06/., '!" ) # $ 6# -
188°C. 1H NMR (300 MHz, CDCl3):  = 7.04 (t, 2H, J = 8.76 Hz, ArH), 
7.14 (d, 2H, J = 8.70 Hz, ArH), 7.17-7.23 (m, 3H, ArH), 7.27-7.51 (m, 6H, 
ArH), 8.18 (dd, 1H, J = 1.05, 8.61 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):
 = -115.9, -112.6. 13C NMR (75.5 MHz, CDCl3):  = 113.9 (d, JF,C = 21.5 
Hz, CH), 114.8 (d, JF,C  = 21.7 Hz, CH), 124.5, 125.4 (CH), 127.1 (C), 128.2 
(CH), 128.4 (d, JF,C = 7.87 Hz, CH), 128.7 (CH), 129.9 (C), 130.4 (d,  JF,C  = 8.27 Hz, CH), 
130.9, 131.0 (CH), 133.3 (d, JF,C = 3.35 Hz, C), 135.0, 136.8, 137.1 (C), 138.3 (d, JF,C  = 3.61 Hz, 
C), 143.1 (C), 160.7 (d, JF,C  = 245.5 Hz, C-F), 161.9 (d, JF,C = 248.6 Hz, C-F), 180.8 (CO). IR 
(KBr): v = 3072, 3045, 2961, 2920, 2850 (w), 1639 (s), 1600 (m), 1590 (s), 1558, 1550 (w), 
1506 (s), 1463 (w), 1434 (s), 1406, 1359 (w), 1307 (m), 1288, 1279, 1259 (w), 1220 (s), 1168 
(w), 1157, 1090 (m), 1070, 1043, 1033 (w), 1013 (m), 961 (w), 931 (m), 866 (w), 845 (m), 823, 
797 (s), 785 (m), 760, 738 (s), 688 (w), 660, 650, 641 (m), 630, 608 (w), 591 (m), 553, 533 (s) 
cm−1. GC-MS (EI, 70 eV): m/z (%) = 400 ([M]+, 59), 399 ([M-H]+, 100). HRMS (EI, 70 eV): 
calcd for C25H31F2OS [M-H]+: ''! '9%)34,''! 
Synthesis of 1-Aryl-4-(trifluorosulfonyloxy)-thioxanthones 10a-i:
1-(4-Ethylphenyl)-9-oxo-9H-thioxanthen-4-yltrifluoromethanesulfonate (10a): Starting with 
8 (100 mg, 0.197 mmol), 4-ethylphenylboronic acid 3b (32 mg, 0.22 
mmol), Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 0.29 mmol) and
THF (5 mL), 10a was isolated as a 1)?2)4
#0:'!@%reaction 
temperature: 65°C for 8 h. Mp.196-198°C (CH2Cl2/EtOH 1:1). 1H 
NMR (300 MHz, CDCl3):  = 1.23 (t, 3H, J = 7.6 Hz, CH3), 2.67 (q, 
2H, J = 7.6 Hz, CH2), 7.10 (d, 2H, J = 8.20 Hz, ArH), 7.15-7.20 (m, 
2H, ArH), 7.25 (d, 1H, J = 8.4 Hz, ArH), 7.27-7.41 (m, 1H, ArH), 7.49-7.54 (m, 3H, ArH), 8.19 
(dd, 1H, J = 0.99, 8.10 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):  = -73.1. 13C NMR 





(75.5 MHz, CDCl3):  = 14.2 (CH3), 27.6 (CH2), 117.6 (q, JF,C = 318.7 Hz, CF3), 122.1, 124.8, 
126.1, 126.6, 126.7 (CH), 128.2 (C), 128.6, 129.1 (CH), 130.0 (C), 131.4 (CH), 132.8, 138.1, 
142.2, 142.4, 145.0, 179.3 (CO). IR (KBr): v = 3060, 3028, 2960, 2928, 2870, 2852 (w), 1644 
(s), 1614 (w), 1593, 1580 (m), 1555, 1511, 1454 (w), 1430 (s), 1372,  1316 (w), 1303 (m), 1274, 
1260 (w), 1247 (m), 1219, 1205, 1186 (s), 1160 (m), 1134 (s), 1114, 1079, 1049, 1034, 1017, 
971 (m), 883 (s), 857, 836, 831 (m), 802, 756, 739 (s), 724 (m), 693, 666, 652 (w), 640 (s), 632 
(m), 603, 590 (s), 566, 535 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) = 464 ([M]+, 26), 331 (100), 
302 (89), 274 (24). HRMS (EI, 70 eV): calcd for C22H15F3O4S2 [M]+,  !#% )34,
464.03664. 
1-(4-(Tert-butyl)phenyl)-9-oxo-9H-thioxanthen-4-yltrifluoromethanesulfonate(10b):Starting 
with 8 (100 mg, 0.197 mmol), 4-tert-butylphenylboronic acid 3c (39 
mg, 0.22 mmol), Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 0.29 
mmol) and THF (5 mL), 10b was isolated as a yellow solid (74 mg, 
9 @% reaction temperature: 65°C for 8 h. Mp.181-183°C. 1H NMR 
(300 MHz, CDCl3):  = 1.32 (s, 9H, 3CH3), 7.13 (d, 2H, J = 8.48 Hz, 
ArH), 7.27 (d, 1H, J = 8.48 Hz, ArH), 7.35-7.39 (m, 3H, ArH), 7.52 (d, 
1H, J = 8.48 Hz, ArH), 7.55-7.60 (m, 2H, ArH), 8.22 (dd, 1H, J = 0.99, 8.07 Hz, ArH). 19F NMR 
(282.4 MHz, CDCl3):  = -73.1. 13C NMR (75.5 MHz, CDCl3):  = 30.4 (3CH3), 33.6 (C), 117.6 
(q, JF,C = 320.8 Hz, CF3), 122.1, 123.9, 124.8, 126.1, 126.5 (CH), 128.2 (C), 128.6, 129.3 (CH), 
130.1 (C), 131.4 (CH), 132.8, 137.8, 142.4, 145.0, 149.1 (C), 179.4 (CO). IR (KBr): v = 3106, 
3071, 3027, 2959, 2903, 2865 (w), 1643 (s), 1614 (w), 1591, 1582 (m), 1507, 1474, 1461 (w), 
1419 (s), 1373, 1316 (w), 1305 (m), 1283, 1263, 1247, 1238  (w), 1214 (s), 1187 (m), 1269, 
1160 (w), 1130 (s), 1115 (m), 1078, 1052, 1035,1014 (w), 972 (m), 906 (w), 884 (s), 854 (w), 
844, 821 (m), 796 (s), 765 (w), 758 (m), 747 (w), 735 (s), 720 (m), 686, 666, 653, 632 (w),  603 
(s), 593 (m), 573, 564 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) = 492 ([M]+, 41), 477 (13), 359 
(68), 344 (23), 303 (63), 302 (100), 274 (15). HRMS (EI, 70 eV): calcd for C24H19F3O4S2 [M]+: 
'! 9%)34,'!  #


9-Oxo-1-(p-tolyl)-9H-thioxanthen-4-yl trifluoromethanesulfonate (10c): Starting with 8 (100 
mg, 0.197 mmol), 4-methylphenylboronic acid 3e (30 mg, 0.22 mmol), 
Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 0.29 mmol) and THF (5 
mL), 10c was isolated as a 1)? 2)4 
99 0: #9@% reaction 
temperature: 65°C for 8 h. Mp.130-132°C. 1H NMR (300 MHz, CDCl3): 
 = 2.37 (s, 3H, CH3), 7.09 (d, 2H, J = 8.16 Hz, ArH), 7.16-7.19 (m, 2H, 
ArH), 7.25 (d, 1H, J = 8.61 Hz, ArH), 7.35-7.42 (m, 1H, ArH), 7.52-7.57 
(m, 3H, ArH), 8.22 (d, 1H, J = 8.16 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):  = -73.1. 13C 
NMR (75.5 MHz, CDCl3):  = 21.37 (CH3), 118.6 (q, JF,C = 320.7  Hz, CF3), 123.1, 125.9, 127.2, 
127.7, 128.9 (CH), 129.2 (C), 129.6, 130.1 (CH), 131.1 (C), 132.4 (CH), 132.5, 133.8, 137.1, 
138.9, 143.4, 146.1 (C), 180.4 (CO). IR (KBr): v = 3290, 3090, 3055, 3028, 2953, 2921, 2850, 
2666 (w), 1652 (s), 1614 (w), 1589, 1582 (m), 1552, 1515, 1463 (w), 1436 (m), 1424 (s), 1407 
(m), 1312 (w), 1301, 1294, 1248 (m), 1206, 1190 (s), 1166 (w), 1157 (m), 1137, 1131 (s), 1109 
(m), 1076, 1050, 1034, 1017 (w), 968 (m), 945, 934 (w), 883 (s), 872 (m), 851 (w), 834, 801 (s), 
780 (m), 760, 732 (s), 689, 675, 649, 639 (w), 618, 601, 590 (s), 571 (m), 563, 552 (w), 533 (m) 
cm−1. GC-MS (EI, 70 eV): m/z (%) = 450 ([M]+, 43), 317 (100), 302 (78), 274 (17). HRMS (EI, 
70 eV): calcd for C21H13F3O4S2 [M]+,!!!'%)34,!!' 9
1-(4-Chlorophenyl)-9-oxo-9H-thioxanthen-4-yl trifluoromethanesulfonate (10d): Starting 
with 8 (100 mg, 0.197 mmol), 4-chlorophenylboronic acid 3f (34 mg, 
0.22 mmol), Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 0.29 mmol) 
and THF (5 mL), 10d was isolated as a 1)? 2)4 
9#0:#@%
reaction temperature: 65°C for 8 h. Mp.133-135°C. 1H NMR 
(300 MHz, CDCl3):  = 7.12 (d, 2H, J = 8.45 Hz, ArH), 7.22 (d, 1H, J 
= 8.45 Hz,  ArH), 7.33 (d, 2H, J = 8.45 Hz, ArH), 7.38-7.43 (m, 1H,
ArH), 7.54-7.61 (m, 3H, ArH), 8.22 (d, 1H, J = 8.12 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):
 = -73.1. 13C NMR (75.5 MHz, CDCl3):  = 118.6 (q, JF,C = 320.8 Hz, CF3), 123.3, 126.0, 
127.3, 128.4, 129.1, 129.7, 129.9 (CH), 130.7, 131.2 (C), 132.7 (CH), 132.9, 133.4, 133.8, 140.4, 
143.8, 144.7 (C), 180.1 (CO). IR (KBr): v = 3281, 3097, 3066, 2922, 2853, 2667, 2554 (w), 1649 
(s), 1614 (w), 1588 (m), 1568, 1551, 1492, 1464, 1455 (w), 1424 (s), 1407, 1397 (m), 1377, 
1315 (w), 1302, 1294  (m), 1277, 1247, 1238  (w), 1223, 1205, 1209, 1188 (s), 1158 (m), 1135, 
1129 (s), 1090, 1077 (m), 1048, 1035 (w), 1012, 971 (m), 881 (s), 871 (m), 847, 834 (m), 815, 
805, 759 (s), 739 (w), 734 (s), 711, 686, 665 (w), 647, 631 (m), 615, 601 (s), 588  (m), 568, 555, 


538 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) = 470 ([M+H]+, 38), 337 (100), 302 (68), 274 (26), 
245 (14). HRMS (EI, 70 eV): calcd for C20H10F3ClO4S2 [M]+: 469.'  %)34, '' 9
1-(4-Methoxyphenyl)-9-oxo-9H-thioxanthen-4-yl trifluoromethanesulfonate (10e): Starting 
with 8 (100 mg, 0.197 mmol), 4-methoxyphenylboronic acid 3h (33 mg, 
0.22 mmol), Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 0.29 mmol) 
and THF (5 mL), 10e was isolated as a 1)? 2)4 
9 0: #@%
reaction temperature: 65°C for 8 h. Mp.162-164°C. 1H NMR (300 MHz, 
CDCl3):  = 3.79 (s, 3H, OCH3), 6.89 (d, 2H,  J = 8.31 Hz, ArH), 7.12 
(d, 2H, J = 8.31 Hz, ArH), 7.25 (d, 1H, J = 8.31 Hz, ArH ), 7.35-7.41 
(m, 1H, ArH), 7.50-7.56 (m, 3H, ArH), 8.21 (d, 1H, 8.31 Hz, ArH). 19F NMR (282.4 MHz, 
CDCl3):  = -73.1. 13C NMR (75.5 MHz, CDCl3): = 54.2 (OCH3), 112.6 (CH),117.6 (q, JF,C = 
320.9  Hz, CF3), 122.1, 124.8, 126.1, 128.0 (CH), 128.1 (C), 128.6, 129.1 (CH), 130.1 (C), 131.4 
(CH), 131.5, 132.8, 133.0, 142.3, 144.7, 158.0 (C), 179.5 (CO). IR (KBr): v = 3290, 3104, 3071, 
3034, 2996, 2950, 2934, 2907, 2853, 2833, 1682 (w), 1652 (s), 1607 (w), 1589, 1589 (m), 1567, 
1552 (w), 1513 (m), 1464, 1455 (w), 1424 (s), 1375, 1353, 1314 (w), 1303, 1295 (m), 1271 (w), 
1248, 1241 (m), 1224, 1202, 1191, 1178 (s), 1164, 1157 (w), 1131 (s), 1108 (m), 1078, 1055, 
1035 (w), 1026, 972 (m), 885 (s), 846 (m), 832 (w), 819, 807 (s), 779 (w), 761, 734 (s), 690, 673 
(w), 650, 643 (m), 619, 599, 592 (s), 574, 544 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 466 
([M]+, 36), 333 (100), 302 (31), 274 (10). HRMS (EI, 70 eV): calcd for C21H13F3O5S2 [M]+: 
  !!%)34,  !'
9-Oxo-1-phenyl-9H-thioxanthen-4-yl trifluoromethanesulfonate (10f): Starting with 8 (100 
mg, 0.197 mmol), phenylboronic acid 3i (27 mg, 0.22 mmol), 
Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 0.29 mmol) and THF (5 
mL), 10f was isolated as a 1)? 2)4 
9  0: ##@% reaction 
temperature: 65°C for 8 h. Mp.178-180°C. 1H NMR (300 MHz, 
CDCl3):  = 7.17-7.21 (m, 1H, ArH), 7.26 (d, 2H, J = 8.37 Hz, ArH), 
7.35-7.42 (m, 4H, ArH), 7.53-7.57 (m, 3H, ArH), 8.21 (dd, 1H, J = 0.90, 8.01 Hz, ArH). 19F 
NMR (282.4 MHz, CDCl3):  = -73.1. 13C NMR (75.5 MHz, CDCl3):  = 117.6 (q, JF,C = 318.8  
Hz, CF3), 122.1, 124.9, 126.2, 126.3, 126.7, 127.1 (CH), 128.2 (C), 128.6, 129.0 (CH), 129.9 
(C), 131.5 (CH), 131.6, 132.8, 140.9, 142.5, 145.0 (C), 179.2 (CO). IR (KBr): v = 3274, 3064, 
2960, 1901 (w), 1667 (w), 1645 (s), 1622 (w), 1587 (m), 1552, 1493, 1461 (m), 1427 (s), 1409 
	

(m), 1315, 1305 (w), 1292 (m), 1260, 1251 (w), 1227, 1207, 1187 (s), 1158 (m), 1129 (s), 1112, 
1079, 1054, 1034, 1020, 971 (m), 912 (w), 879 (s), 861 (w), 842 (s), 821 (w), 799 (s), 768 (m), 
756 (s), 738, 732, 701, 695, 680 (m), 651 (w), 637 (m), 616 (w), 598 (s), 569, 554 (w), 535 (m) 
cm−1. GC-MS (EI, 70 eV): m/z (%) = 436 ([M]+, 36), 303 (100), 302 (45), 274 (38), 245 (12). 
HRMS (EI, 70 eV): calcd for C20H11F3O4S2 [M]+, !!%)34, !!! 
1-(4-Fluorophenyl)-9-oxo-9H-thioxanthen-4-yl trifluoromethanesulfonate (10g): Starting 
with 8 (100 mg, 0.197 mmol), 4-flourophenylboronic acid 3j (31 mg, 
0.22 mmol), Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 0.29 mmol) 
and THF (5 mL), 10g was isolated as a 1)? 2)4 
9 0: #@%
reaction temperature: 65°C for 8 h. Mp.157-159°C. 1H NMR (300 MHz, 
CDCl3):  = 7.05 (t, 2H, J = 8.73 Hz, ArH), 7.12-7.18 (m, 2H, ArH), 
7.23 (d, 1H, J = 8.21 Hz, ArH), 7.37-7.43 (m, 1H, ArH), 7.53-7.61 (m, 
3H, ArH), 8.21 (d, 1H, J = 8.10 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):  = -114.9, -73.1. 13C 
NMR (75.5 MHz, CDCl3):  = 114.1 (d, JF,C = 21.6 Hz, CH), 117.6 (q, JF,C = 320.9 Hz, CF3), 
122.2, 124.9, 126.3 (CH), 128.1(C), 128.4(d, JF,C = 7.98 Hz, CH), 128.6, 129.0 (CH), 129.7 (C), 
131.6 (CH), 131.8, 132.8 (C), 136.7 (d, JF,C = 3.45 Hz, C), 142.7, 143.9 (C), 161.2 (d, JF,C = 
245.4 Hz,   C-F), 179.1 (CO). IR (KBr): v = 3068, 3044, 2957, 2917, 2848 (w), 1649 (s), 1620, 
1601 (w), 1589 (m), 1567, 1551 (w), 1510 (m), 1463 (w), 1429 (s), 1408 (m), 1370, 1316, 1303, 
1293, 1248 (w), 1213 (s), 1188, 1156 (m), 1129 (s),  1092, 1078, 1048, 1034, 1012 (w), 972 (m), 
883 (s), 871, 843 (m), 832 (s), 815 (m), 804 (s), 791 (m), 761 (s), 741 (w), 733 (m), 690, 674 
(w), 650, 639 (m), 617, 598 (s), 588, 571 (m), 563, 549 (w), 537 (m) cm−1. GC-MS (EI, 70 eV): 
m/z (%) = 454 ([M+H]+, 33), 321 (100), 292 (42), 263 (13). HRMS (EI, 70 eV): calcd for 
C20H10F4O4S2 [M]+,''%)34,''!
9-Oxo-1-(o-tolyl)-9H-thioxanthen-4-yl trifluoromethanesulfonate (10h): Starting with 8 (100 
mg, 0.197 mmol), 2-methylphenylboronic acid 3l (30 mg, 0.22 mmol), 
Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 0.29 mmol) and THF (5 
mL), 10h was isolated as a 1)? 2)4 
 9 0: 9 @% reaction 
temperature: 65°C for 8 h. Mp.100-102°C. 1H NMR (300 MHz, CDCl3): 
 = 1.95 (s, 3H, CH3), 6.97 (d, 1H, J = 7.23 Hz, ArH), 7.17 (d, 1H, J = 
3.51 Hz, ArH), 7.19-7.29 (m, 3H, ArH), 7.33-7.39 (m, 1H, ArH), 7.54-7.58 (m, 3H, ArH), 8.22 
(dd, 1H, J = 8.11 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):  = -73.1. 13C NMR (75.5 MHz, 



CDCl3):  = 20.2 (CH3), 118.6 (q, JF,C = 320.9 Hz, CF3), 123.4, 125.6, 126.0, 127.2, 127.3, 127.4 
(CH), 129.4 (C), 129.5, 129.6, 129.8 (CH), 130.3, 132.4 (C), 132.6 (CH), 133.9, 134.6, 141.9, 
143.6, 145.5 (C), 179.6 (CO). IR (KBr): v = 3292, 3063, 3018, 2953, 2922, 2857 (w), 1650 (s), 
1592 (m), 1554, 1489 (w), 1425 (s), 1377 (w), 1301 (m), 1271 (w), 1261 (w), 1248 (m), 1209, 
1188 (s), 1161 (m), 1133, 1118 (s), 1078, 1055, 1035 (w), 974 (m), 884 (s), 838 (m), 800 (s), 785 
(w), 752, 737, 729 (s), 693, 675 (w), 650 (m), 602 (s), 568, 536 (w) cm−1. GC-MS (EI, 70 eV): 
m/z (%) = 450 ([M]+, 30), 435 (16), 317 (68), 302 (100), 274 (30). HRMS (EI, 70 eV): calcd for 
C21H13F3O4S2 [M]+,!!!'%)34,!!!'
9-Oxo-1-(m-tolyl)-9H-thioxanthen-4-yl trifluoromethanesulfonate (10i): Starting with 8 (100 
mg, 0.197 mmol), 3-methylphenylboronic acid 3m (30 mg, 0.22 
mmol), Pd(PPh3)4 (11 mg, 5 mol%), K3PO4 (63 mg, 0.29 mmol) and
THF (5 mL), 10i was isolated as a 1)?2)4
9!0:9'@%reaction 
temperature: 65°C for 8 h. Mp.151-153°C. 1H NMR (300 MHz, 
CDCl3):  = 2.37 (s, 3H, CH3), 6.98 (d, 1H, J = 7.52 Hz, ArH), 7.02 
(brs, 1H, ArH), 7.15 (d, 1H, J = 7.52 Hz, ArH), 7.22-7.27 (m, 2H, ArH), 7.36-7.42 (m, 1H,
ArH), 7.51-7.57 (m, 3H, ArH), 8.22 (d, 1H, J = 8.14 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):
 = -73.1. 13C NMR (75.5 MHz, CDCl3):  = 20.5 (CH3), 117.6 (q, JF,C = 320.7 Hz, CF3), 122.1, 
123.9, 124.9, 126.2, 126.9, 127.1, 127.4 (CH), 128.2 (C), 128.6, 129.0 (CH), 130.0 (C), 131.5 
(CH), 132.8, 136.7, 140.8, 142.5, 145.1 (C), 179.2 (CO). IR (KBr): v = 3283, 3061, 2961, 2922, 
2859, 2736, 2668, 2554 (w), 1651 (s), 1613, 1605 (w), 1589 (m), 1568, 1552, 1537, 1484, 1463 
(w), 1426 (s), 1387, 1314 (w), 1300, 1292 (m), 1261 (w), 1249 (m), 1230, 1202 (s), 1183, 1167, 
1158 (m), 1131 (s), 1119 (m), 1094, 1078, 1035 (w), 970 (m), 900 (w), 880 (s), 864 (w), 840, 
806, 792, 774 (s), 763 (w), 751 (s), 740 (w), 727, 702 (m), 692, 679, 653 (w), 634 (m), 600 (s), 
568, 551 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) = 450 ([M]+, 33), 317 (100), 302 (37), 288 (12). 
HRMS (EI, 70 eV): calcd for C21H13F3O4S2 [M]+,!!!'%)34,!!''#
General procedure for the synthesis of unsymmetrical diarylthioxanthones 11a-d:
The reaction was carried out in a pressure tube. To a THF suspension (4-5 mL) of 1,4-
bis(triflates) 8 (100 mg, 0.197 mmol), Pd(PPh3)4 (5 mol%) and of the Ar1B(OH)2 (1.1 equiv.), 
K3PO4 (1.5 equiv.) was added. The mixture was heated at the indicated temperature  at  (65°C) 
under Argon atmosphere for the indicated period of time (8 h) and cooled to room temperature, 
then Ar2B(OH)2 (1.1 equiv.) was added, the reaction mixture was further heated at (90°C) for (6 


h). The reaction mixture was again cooled to room temperature and diluted with water and 
extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were dried (Na2SO4), filtered 
and the filtrate was concentrated in vacuo. The residue was purified by flash chromatography 
(silica gel, EtOAc/ heptanes). 
1-(4-Methoxyphenyl)-4-(p-tolyl)-9H-thioxanthen-9-one (11a): Starting with 8 (100 mg, 
0.197mmol), 4-methoxyphenylboronic acid 3h (33 mg, 0.22 mmol), 4-
methylphenylboronic acid 3e (29 mg, 0.22 mmol), Pd(PPh3)4 (23 mg, 10  
mol%), K3PO4 (125 mg, 0.59 mmol) and THF (5 mL), 11a was isolated as a
1)?2)4
90:'!@%reaction temperature: at 65°C for 8 h, at 90°C for 
6 h. Mp.160-162°C. 1H NMR (300 MHz, CDCl3):  = 2.39 (s, 3H, CH3), 
3.79 (s, 3H, OCH3), 6.89 (d, 2H, J = 8.76 Hz, ArH), 7.16-7.22 (m, 2H, ArH), 
7.24-7.45 (m, 9H, ArH), 8.18 (dd, 1H, J = 1.08, 8.04 Hz, ArH).13C NMR 
(75.5 MHz, CDCl3):  = 21.44 (CH3), 55.2 (OCH3), 113.5, 125.5, 126.2 
(CH), 128.1 (C), 129.1, 129.2, 129.4, 129.6, 129.8 (CH), 131.4 (C), 131.7, 132.0 (CH), 135.7, 
135.8, 136.4, 137.5, 138.5, 138.6, 144.5, 158.6 (C), 182.4 (CO). IR (KBr): v = 3055, 3029, 3008, 
2955, 2918, 2857, 2835 (w), 1635 (s), 1606, 1591 (m), 1576, 1548 (w), 1512 (m), 1461 (w), 
1434 (s), 1410, 1384, 1359 (w), 1318, 1307, 1290 (m), 1271 (w), 1254 (m), 1241 (s), 1172 (m), 
1161, 1118, 1105, 1080, 1073 (w), 1149,1026, 1019 (m), 973, 964, 935 (w), 920 (m), 902, 865, 
854, 834 (w), 825 (m), 813 (s), 772 (w), 758, 731, 719 (s), 687, 660 (w), 651, 644 (m), 634, 609, 
593 (w), 563 (m), 547 (w), 537 (s) cm−1. GC-MS (EI, 70 eV): m/z (%) = 409 ([M+H]+, 23), 408 
([M]+, 76), 407 ([M-H]+, 100). HRMS (ESI): calcd for C27H21O2S [M+H]+,!' #% )34,
409.12630. 
1-(4-Fluorophenyl)-4-(4-methoxyphenyl)-9H-thioxanthen-9-one (11b): Starting with 8 (100 
mg, 0.197 mmol), 4-flourophenylboronic acid 3j (30 mg, 0.22 mmol), 4-
methoxyphenylboronic acid 3h (33 mg, 0.22 mmol), Pd(PPh3)4 (23 mg, 10 
mol%), K3PO4 (125 mg, 0.59 mmol) and THF (5 mL), 11b was isolated as a
1)?2)4 
90:##@%reaction temperature: at 65°C for 8 h, at 90°C 
for 6 h. Mp.194-196°C. 1H NMR (300 MHz, CDCl3):  = 3.80 (s, 3H, 
OCH3), 7.05 (q, 4H, J = 8.76 Hz, ArH), 7.19-7.24 (m, 3H, ArH), 7.28-7.48 
(m, 6H, ArH), 8.19 (dd, 1H, J = 1.05, 8.01 Hz, ArH). 19F NMR (282.4 MHz, 
CDCl3):  = -116.2. 13C NMR (75.5 MHz, CDCl3):  = 54.3 (OCH3), 113.1 


(CH), 113.9 (d, JF,C = 21.5 Hz, CH), 124.5, 125.2 (CH), 127.0 (C), 128.2 (CH), 128.4 (d, JF,C = 
7.99 Hz, CH), 128.7 (CH), 129.6 (C), 129.8 (CH), 129.9 (C), 130.8, 131.1 (CH) 135.4, 137.1, 
137.9 (C), 138.5 (d, JF,C = 3.42 Hz, C), 142.7, 158.9 (C), 160.8 (d, JF,C = 245.4 Hz, C-F), 180.9 
(CO). IR (KBr): v = 3057, 3031, 2954, 2920, 2850, 2251 (w), 1633 (s), 1601 (m), 1589 (s), 1574, 
1548 (w), 1509 (s), 1461 (m), 1434 (s), 1359 (w), 1305, 1307, 1290 (m), 1245, 1219 (s), 1174, 
1157 (m), 1105, 1092, 1081, 1045 (w), 1022 (s), 965, 931, 914, 896, 877, 867 (w), 844 (m), 828, 
821 (s), 795 (m), 777 (w), 760, 731, 725 (s), 700, 689 (w), 662, 649, 641 (m), 628 (w), 607, 593 
(m), 561, 550 (m), 535 (s) cm−1. GC-MS (EI, 70 eV): m/z (%) = 412 ([M]+, 78), 411 ([M-H]+, 
100), 368 (14). HRMS (EI, 70 eV): calcd for C26H16FO2S [M-H]+,!#' %)34,!#'
4-(4-(Tert-butyl)phenyl)-1-(4-methoxyphenyl)-9H-thioxanthen-9-one (11c): Starting with 8 
(100 mg, 0.197 mmol), 4-methoxyphenylboronic acid 3h (33 mg, 0.22 mmol), 
4-tert-butylphenylboronic acid 3c (39 mg, 0.22 mmol), Pd(PPh3)4 (23 mg, 10 
mol%), K3PO4 (125 mg, 0.59 mmol) and THF (5 mL), 11c was isolated as a
1)?2)4
90:#@%reaction temperature: at 65°C for 8 h, at 90°C for 
6 h. Mp.212-214°C. 1H NMR (300 MHz, CDCl3):  = 1.35 (s, 9H, 3CH3), 
3.80 (s, 3H, OCH3), 6.89 (d, 2H, J = 8.64 Hz, ArH), 7.18 (d, 2H, J = 8.70 Hz, 
ArH), 7.22-7.43 (m, 7H, ArH),7.47 (d, 2H, J = 8.31 Hz, ArH), 8.18 (dd, 1H, J 
= 0.90, 7.89 Hz, ArH). 13C NMR (75.5 MHz, CDCl3):  = 30.4 (CH3), 33.8 
(C), 54.2 (OCH3), 112.5, 124.5, 124.6, 125.1 (CH), 127.0 (C), 128.1, 128.3, 128.8, 129.8 (CH), 
130.3 (C), 130.6, 131.0 (CH), 134.5, 134.8, 135.4, 136.5, 137.6, 143.4, 150.5, 157.5 (C), 181.4 
(CO). IR (KBr): v = 3059, 2997, 2959, 2931, 2903, 2866, 2834, 2248 (w), 1640, 1633 (s), 1606, 
1589 (m), 1575, 1558, 1544 (w), 1510 (s), 1461 (m), 1350 (w), 1433 (s), 1410, 1360 (w), 1306 
(m), 1290, 1271 (w), 1240 (s), 1174 (m), 1139 (w), 1113, 1105 (m), 1081 (w), 1049 (m), 1026, 
1015 (m), 972, 935, 918, 907, 888, 863, 847,  838 (w), 817 (s), 779 (w), 759 (m), 744 (w), 729 
(s), 688 (w), 649 (m), 630, 621, 607, 594 (w), 568, 545 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 
451 ([M+H]+, 28), 450 ([M]+, 91), 449 ([M-H]+, 100), 435 (12). HRMS (EI, 70 eV): calcd for 
C30H25O2S [M-H]+: 449. '#%)34,'  !





4-(3-Chlorophenyl)-1-(4-methoxyphenyl)-9H-thioxanthen-9-one (11d): Starting with 8 (100 
mg, 0.197 mmol), 4-methoxyphenylboronic acid 3h (33 mg, 0.22 mmol), 
3-chlorophenylboronic acid 3n (34 mg, 0.22 mmol), Pd(PPh3)4 (23 mg, 10 
mol%), K3PO4 (125 mg, 0.59 mmol) and THF (5 mL), 11d was isolated as
a 1)?2)4
90:#'@%reaction temperature: at 65°C for 8 h, at 90°C 
for 6 h. Mp.190-191°C. 1H NMR (300 MHz, CDCl3):  =  3.79 (s, 3H, 
OCH3), 6.88 (d, 2H, J = 8.73 Hz, ArH), 7.17 (d, 2H, J = 8.73 Hz, ArH), 
7.24 (d, 1H, J = 7.62 Hz, ArH), 7.28-7.46 (m, 8H, ArH), 8.18 (dd, 1H, J = 
1.08, 8.04 Hz, ArH). 13C NMR (75.5 MHz, CDCl3):  = 55.2 (OCH3), 113.6, 125.5, 126.4, 128.0 
(CH), 128.2 (C), 128.7, 129.2, 129.3, 129.8, 129.9, 130.0 (CH), 131.3 (C), 131.9 (CH), 134.6, 
135.5, 135.9, 137.1, 137.3, 140.3, 145.2, 158.7 (C), 182.2 (CO). IR (KBr): v = 3100, 3070, 3053, 
2998, 2947, 2931, 2902, 2831 (w), 1650 (s), 1633 (s), 1605 (w), 1588 (m), 1575, 1564, 1546 (w), 
1510 (m), 1462, 1454 (w), 1432 (s), 1407, 1365 (w), 1307, 1299 (m), 1288 (w), 1237  (s), 1178 
(m), 1165, 1155, 1121 (w), 1106, 1074, 1049, 1025 (m), 963 (w), 941 (m), 928, 898, 885, 866 
(w), 841 (m), 819 (s), 783, 779 (m), 762 (s), 748 (w), 734 (s), 715, 692 (m), 665, 645, 623, 609, 
583, 571 (w), 546 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 428 ([M]+, 72), 427 ([M-H]+, 100), 
413 (10). HRMS (EI, 70 eV): calcd for C26H16ClO2S [M-H]+,9!!%)34,9!
Site-Selective Synthesis of Arylated Indenones by Suzuki–Miyaura Cross-Coupling 
Reactions of 2,3,5-Tribromoinden-1-one 
Synthesis of 2,3,5-Tribromo-1H-inden-1-one (13): A round bottom flask was equipped with 
condenser. Benzene suspension (35 mL) of 5-bromo-indanone 12 (1.50 g, 
7.10 mmol), N-bromosccinamide (4.43 g, 24.9 mmol) and AIBN (0.12 g, 
10 mol %) was refluxed under Argon for 7 h and then cooled to 20°C. 
Reaction mixture was quenched with triethylamine (1 mL) and benzene 
was evaporated in vacuo. Then reaction mixture was diluted with water and extracted with 
CH2Cl2 (3 x 25 mL). The combined organic layers were dried (Na2SO4), filtered and the filtrate 
was concentrated in vacuo. The residue was purified by flash chromatography (silica gel, 
heptanes). 14 were isolated as light yellow crystalline solid (1.60 g, 62%).Mp.160-161°C. 1H 
NMR (300 MHz, CDCl3): δ = 7.26 (d, 1H, J = 7.65 Hz, ArH), 7.28 (d, 1H, J = 1.50 Hz, ArH), 
7.41 (dd, 1H, J = 1.62, 7.65 Hz, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 123.8 (C), 124.0, 
124.7 (CH), 127.6, 129.4 (C), 132.6 (CH), 144.1, 144.6 (C), 185.4 (CO). IR (KBr): v = 3416, 


3084, 3015, 2922, 2850, 2674 (w), 1722 (s), 1594, 1584 (w), 1540, 1438, 1401, 1337 (m), 1260, 
1218 (w), 1200 (s), 1094 (m), 1085, 1054 (s), 1041(m), 959 (w), 933, 876 (s), 811(m), 764, 691, 
680 (s), 618, 593, 577 (m). GC-MS (EI, 70 eV): m/z (%) = 370 ([(M+H), 81Br, 81Br, 81Br]+, 13), 
368 ([(M+H), 79Br, 81Br, 81Br]+, 41), 366 ([(M+H), 79Br, 79Br, 81Br]+, 42), 364 ([(M+H), 79Br, 
79Br, 79Br]+, 15), 287 (100), 259 (23), 178 (17). HRMS (EI, 70 eV): calcd for C9H3Br3O [M, 81Br, 
81Br, 81Br]+, '9  9%)34, '9 ''7/74)9H3Br3O [M, 79Br, 81Br, 81Br]+, 99 #9 %
found: 367.76801, calcd for C9H3Br3O [M, 79Br, 79Br, 81Br]+,  99!#% )34,  99!!
calcd for C9H3Br3O [M, 79Br, 79Br, 79Br]+, 99#%)34, 99#
General procedure (A) for Suzuki cross-coupling reactions of brominated indenone (13): The 
reaction was carried out in a pressure tube. To a 1,4-dioxane suspension (3-5 mL) of the 
brominated indenone, Pd(PPh3)4 or Pd(PPh3)2Cl2 (3-5 mol%) and of the arylboronic acid (1.0-1.1 
per cross coupling), K3PO4 (1.5 equiv. per cross coupling) or an aqueous solution of K2CO3 (2 
M, 1 mL) was added. The mixture was heated at the indicated temperature (45-70°C) under 
Argon atmosphere for the indicated period of time (6-9 h). The reaction mixture was diluted with 
water and extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were dried 
(Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was purified by flash 
chromatography (silica gel, EtOAc/ heptanes). 
Synthesis of triaryl-1H-inden-1-ones 14a-g: 
2,3,5-Triphenyl-1H-inden-1-one (14a): Starting with 13 (80 mg, 0.22 mmol), Pd(PPh3)4 (13 
mg, 5 mol%), 1,4-dioxane (5 mL), K2CO3 (2 M, 1 mL) and 
phenylboronic acid 3i (88 mg, 0.72 mmol), 16a was isolated as a  
brownish yellow solid (65 mg, 83%). reaction temperature: 70°C 
for 6 h. Mp.182-183°C. 1H NMR (300 MHz, CDCl3): δ = 7.17-
7.21 (m, 5H, ArH), 7.26-7.42 (m, 10H, ArH), 7.46-7.49 (m, 2H, 
ArH), 7.57 (d, 1H, J = 7.44 Hz, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 120.5, 123.4, 127.2, 
127.5, 127.8, 128.1, 128.3, 128.5, 128.9, 129.3 (CH), 129.5 (C), 130.0 (CH), 130.7, 132.7, 133.2, 
140.4, 146.1, 146.8, 154.8 (C), 196.1 (CO). IR (KBr): v = 3388, 3054, 3030, 2955, 2921, 2849 
(w), 1704, 1597 (s), 1573, 1485, 1467, 1442 (w), 1355 (m), 1340, 1331, 1279, 1263, 1184 (w), 
1177 (m), 1160, 1143 (w), 1097, 1079, 1063, 1029 (m), 1012, 1000, 963 (w), 939 (m), 917 (w), 
894, 850, 837, 793, 778 (m), 758 (s), 742 (w), 727, 690 (s), 672, 657, 638 (m), 616 (w), 596 (m), 


577, 563 (w) cm-1. GC-MS (EI, 70 eV): m/z (%) = 358 ([M]+, 100), 357 (40), 341 (11). 326 (11), 
252 (15). HRMS (EI, 70 eV): calcd for C27H18O [M]+,#%)34,#9
2,3,5-Tris (4-ethylphenyl)-1H-inden-1-one (14b): Starting with 13 (80 mg, 0.22 mmol), 
Pd(PPh3)4 (13 mg, 5 mol%), 1,4-dioxane (5 mL), K2CO3 (2 M, 1 
mL) and 4-ethylphenylboronic acid 3b (108 mg, 0.72 mmol), 
14b was isolated as a brownish yellow solid (85 mg, 88%). 
reaction temperature: 70°C for 6 h. Mp.104-105°C. 1H NMR 
(300 MHz, CDCl3): δ =1.16-1.23 (m, 9H, 3CH3), 2.54 (q, 2H, J 
= 7.5 Hz, CH2), 2.56-2.66 (m, 4H, 2CH2), 7.02 (d, 2H, J = 8.22 
Hz, ArH), 7.13-7.27 (m, 9H, ArH), 7.36 (dd, 1H, J = 1.35, 7.47 Hz, ArH), 7.40 (d, 2H, J = 8.16 
Hz, ArH), 7.52 (d, 1H, J = 7.44 Hz, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 14.1, 14.2, 14.5 
(CH3), 27.5, 27.6, 27.8 (CH2), 119.3, 122.2, 126.0, 126.1, 126.6 (CH), 127.2 (C), 127.2, 127.3, 
127.6 (CH), 128.4 (C), 128.9 (CH), 129.1, 131.7, 136.8, 142.7, 143.5, 144.5, 145.3, 145.6, 153.2 
(C), 195.4 (CO). IR (KBr): v = 3380, 3023, 2962, 2928, 2873 (w), 1698 (s), 1651, 1633 (w), 
1595 (s), 1538, 1516, 1500 (w), 1455 (m), 1410, 1376 (w), 1351 (m), 1336, 1259 (w), 1181 (m), 
1142, 1116 (w), 1095, 1071, 1048, 1017, 1012 (m), 965 (w), 936 (m), 895, 865, 851 (w), 821, 
786 (s), 740, 729, 703, 674, 660, 638, 623 (w), 568 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 442 
([M]+, 100), 413 (26), 207 (26). HRMS (EI, 70 eV): calcd for C33H30O [M]+,'%)34,
442.22947. 
2,3,5-Tris (4-tert-butylphenyl)-1H-inden-1-one (14c): Starting with 13 (80 mg, 0.22 mmol), 
Pd(PPh3)4 (13 mg, 5 mol%), 1,4-dioxane (5 mL), K2CO3
(2 M, 1 mL) and 4-tert-butylphenylboronic acid 3c (129 
mg, 0.72 mmol), 14c was isolated as a brownish yellow 
solid (98 mg, 85%). reaction temperature: 70°C for 6 h. 
Mp.98-100°C. 1H NMR (300 MHz, CDCl3): δ = 1.23 (s, 
9H, 3CH3), 1.27 (s, 9H, 3CH3), 1.29 (s, 9H, 3CH3), 7.16-
7.23 (m, 4H, ArH), 7.28-7.46 (m, 10H, ArH), 7.53 (d, 1H, J = 7.41 Hz, ArH). 13C NMR (75.5 
MHz, CDCl3): δ = 31.2 (6CH3), 31.3 (3CH3), 34.6, 34.7, 34.9 (C), 120.5, 123.2, 125.0, 125.7, 
125.8, 126.9, 127.0 (CH), 128.0 (C), 128.3 (CH), 129.5 (C), 129.6 (CH), 129.9, 132.6, 146.4, 
146.5, 150.6, 151.4, 152.4, 154.2 (C), 196.6 (CO). IR (KBr): v = 3086, 3035, 2958, 2927, 2903, 
2866, 2183, 2161, 1737 (w), 1704 (s), 1637, 1667, 1658, 1651, 1642, 1620 (w), 1598 (m), 1536, 

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1547, 1526, 1519, 1512, 1495 (w), 1462 (m), 1446, 1423, 1402, 1392 (w), 1362, 1351, 1268, 
1187, 1112, 1093, 1069, 1015, 938 (m), 821 (s), 785 (m), 766, 756, 726, 708, 693, 648, 637, 613, 
595 (w), 579 (m), 558 (s), 538, 528 (w) cm-1. GC-MS (EI, 70 eV): m/z (%) = 526 ([M]+, 100), 
511 (60). 248 (27). HRMS (EI, 70 eV): calcd for C39H42O [M]+: 526.!%)34, '
2,3,5-Tris-(3-methoxyphenyl)-1H-inden-1-one (14d): Starting with 13 (80 mg, 0.22 mmol), 
Pd(PPh3)4 (13 mg, 5 mol%), 1,4-dioxane (5 mL), K2CO3
(2 M, 1 mL) and 3-methoxyphenylboronic acid 3o (109 
mg, 0.72 mmol), 14d was isolated as a brownish yellow 
solid (75 mg, 76%). reaction temperature: 70°C for 6 h. 
Mp.163-165°C. 1H NMR (300 MHz, CDCl3): δ = 3.60 
(s, 3H, OCH3), 3.65 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 6.71-6.90 (m, 6H, ArH), 6.93 (dt, 1H, J
= 1.08, 7.56 Hz, ArH), 7.00 (t, 1H, J = 1.80 Hz, ArH), 7.05-7.14 (m, 2H, ArH), 7.25-7.31 (m, 
3H, ArH), 7.40 (dd, 1H, J = 1.44, 7.41 Hz, ArH), 7.56 (d, 1H, J = 7.47 Hz, ArH). 13C NMR (75.5 
MHz, CDCl3): δ = 54.5, 54.7, 54.8 (OCH3), 112.6, 112.7, 113.1, 113.6, 114.3, 114.6, 119.1, 
120.0, 120.2, 121.9, 122.7, 127.0, 128.5 (CH), 129.0 (C), 129.3, 129.5 (CH), 131.4, 132.5, 133.4, 
141.3, 145.4, 146.1, 154.3, 158.5, 159.2, 159.4 (C), 195.3 (CO). IR (KBr): v =  3371, 3070, 
2999, 2921, 2852, 2830 (w), 1698, 1599, 1581 (s), 1461, 1465, 1453, 1440, 1432, 1317, 1351, 
1329, 1319, 1301 (m), 1290, 1281, 1262, 1236, 1218, 1182, 1165 (s), 1136, 1101, 1079, 1056 
(m), 1046, 1032 (s), 992, (w), 962 (m), 923, 907 (w), 879 (m), 845 (s), 795 (m), 784, 767 (s), 739 
(w), 729, 699, 685, 675 (s), 641, 621, 603, 590, 554 (w) cm-1. GC-MS (EI, 70 eV): m/z (%) = 
448 ([M]+, 100), 417 (11). HRMS (EI, 70 eV): calcd for C30H24O4 [M]+, #  '% )34,
448.16680. 
2,3,5-Tris (3-chlorophenyl)-1H-inden-1-one (14e): Starting with 13 (80 mg, 0.22 mmol), 
Pd(PPh3)4 (13 mg, 5 mol%), 1,4-dioxane (5 mL), K2CO3 (2 M, 1 
mL) and 3-chlorophenylboronic acid 3n (113 mg, 0.72 mmol), 
14e was isolated as a brownish yellow solid (80 mg, 79%). 
reaction temperature: 70°C for 6 h. Mp.135-137°C. 1H NMR (300 
MHz, CDCl3): δ = 7.01 (dt, 1H, J = 1.31, 7.27 Hz, ArH), 7.09-
7.24 (m, 5H, ArH), 7.28-7.44 (m, 8H, ArH), 7.58 (d, 1H, J = 7.44 Hz, ArH). 13C NMR (62.9 
MHz, CDCl3): δ = 120.3, 123.8, 125.4, 126.6, 127.3, 128.0, 128.1, 128.2, 128.3, 128.4, 129.5 
(CH), 129.5 (C), 129.8, 129.9, 130.2, 130.6 (CH), 131.9, 132.5, 134.0, 134.2, 134.9, 135.2, 
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141.9, 145.5, 145.6, 154.0 (C), 194.9 (CO). IR (KBr): v = 3384, 2058, 2955, 2921, 2851 (w), 
1699 (s), 1596, 1579, 1561 (m), 1488 (w), 1461(m), 1437, 1423 (w), 1402, 1344, 1328 (m), 
1297, 1259, 1249, 1218 (w), 1186 (m), 1163,1149 (w), 1078, 1063 (m), 996, 979 (w),  957 (m), 
914, 905 (w), 892, 875, 851, 799 (m), 779, 769, 743, 713 (s), 689 (m), 682, 667 (s), 650, 637, 
602, 592, 574, 556, 545 (w) cm-1. GC-MS (EI, 70 eV): m/z (%) = 464 ([M, 37Cl, 37Cl, 35Cl]+, 37), 
462 ([M, 37Cl,35Cl, 35Cl,]+, 98), 460 ([M, 35Cl, 35Cl, 35Cl,]+, 100), 425 (42), 362 (21), 326 (31). 
HRMS (EI, 70 eV): calcd for C27H15Cl3O [M, 35Cl, 35Cl, 35Cl,]+, !!#!%)34, !!9!
2,3,5-Tris (4-fluorophenyl)-1H-inden-1-one (14f): Starting with 13 (80 mg, 0.22 mmol), 
Pd(PPh3)4 (13 mg, 5 mol%), 1,4-dioxane (5 mL), K2CO3 (2 M, 1 
mL) and 4-fluorophenylboronic acid 3j (101 mg, 0.72 mmol), 14f
was isolated as a brownish yellow solid (73 mg, 81%). reaction 
temperature: 70°C for 6 h. Mp.236-237°C. 1H NMR (300 MHz, 
CDCl3): δ = 6.90 (t, 2H, J = 8.79 Hz, ArH), 7.03-7.10 (m, 4H, 
ArH), 7.15-7.20 (m, 3H, ArH), 7.29-7.34 (m, 2H, ArH), 7.37 (dd, 
1H, J = 1.35, 7.47 Hz, ArH), 7.42-7.47 (m, 2H, ArH), 7.56 (d, 1H, J = 7.44 Hz, ArH). 19F NMR 
(282.4 MHz, CDCl3): δ = -113.6, -112.8, -110.3. 13C NMR (75.5 MHz, CDCl3): δ = 114.4 (d, 
JF,C = 21.5 Hz, CH), 114.9 (d, JF,C = 21.6 Hz, CH), 115.3 (d, JF,C = 21.8 Hz, CH), 119.1, 122.6 
(CH), 125.4 (d, JF,C = 3.37 Hz, C), 126.5 (CH), 127.3 (d, JF,C = 3.54 Hz, C), 128.9 (d, JF,C = 8.21 
Hz, CH), 128.2 (C), 129.5 (d, JF,C = 8.28 Hz, CH), 130.8 (d, JF,C = 7.98 Hz, CH), 131.4 (C), 
135.3 (d, JF,C = 3.25 Hz, C), 144.8, 144.9, 152.5 (C), 161.5 (d, JF,C = 248.8 Hz, C-F), 161.7 (d, 
JF,C = 249.3 Hz, C-F), 162.0 (d, JF,C = 250.8 Hz, C-F), 194.6 (CO). IR (KBr): v = 3375, 3059, 
2956, 2922, 2851 (w), 1697, 1592 (s), 1515, 1496, 1463 (m), 1430, 1410, 1402 (w), 1350 (m), 
1328, 1299, 1275, 1260 (w), 1220 (s), 1185 (m), 1158 (s), 1143, 1094, 1070, 1012 (m), 964, 950, 
935, 908, 871, 857 (w), 827, 812, 799 (s), 787, 748, 740 (m), 722, 712, 700, 661, 620 (w), 569, 
557, 538 (m)  cm-1. GC-MS (EI, 70 eV): m/z (%) = 412 ([M]+, 100), 395 (11), 288 (13). HRMS 
(EI, 70 eV): calcd for C27H15F3O [M]+,! '%)34,!9! 
2,3,5-Tris (3-(trifluoromethyl)phenyl)-1H-inden-1-one (14g): Starting with 14 (80 mg, 0.22 
mmol), Pd(PPh3)4 (13 mg, 5mol%), 1,4-dioxane (5 mL), 
K2CO3 (2 M, 1 mL) and 3-(trifluoromethyl)phenylboronic 
acid 3g (137 mg, 0.72 mmol), 14g was isolated as a  
brownish yellow solid (96 mg, 78%). reaction 




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temperature: 70°C for 6 h. Mp.155-156°C. 1H NMR (300 MHz, CDCl3): δ = 7.20 (d, 1H, J = 
1.17 Hz, ArH), 7.31-7.44 (m, 4H, ArH), 7.48 (dd, 2H, J = 1.17, 7.49 Hz, ArH), 7.52-7.66 (m, 7H, 
ArH), 7.71 (brs, 1H, ArH). 19F NMR (282.4 MHz, CDCl3): δ = -63.1, -63.0, -62.7. 13C NMR 
(75.5 MHz, CDCl3): δ = 120.4 (CH), 123.5 (q, JF,C = 272.7 Hz, CF3), 123.7 (q, JF,C = 272.0 Hz, 
CF3), 123.8 (q, JF,C = 271.3 Hz, CF3),  123.9 (q, JF,C = 3.81 Hz, CH), 124.1 (CH), 124.9 (q, JF,C = 
3.62 Hz, CH), 125.2 (q, JF,C = 3.50 Hz, CH), 125.3 (q, JF,C = 3.83 Hz, CH), 126.5 (q, JF,C = 3.82 
Hz, CH), 126.7 (q, JF,C = 3.90 Hz, CH), 128.6, 128.8, 129.6, 129.9, 130.5 (CH), 130.7 (C), 130.6 
(q, JF,C = 22.6 Hz, C-CF3), 130.7 (q, JF,C = 22.4 Hz, C-CF3), 130.6 (q, JF,C = 24.8 Hz, C-CF3), 
131.6 (CH), 132.7, 132.9 (C), 133.1 (CH), 140.8, 145.4, 145.7, 154.1(C), 194.7 (CO). IR (KBr):
v = 3390, 3065, 2922, 2850 (w), 1706, 1600 (m), 1483, 1469 (w), 1438, 1429, 1361 (m), 1327, 
1314 (s), 1303, 1283, 1241 (m), 1212 (w), 1182, 1162, 1112, 1098, 1067 (s), 1031 (m), 999, 955, 
917, 907, 895, 849, 817 (m), 798 (s), 782, 769, 738 (m), 698, 689 (s), 677, 654 (m), 636, 621, 
601, 533 (w) cm1. GC-MS (EI, 70 eV): m/z (%) = 562 ([M]+, 100), 493 (16). HRMS (EI, 70 eV):
calcd for C30H15F9O [M]+, !'99%)34, !'99
Synthesis of 3-aryl-2,5-dibromo-1H-inden-1-ones 15a-g: 
2,5-Dibromo-3-phenyl-1H-inden-1-one (15a): Starting with 13 (100 mg, 0.27 mmol), 
Pd(PPh3)4 (9 mg, 3 mol%), 1,4-dioxane (5 mL), K3PO4 (86 mg, 0.41 
mmol) and phenylboronic acid 3i (33 mg, 0.27 mmol), 15a was isolated as 
a brownish yellow solid (82 mg, 83%). reaction temperature: 45°C for 9 h. 
Mp.108-110 °C. 1H NMR (300 MHz, CDCl3): δ = 7.19-7.20 (m, 1H, ArH), 
7.32-7.37 (m, 2H, ArH), 7.45-7.57 (m, 5H, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 119.1 (C), 
124.7, 128.1 (CH), 128.5, 128.8 (C), 128.9 (CH), 130.5 (C), 130.6, 131.6 (CH), 146.3, 155.8 (C), 
188.6 (CO). IR (KBr): v = 3422, 3087, 3062, 2921, 2850 (w), 1728 (s), 1681 (w), 1599, 1557 
(m), 1498 (w), 1485, 1442, 1397, 1342 (m), 1299, 1282 (w), 1266 (m), 1190 (w), 1176, 1149, 
1098, 1076, 1051, 1028 (m), 1000, 979, 966 (w), 931, 917, 875, 833, 814 (m), 785 (w), 769, 755, 
714 (m), 688 (s), 663, 634, 611, 586  (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 366 [(M+H), 81Br, 
81Br]+, 51), 364 [(M+H), 79Br, 81Br]+, 100), 362 [(M+H), 79Br, 79Br]+, 51), 285 (27), 176 (51). 
HRMS (EI, 70 eV): calcd for C15H8Br2O [M, 81Br, 81Br]+ , ##'%)34, ##'#7/74
for C15H8Br2O [(M, 79Br, 81Br]+, #' !% )34, #'7/74 )15H8Br2O [M, 79Br, 
79Br]+, #' %)34, #9368. 
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2,5-Dibromo-3-(4-tert-butylphenyl)-1H-inden-1-one (15b): Starting with 13 (100 mg, 0.27 
mmol), Pd(PPh3)4 (9 mg, 3mol%), 1,4-dioxane (5 mL), K3PO4 (86 mg, 
0.41mmol) and 4-tert-butylphenylboronic acid 3c (49 mg, 0.27 mmol), 
15b was isolated as a brownish yellow solid (98 mg, 86%). reaction 
temperature: 45°C for 9 h. Mp.146-148°C. 1H NMR (300 MHz, 
CDCl3): δ = 1.32 (s, 9H, 3CH3), 7.26-7.38 (m, 3H, ArH), 7.48-7.55 (m, 
4H, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 31.2 (3CH3), 35.1, 118.5 (C), 124.5, 124.8, 125.9 
(CH), 127.6 (C), 128.0 (CH), 128.6, 128.7 (C), 131.5 (CH), 146.3, 154.2, 155.8 (C), 188.7 (CO). 
IR (KBr): v = 3427, 3088, 3028, 2960, 2903, 2865 (w), 1720 (s), 1682 (w), 1600, 1592, 1564 
(m), 1495, 1463 (w), 1447 (m), 1400, 1362, 1339 (m), 1309 (w), 1288, 1271, 1190, 1176 (w), 
1155, 1106, 1092, 1047, 1016 (m), 929 (s), 878 (m), 849 (w), 834, 811 (s), 770 (m), 746 (w), 
717, 686, 632 (s), 588 (w), 550 (s) cm-1. GC-MS (EI, 70 eV): m/z (%) = 420 [(M+H), 79Br, 
81Br]+, 49), 418 [(M+H), 79Br, 79Br]+, 24), 405 (100), 377 (17), 202 (11). HRMS (EI, 70 eV):
calcd for C19H16Br2O [(M, 79Br, 81Br]+,''!%)34,''97/74)19H16Br2O [M, 
79Br, 79Br]+,9' %)34,9'9
2,5-Dibromo-3-(3-chlorophenyl)-1H-inden-1-one (15c): Starting with 13 (100 mg, 0.27 
mmol), Pd(PPh3)4 (9 mg, 3 mol%), 1,4-dioxane (5 mL), K3PO4 (86 mg, 
0.41 mmol) and 3-chlorophenylboronic acid 3n (42 mg, 0.27 mmol), 
15c was isolated as a brownish yellow solid (87 mg, 80%). reaction 
temperature: 45°C for 9 h. Mp.120-122°C. 1H NMR (300 MHz, 
CDCl3): δ = 7.15 (d, 1H, J = 1.05 Hz, ArH), 7.35-7.45 (m, 5H, ArH), 7.51-7.52 (m, 1H, ArH). 
13C NMR (62.9 MHz, CDCl3): δ = 120.8 (C), 124.5, 125.0, 126.2, 128.0 (CH), 128.1, 129.0 (C), 
130.3, 130.6, 131.8 (CH), 132.3, 135.1, 145.9, 154.3 (C), 188.2 (CO). IR (KBr): v = 3415, 3064, 
2918, 2849, 2156, 2137 (w), 1721 (s), 1682 (w), 1598, 1585, 1553 (m), 1519, 1504 (w), 1469, 
1446, 1420, 1397, 1336 (m), 1302 (w), 1272 (m), 1221, 1179, 1166, 1152 (w), 1097, 1090, 1080, 
1050 (m), 997 (w), 950 (m), 909 (w), 884, 834, 817 (m), 786 (s), 767 (m), 746, 732 (w), 712 (m), 
705 (s), 682 (m), 665 (w), 649, 638 (m), 618, 599 (w), 588 (m) cm-1. GC-MS (EI, 70 eV): m/z
(%) = 400 [(M+H), 81Br, 81Br]+, 63), 398 [(M+H), 79Br, 81Br]+, 100), 396 [(M+H), 79Br, 79Br]+, 
43), 319 (33), 210 (29), 174 (20). HRMS (EI, 70 eV): calcd for C15H7Br2ClO [M, 81Br, 81Br]+: 
''#!#% )34, ''#!9 7/74 ) 15H7Br2ClO [M, 79Br, 81Br]+, '9# % )34,
397.85271, calcd for C15H7Br2ClO [M, 79Br, 79Br]+,'# 9%)34,'#!
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2,5-Dibromo-3-(3-(trifluoromethyl)phenyl)-1H-inden-1-one (15d): Starting with 13 (100 mg, 
0.27 mmol), Pd(PPh3)4 (9 mg, 3 mol%), 1,4-dioxane (5 mL), K3PO4
(86 mg, 0.41 mmol) 3-(trifluoromethyl)phenylboronic acid 3g (51 
mg, 0.27 mmol), 15d was isolated as a brownish yellow solid (94 mg, 
80%). reaction temperature: 45°C for 9 h. Mp.111-113°C. 1H NMR 
(300 MHz, CDCl3): δ = 7.12 (d, 1H, J = 0.96 Hz, ArH), 7.35-7.42 (m, 
2H, ArH), 7.61-7.74 (m, 3H, ArH), 7.81 (brs, 1H, ArH). 19F NMR (282.4 MHz, CDCl3): δ = -
62.8. 13C NMR (75.5 MHz, CDCl3): δ = 123.6 (q, JF,C = 272.8 Hz, CF3), 124.4 (CH), 125.0 (q, 
JF,C = 3.85 Hz, CH), 125.1 (CH), 127.2 (q, JF,C = 3.56 Hz, CH), 128.1, 129.1 (C), 129.7, 131.3 
(CH), 131.5 (C), 131.6 (q, JF,C = 32.80 Hz, C-CF3), 132.0 (CH), 145.8, 154.2 (C), 188.1 (CO). IR 
(KBr): v = 3413, 3074, 2959, 2929, 2854 (w), 1716 (m), 1582, 1614 (w), 1595, 1586, 1556 (m), 
1491(w), 1449, 1428, 1404, 1345 (m), 1326 (s), 1296, 1265 (w), 1250 (m), 1182 (w), 1165, 1150 
(m), 1122, 1094, 1073, 1054 (s), 934, 926, 880, 861, 833, 818 (m), 800 (s), 766, 718, 703 (m), 
697 (s), 677, 651, 622, 600, 585 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 434 [(M+H), 81Br, 
81Br]+, 48), 432 [(M+H), 79Br, 81Br]+, 100), 430 [(M+H), 79Br, 79Br]+, 51), 351 (35), 244 (36). 
HRMS (EI, 70 eV): calcd for C16H7F3Br2O [M, 81Br, 81Br]+,#9 '%)34,#99!7/74
for C16H7F3Br2O [M, 79Br, 81Br]+, #9#'#% )34, #9#9# 7/74 ) 16H7F3Br2O [M, 
79Br, 79Br]+,'##!%)34,'##! 
2,5-Dibromo-3-(4-(trifluoromethoxy)phenyl)-1H-inden-1-one (15e): Starting with 13 (100 
mg, 0.27 mmol), Pd(PPh3)4 (9 mg, 3 mol%), 1,4-dioxane (5 mL), 
K3PO4 (86 mg, 0.41 mmol) and 4-(trifluoromethoxy)phenylboronic 
acid 3p (56 mg, 0.27 mmol), 15e was isolated as a brownish yellow 
solid (95 mg, 78%). reaction temperature: 45°C for 9 h. Mp.113-
115°C. 1H NMR (300 MHz, CDCl3): δ = 7.18-7.19 (m, 1H, ArH), 
7.32-7.38 ((m, 4H, ArH), 7.61 (d, 2H, J = 8.85 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):  δ = -
57.6. 13C NMR (75.5 MHz, CDCl3): δ = 118.8 (C), 119.4 (q, JF,C = 259.6 Hz, OCF3), 120.2, 
123.5, 123.9 (CH), 127.2, 127.9, 128.0 (C), 128.9, 130.8 (CH), 144.9, 149.5, 153.3 (C), 187.2 
(CO). IR (KBr): v = 3024, 3089, 2921, 2850 (w), 1729, 1609, 1597, 1590, 1504 (m), 1446,1399, 
1342 (w), 1301 (m), 1246, 1205, 1149, 1116, 1049, 1052, 1017 (s), 969, 953 (w), 925 (m), 887 
(w), 832, 816, 802, 765 (m), 732 (w), 717, 688 (m), 666, 644, 631 (w), 619 (m), 537 (w) cm-1. 
GC-MS (EI, 70 eV): m/z (%) = 450 ([(M+H), 81Br, 81Br]+, 50), 448 ([(M+H), 79Br, 81Br]+, 100), 

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446 ([(M+H), 79Br, 79Br]+, 51), 367 (29), 260 (21). HRMS (EI, 70 eV): calcd for C16H7F3Br2O2 
[M, 81Br, 81Br]+, '#9#% )34, '#99! 7/74 ) 16H7F3Br2O2 [M, 79Br, 81Br]+: 
9#9#'% )34, 9#9 7/74 ) 16H7F3Br2O2 [M, 79Br, 79Br]+,  #9'% )34,
445.87555. 
2,5-Dibromo-3-p-tolyl-1H-inden-1-one (15f): Starting with 13 (100 mg, 0.27 mmol), Pd(PPh3)4
(9 mg, 3 mol%), 1,4-dioxane (5 mL), K3PO4 (86 mg, 0.41 mmol) and                
p-tolylboronic acid 3e (37 mg, 0.27 mmol), 15f was isolated as a  
brownish yellow solid (88 mg, 86%). reaction temperature: 45°C for 9 h. 
Mp.129-131°C. 1H NMR (300 MHz, CDCl3): δ = 2.38 (s, 3H, CH3), 7.21-
7.22 (m, 1H, ArH), 7.29 (d, 2H, J = 8.07 Hz, ArH), 7.33-7.37 (m, 2H, 
ArH), 7.26 (d, 2H, J = 8.19 Hz, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 
21.7 (CH3), 118.5 (C), 124.6, 124.7 (CH), 127.7 (C), 128.1 (CH), 128.6, 128.7 (C), 129.6, 131.5 
(CH), 141.2, 146.3, 155.9 (C), 188.6 (CO). IR (KBr): v = 3424, 3089, 3027, 2915, 2850 (w), 
1729 (s), 1599, 1590, 1564, 1556, 1444 (m), 1398 (w), 1343, 1289, 1270, 1184, 1150, 1097, 
1053 (m), 1019 (w), 928, 880, 835 (m), 810 (s), 779 (w), 765, 720, 715, 687 (m), 654 (w), 631, 
588 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 380 ([(M+H), 81Br, 81Br]+, 50), 378 ([(M+H), 79Br, 
81Br]+, 100), 376 ([(M+H), 79Br, 79Br]+, 52), 297 (25), 189 (50). HRMS (EI, 70 eV): calcd for 
C16H10Br2O [M, 81Br, 81Br]+, 9''!!% )34, 9''!99 7/74 ) 16H10Br2O [M, 79Br, 
81Br]+,99'!9%)34,99'!9'7/74)16H10Br2O [M, 79Br, 79Br]+,9'!''%)34,
375.90918. 
2,5-Dibromo-3-(4-methoxyphenyl)-1H-inden-1-one (15g): Starting with 13 (100 mg, 0.27 
mmol), Pd(PPh3)4 (9 mg, 3 mol%), 1,4-dioxane (5 mL), K3PO4 (86 mg, 
0.41 mmol) and 4-methoxyphenylboronic acid 3h (41 mg, 0.27 mmol), 
15g was isolated as a brownish yellow solid (99 mg, 92%). reaction 
temperature: 45°C for 9 h. Mp.194-195°C. 1H NMR (300 MHz, CDCl3): 
δ = 3.84 (s, 3H, OCH3), 6.70 (d, 2H, J = 8.88 Hz, ArH), 7.26 (d, 1H, J = 
0.93 Hz, ArH), 7.32-7.36 (m, 2H, ArH), 7.56 (d, 2H, J = 8.85 Hz, ArH). 
13C NMR (62.9 MHz, CDCl3): δ = 55.5 (OCH3), 114.4 (CH), 117.8, 122.8 (C), 124.5, 124.7 
(CH), 128.5, 128.8 (C), 130.0, 131.5 (CH), 146.3, 155.5, 161.5 (C), 188.7 (CO). IR (KBr): v = 
3409, 3070, 3025, 2985, 2955, 2921, 2850, 2282, 2035 (w), 1715, 1597 (s), 1567, 1555 (m), 
1503 (s), 1470 (w), 1444, 1419 (m), 1401(w), 1341, 1307, 1275 (m), 1257 (s), 1193 (w), 1173 


(s), 1152, 1118, 1102, 1091, 1052 (m), 1017 (s), 954 (w), 927 (m), 873 (w), 822, 813 (s), 782, 
766, 732, 712, 690, 632, 621, 576 (m), 528 (s) cm-1. GC-MS (EI, 70 eV): m/z (%) = 396 
([(M+H), 81Br, 81Br]+, 52), 394 ([(M+H), 79Br, 81Br]+, 100), 392 ([(M+H), 79Br, 79Br]+, 53), 313 
(10), 191 (09), 163 (34). HRMS (EI, 70 eV): calcd for C16H10Br2O2 [M, 81Br, 81Br]+,''!!%
found: 395.90004, calcd for C16H10Br2O2 [M, 79Br, 81Br]+: 393.'! % )34,''! 7/74
for C16H10Br2O2 [M, 79Br, 79Br]+,''!%)34,''!9!
Synthesis of symmetrical 2,3-diaryl-5-bromo-1H-inden-ones 16a-g: 
5-Bromo-2,3-bis(4-ethylphenyl)-1H-inden-1-one (16a): Starting with 13 (100 mg, 0.27 
mmol), Pd(PPh3)4 (15 mg, 5 mol%), 1,4-dioxane (5mL), K3PO4
(172 mg, 0.81 mmol) and 4-ethylphenylboronic acid 3b (82 mg, 
0.55 mmol), 16a was isolated as a brownish yellow solid (100 mg, 
88%). reaction temperature: 60°C for 6 h. Mp.102-104°C. 1H NMR 
(300 MHz, CDCl3): δ = 1.15 (t, 3H, J = 7.56 Hz, CH3), 1.23 (t, 3H, 
J = 7.56 Hz, CH3), 2.55 (q, 2H, J = 7.59 Hz, CH2), 2.64 (q, 2H, J = 7.59 Hz, CH2), 7.03 (d, 2H, J 
= 8.43 Hz, ArH), 7.14 (d, 2H, J = 8.31 Hz, ArH), 7.19-7.24 (m, 5H, ArH),  7.33-7.38 (m, 2H, 
ArH). 13C NMR (75.5 MHz, CDCl3): δ = 14.1, 14.2 (CH3), 27.7, 28.8 (CH2), 123.9, 124.6, 127.7 
(CH), 128.1 (C), 128.4, 128.5 (CH), 129.5, 129.6 (C), 129.9, 131.4 (CH), 132.9, 144.1, 145.9, 
147.5, 153.6 (C), 195.0 (CO). IR (KBr): v = 3389, 3068, 3034, 2961, 2923, 2851, 1737, 1731 
(w), 1702 (s), 1590, 1576, 1501, 1454, 1411, 1350 (m), 1328 (w), 1259, 1174, 1116, 1095, 1068 
(m), 1047, 1017 (s), 961, 953 (w), 930, 883, 862, 837(m), 819 (s), 801 (m), 765, 743, 735, 718 
(w), 699, 661, 648, 638, 582, 564, 527 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 416 ([M, 79Br]+, 
100), 387 (36), 263 (23). HRMS (EI, 70 eV): calcd for C25H21BrO [M, 79Br]+, !99!%)34,
416.07706. 
5-Bromo-2,3-bis(4-tert-butylphenyl)-1H-inden-1-one (16b): Starting with 13 (100 mg, 0.27 
mmol), Pd(PPh3)4 (15 mg, 5 mol%), 1,4-dioxane (5 mL), K3PO4
(172 mg, 0.81 mmol) and 4-tert-butylphenylboronic acid 3c (98 
mg, 0.55 mmol), 16b was isolated as a brownish yellow solid 
(107 mg, 83%). reaction temperature: 60°C for 6 h. Mp188-
190°C. 1H NMR (300 MHz, CDCl3): δ = 1.22 (s, 9H, 3CH3), 
1.29 (s, 9H, 3CH3), 7.15 (d, 2H, J = 8.49 Hz, ArH), 7.19-7.26 
(m, 5H, ArH), 7.34-7.39 (m, 4H, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 31.3 (6CH3), 34.7, 

	


34.9 (C), 123.9, 124.7, 125.1, 125.9 (CH), 127.4 (C), 128.2 (CH), 129.3, 129.5 (C), 129.6, 131.3 
(CH), 132.8, 147.7, 151.0, 152.8, 153.5 (C), 195.7 (CO). IR (KBr): v = 3099, 3058, 3046, 3027, 
2960, 2928, 2903, 2865 (m), 1707 (s), 1602, 1589, 1577 (m), 1556, 1459 (w), 1459, 1396, 1362, 
1349, 1262 (m), 1199, 1181, 1113, 1104, 1092 (w), 1069, 1050, 1014 (m), 975, 958 (w), 933,  
865, 857, 850, 841, 829 (m), 818 (s), 779, 739, 730 (m), 654, 635, 625, 566 (w), 559 (s) cm-1. 
GC-MS (EI, 70 eV): m/z (%) = 474 ([M, 81Br]+, 75), 472 ([M, 79Br]+, 73), 459 (100), 457 (98), 
194 (16). HRMS (EI, 70 eV): calcd for C29H29BrO [M, 81Br]+, 99#% )34, 9#!%
calcd for C29H29BrO [M, 79Br]+,9' %)34,9'
5-Bromo-2,3-bis(3-methoxyphenyl)-1H-inden-1-one (16c): Starting with 13 (100 mg, 0.27 
mmol), Pd(PPh3)4 (15 mg, 5 mol%), 1,4-dioxane (5 mL), K3PO4
(172 mg, 0.81 mmol) and 3-methoxyphenylboronic acid 3o (83 
mg, 0.55 mmol), 18c was isolated as a brownish yellow solid (86 
mg, 75%). reaction temperature: 60°C for 6 h. Mp.164-166°C. 1H 
NMR (300 MHz, CDCl3): δ = 3.59 (s, 3H, OCH3), 3.65 (s, 3H, 
OCH3), 6.72-6.89 (m, 6H, ArH), 7.10 (t, 1H, J = 7.68 Hz, ArH), 7.18-7.20 (m, 1H, ArH), 7.31 (t, 
1H, J = 7.90 Hz, ArH), 7.33-7.39 (m, 2H, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 55.1, 55.3 
(OCH3), 113.7, 114.4, 115.0, 115.3, 120.6, 122.5, 124.1, 124.8 (CH), 128.4 (C), 129.2 (CH), 
129.3 (C), 130.2 (CH), 131.5 (C), 131.7 (CH), 133.3, 133.5, 147.2, 154.2, 159.2, 159.9 (C), 
195.1 (CO). IR (KBr): v = 3400, 3070, 2999, 2954, 2919, 2849, 2833 (w), 1709, 1590, 1575 (s), 
1479, 1453,1426 (m), 1401 (w), 1348, 1329, 1286 (m), 1263 (w), 1228 (m), 1171, 1132, 1093 
(m), 1042 (s), 960 (m), 929, 919 (w), 887, 879, 832 (m), 786, 772 (s), 721, 688 (s), 647 (m), 606 
(w), 593 (m), 566, 556 (w) cm-1. GC-MS (EI, 70 eV): m/z (%) = 422 ([M, 81Br]+, 71), 420 ([M, 
79Br]+, 100), 389 (15), 298 (15), 226 (36). HRMS (EI, 70 eV): calcd for C23H17BrO3 [M, 81Br]+: 
!%)34,!97/74)23H17BrO3 [M, 79Br]+,!! %)34,!!9
5-Bromo-2,3-bis(4-fluorophenyl)-1H-inden-1-one (16d): Starting with 13 (100 mg, 0.27 
mmol), Pd(PPh3)4 (15 mg, 5 mol%), 1,4-dioxane (5 mL), K3PO4 (172 
mg, 0.81 mmol) and 4-fluorophenylboronic acid 3j (77 mg, 0.55 
mmol), 16d was isolated as a brownish yellow solid (84 mg, 78%). 
reaction temperature: 60°C for 6 h. Mp.184-185°C. 1H NMR (300 
MHz, CDCl3): δ = 6.90 (t, 2H, J = 8.61 Hz, ArH), 7.07 (t, 2H, J = 
8.61 Hz, ArH), 7.13-7.18 (m, 3H, ArH), 7.24-7.29 (m, 2H, ArH), 7.34-7.41 (m, 2H, ArH). 19F 


NMR (282.4 MHz, CDCl3): δ = -112.3, -109.8. 13C NMR (75.5 MHz, CDCl3): δ = 115.4 (d, JF,C 
= 21.7 Hz, CH), 116.4 (d, JF,C = 21.9 Hz, CH), 124.2, 124.6 (CH), 126.1 (d, JF,C = 3.56 Hz, C),  
127.9 (d, JF,C = 3.49 Hz, C), 128.5, 129.1 (C), 130.4 (d, JF,C = 8.31 Hz, CH), 131.8 (d, JF,C = 7.71 
Hz, CH), 131.9 (CH), 132.5, 146.9, 152.9 (C), 162.9 (d, JF,C = 249.3 Hz, CF), 163.2 (d, JF,C = 
251.2 Hz, CF), 194.9 (CO). IR (KBr): v = 3407, 3076, 3047, 2922, 2852, 2158, 1895 (w), 1709 
(s), 1596, 1584, 1575 (s), 1511(m), 1499 (s), 1456, 1404, 1351, 1330, 1301 (m), 1278 (w), 1224 
(s), 1178 (m), 1159 (s), 1093, 1065, 1050, 1015, 941, 927, 880, 864, 856, 845 (m), 825, 818 (s), 
800, 776, 744, 732, 694, 662, 631, 619, 592, 567(m), 546, 532 (s) cm-1. GC-MS (EI, 70 eV): m/z 
(%) = 398 ([(M+H), 81Br]+, 98), 396 ([(M+H), 79Br]+, 100), 317 (52), 288 (79). HRMS (EI, 70 
eV): calcd for C21H11F2BrO [M, 81Br]+, '9''% )34, '9'' 7/74 )21H11F2BrO
[M, 79Br]+,''''%)34,'''
5-Bromo-2,3-bis(3-(trifluoromethyl)phenyl)-1H-inden-1-one (16e): Starting with 13 (100 mg, 
0.27 mmol), Pd(PPh3)4 (15 mg, 5 mol%), 1,4-dioxane (5 mL), 
K3PO4 (172 mg, 0.81 mmol) and 3-(trifluoromethyl)phenylboronic 
acid 3g (104 mg, 0.55 mmol), 16e was isolated as a brownish 
yellow solid (105 mg, 77%). reaction temperature: 60°C for 6 h. 
Mp.150-152°C. 1H NMR (300 MHz, CDCl3): δ = 7.15 (d, 1H, J = 
1.02 Hz, ArH), 7.32-7.57 (m, 9H, ArH), 7.15 (brs, 1H, J = 7.68 Hz, ArH). 19F NMR (282.4 MHz, 
CDCl3): δ = -63.1, -63.0. 13C NMR (75.5 MHz, CDCl3): δ = 123.3 (q, JF,C = 272.8 Hz, CF3), 
123.4 (q, JF,C = 272.5 Hz, CF3), 124.7, 124.8 (CH), 125.1 (q, JF,C = 3.54 Hz, CH), 125.2 (q, JF,C = 
3.58 Hz, CH), 126.6 (q, JF,C = 3.69 Hz, CH), 126.7 (q, JF,C = 3.76 Hz, CH), 128.8 (C), 128.9, 
129.9 (CH), 130.4 (C), 130.9 (q, JF,C = 32.5 Hz, C-CF3), 131.5 (CH), 132.0 (q, JF,C = 32.9 Hz, C-
CF3), 132.5 (CH), 132.5, 132.8 (C), 133.1 (CH), 146.2, 153.5 (C), 194.0 (CO). IR (KBr): v = 
3070, 2923, 2851, 2143 (w), 1704 (s), 1600, 1583 (m), 1479 (w), 1442 (m), 1403 (w), 1354 (m), 
1324, 1313, 1295 (s), 1276, 1261, 1163 (m), 1120, 1097, 1068 (s), 1051 (m), 1000 (w), 951 (m), 
932 (w), 911,  881, 861, 840 (m), 806 (s), 781, 769, 740, 720 (m), 698 (s), 672, 658 (m), 650, 
642, 631, 621 (w), 595 (m), 530 (w) cm-1. GC-MS (EI, 70 eV): m/z (%) = 498 ([(M+H), 81Br]+, 
98), 496 ([(M+H), 79Br]+, 100), 417 (20), 397 (22), 320 (30). HRMS (EI, 70 eV): calcd for 
C23H11F6BrO [M, 81Br]+, '9'#9% )34, '9'# 9 7/74 ) 23H11F6BrO [M, 79Br]+: 
''#'!%)34,''##'#


5-Bromo-2,3-bis(4-methoxyphenyl)-1H-inden-1-one (16f): Starting with 13 (100 mg, 0.27 
mmol), Pd(PPh3)4 (15 mg, 5 mol%), 1,4-dioxane (5 mL), 
K3PO4 (172 mg, 0.81 mmol) and 4-methoxyphenylboronic 
acid 3h (83 mg, 0.55 mmol), 18f was isolated as a brownish 
yellow solid (98 mg, 85%). reaction temperature: 60°C for 6 h. 
Mp.126-128°C. 1H NMR (300 MHz, CDCl3): δ = 3.72 (s, 3H, 
OCH3), 3.79 (s, 3H, OCH3), 6.75 (d, 2H, J = 8.91 Hz, ArH), 
6.88 (d, 2H, J = 8.85 Hz, ArH), 7.16 (d, 2H, J = 8.94 Hz, ArH), 7.21 (brs, 1H, ArH), 7.25 (d, 2H, 
J = 8.82 Hz, ArH), 7.33-7.34 (m, 2H, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 55.2, 55.34 
(OCH3), 113.1, 113.8 (CH), 122.9 (C), 123.2, 123.8 (CH), 124.6, 128.1, 129.6 (C), 130.1, 131.2, 
131.3 (CH), 132.2, 147.6, 152.6, 159.4, 160.5 (C), 195.7 (CO). IR (KBr): v = 3409, 3071, 3026, 
2987, 2956, 2920, 2850, 1898 (w), 1715, 1597, 1555, 1503, 1444 (s), 1420, 1401, 1342, 1307, 
1275 (m), 1257, 1173 (s), 1152, 1118, 1103, 1091, 1052 (m), 1017 (s), 954 (w), 927 (m), 872 
(w), 821 (s), 782, 766, 732, 712, 690, 632, 621, 588, 576 (m), 528 (s) cm-1. GC-MS (EI, 70 eV): 
m/z (%) = 422 ([M, 81Br]+, 98), 420 ([M, 79Br]+, 100), 405 (12), 255 (13), 226 (26). HRMS (EI, 
70 eV): calcd for C23H17BrO3 [M, 81Br]+, !% )34,! ! 7/74 )23H17BrO3 
[M, 79Br]+,!! %)34,!!9
5-Bromo-2,3-bis(4-chlorophenyl)-1H-inden-1-one (16g): Starting with 13 (100 mg, 0.27 
mmol), Pd(PPh3)4 (15 mg, 5 mol%), 1,4-dioxane (5 mL), K3PO4
(172 mg, 0.81 mmol) and 4-chlorophenylboronic acid 3f (86 mg, 
0.55 mmol), 16g was isolated as a brownish yellow solid (102 mg, 
87%). reaction temperature: 60°C for 6 h. Mp.172-174°C. 1H NMR 
(300 MHz, CDCl3): δ = 7.09 (d, 2H, J = 8.64 Hz, ArH), 7.14-7.22 
(m, 5H, ArH), 7.33-7.40 (m, 4H, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 124.4, 124.6 (CH), 
128.4, 128.6 (C), 128.7 (CH), 129.1 (C), 129.6, 129.7 (CH), 130.3 (C), 131.2, 132.0 (CH), 132.5, 
134.5, 135.9, 146.6, 153.1 (C), 194.5 (CO). IR (KBr): v = 3419, 3089, 3075, 3063, 2919, 2850 
(w), 1715 (s), 1601, 1586, 1574, 1557, 1484, 1454, 1395, 1348 (m), 1330, 1305, 1282, 1265, 
1210 (w), 1174, 1150 (m), 1087 (s), 1063, 1045 (m), 1013 (s), 974, 955, 946 (w), 929, 877, 858, 
832, 821 (m), 812 (s), 776 (m), 740 (w), 726 (m), 715, 707, 688, 647, 630, 626, 618, 589 (w) cm-
1. GC-MS (EI, 70 eV): m/z (%) = 430 ([M, 81Br, 35Cl, 35Cl]+, 100), 428 ([(M+H), 79Br, 35Cl, 
35Cl]+, 61), 395 (20), 314 (30), 286 (30), 250 (53). HRMS (EI, 70 eV): calcd for C21H11Cl2BrO
[M, 79Br, 35Cl, 35Cl]+: 427.93648, found: 427.93635. 


General procedure (B) for Suzuki cross-coupling reactions of brominated indenone (13): The 
reaction was carried out in a pressure tube. To a 1,4-dioxane suspension (3-5 mL) of the 
brominated indenone, Pd(PPh3)4 or Pd(PPh3)2Cl2 (5 mol%) and of the Ar1B(OH)2 (1.0 equiv. per 
cross-coupling), K3PO4 (1.5 equiv. per cross coupling) or an aqueous solution of K2CO3 (2 M, 1 
mL) was added. The mixture was heated at the indicated temperature (45°C) under Argon 
atmosphere for the indicated period of time (9 h) and cooled to room temperature. Then 
Ar2B(OH)2 (1.0-1.1 equiv. per cross-coupling) was added and reaction mixture was further 
heated (6 h) at 60°C. The reaction mixture was again cooled to room temperature and diluted 
with water and extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were dried 
(Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was purified by flash 
chromatography (silica gel, EtOAc/ heptanes). 
Synthesis of unsymmetrical 2,3-diaryl-5-bromo-1H-inden-ones 17a-c:
5-Bromo-3-(4-ethylphenyl)-2-(4-methoxyphenyl)-1H-inden-1-one (17a): Starting with 13 
(100 mg, 0.27 mmol), Pd(PPh3)4 (15 mg, 5 mol%), was added 
1,4-dioxane (5 mL), K3PO4 (172 mg, 0.81 mmol), 4-
ethylphenylboronic acid 3b (40 mg, 0.27 mmol) and 4-
methoxyphenylboronic acid 3h (41 mg, 0.27 mmol) following the 
general procedure B, 17a was isolated as a brownish yellow 
solid (92 mg, 80%). reaction temperature: at 45°C for 9h, at 60°C for 6 h. Mp.120-122°C. 1H 
NMR (300 MHz, CDCl3): δ = 1.21 (t, 3H, J = 7.59 Hz, CH3), 2.63 (q, 2H, J = 7.62 Hz, CH2), 
3.71 (s, 3H, OCH3), 6.73 (d, 2H, J = 8.91 Hz, ArH), 7.13-7.22 (m, 7H, ArH), 7.31-7.34 (m, 2H, 
ArH). 13C NMR (62.9 MHz, CDCl3): δ = 15.2 (CH3), 28.8 (CH2), 55.2 (OCH3), 113.7 (CH), 
122.8 (C), 123.8, 124.4 (CH), 128.2 (C), 128.4, 128.5 (CH), 129.5, 129.6 (C), 131.2, 131.3 (CH), 
132.5, 145.8, 147.6, 152.8, 159.4 (C), 195.7 (CO). IR (KBr): v = 3419, 3079, 2997, 2962, 2925, 
2852, 2836 (w), 1709 (s), 1600, 1589, 1577, 1514, 1500, 1453, 1444 (m), 1400, 1349, 1329, 
1293 (w), 1248, 1183 (s), 1049, 1117, 1093 (w), 1065, 1049, 1029, 1017 (m), 930 (s), 880, 852 
(m), 838, 820 (s), 774 (m), 743, 733, 717 (w), 699 (m), 681, 660, 649, 632 (w), 582, 561, 540, 
526 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 420 ([M, 81Br]+, 100), 418 ([M, 79Br]+, 96), 239 
(19). HRMS (EI, 70 eV): calcd for C24H19BrO2 [M, 81Br]+,!!%)34,!! #%7/74
for C24H19BrO2 [M, 79Br]+,#! '%)34,#! 


5-Bromo-3-(4-chlorophenyl)-2-(4-ethylphenyl)-1H-inden-1-one (17b): Starting with 13 (100 
mg, 0.27 mmol), Pd(PPh3)4 (15 mg, 5 mol%), was added 1,4-
dioxane (5 mL), K3PO4 (172 mg, 0.81 mmol), 4-
chlorophenylboronic acid 3f (42 mg, 0.27 mmol) and 4-
ethylphenylboronic acid 3b (40 mg, 0.27 mmol) following the 
general procedure B, 17b was isolated as a brownish yellow solid 
(92 mg, 79%). reaction temperature: at 45°C for 9h, at 60°C for 6 h. Mp.133-134°C. 1H NMR 
(300 MHz, CDCl3): δ = 1.14 (t, 3H, J = 7.59 Hz, CH3), 2.54 (q, 2H, J = 7.59 Hz, CH2), 7.02-7.11 
(m, 4H, ArH), 7.13 (brs, 1H, ArH), 7.23 (d, 2H, J = 8.57 Hz, ArH), 7.33-7.35 (m, 4H, ArH). 13C 
NMR (75.5 MHz, CDCl3): δ = 15.2 (CH3), 28.7 (CH2), 124.2, 124.3 (CH), 127.2 (C), 127.9 
(CH), 128.4, 129.2 (C), 129.4, 129.8, 129.9 (CH), 130.8 (C), 131.6 (CH), 133.8, 135.4, 144.6, 
147.1, 152.0 (C), 195.1 (CO). IR (KBr): v = 3390, 3082, 3060, 3030, 2964, 2917, 2871, 2849 
(w), 1705 (s), 1597, 1582, 1574 (m), 1508 (w), 1484, 1450, 1396, 1349, 1328 (m), 1259 (w), 
1171, 1148 (m), 1120, 1108 (w), 1088 (s), 1068, 1047 (m), 1012 (s), 969, 951 (w), 930, 875, 
860, 853 (m), 827, 819 (s), 779, 742, 733, 716, 692, 654, 637, 620, 589, 569, 534 (m) cm-1. GC-
MS (EI, 70 eV): m/z (%) = 426 ([M, 37Cl, 81Br]+, 26), 424 ([M, 35Cl, 81Br]+, 100), 422 ([M, 35Cl, 
79Br]+, 76), 409 (33), 263 (28). HRMS (EI, 70 eV): calcd for C23H16BrClO [M, 35Cl, 79Br]+: 
!! 9 %)34,!!
5-Bromo-3-(4-chlorophenyl)-2-(4-methoxyphenyl)-1H-inden-1-one (17c): Starting with 13 
(100 mg, 0.27 mmol), Pd(PPh3)4 (15 mg, 5 mol%), was added 1,4-
dioxane (5 mL), K3PO4 (172 mg, 0.81 mmol), 4-
chlorophenylboronic acid 3f (42 mg, 0.27 mmol) and 4-
methoxyphenylboronic acid 3h (41 mg, 0.27 mmol) following the 
general procedure B, 17c was isolated as a brownish yellow solid 
(95 mg, 82%). reaction temperature: at 45°C for 9h, at 60°C for 6 h. Mp.170-171°C. 1H NMR 
(250 MHz, CDCl3): δ = 3.71 (s, 3H, OCH3), 6.74 (d, 2H, J = 8.43 Hz, ArH), 7.11-7.18 (m, 3H, 
ArH), 7.23 (d, 2H, J = 8.10 Hz, ArH), 7.31-7.36 (m, 4H, ArH). 13C NMR (62.9 MHz, CDCl3): δ
= 54.2 (OCH3), 112.8 (CH), 121.2 (C), 123.1 (CH), 127.4, 128.1 (C), 128.4, 128.8 (CH), 129.9 
(C), 130.3, 130.4 (CH), 132.2, 134.3, 146.2, 150.0, 158.6 (C), 194.3 (CO). IR (KBr): v = 3041, 
3059, 3018, 2958, 2930, 2838 (w), 1709, 1600, 1576 (s), 1510, 1485, 1455, 1445 (m), 1416, 
1407, 1396 , 1352 , 1329 (w), 1295 (m), 1251, 1174 (s), 1152, 1114 (w), 1090 (s), 1065, 1047 
(m), 1024, 1013 (s), 974, 957, 946 (w), 929 (s), 879, 846 (m), 828, 812 (s), 779, 742, 734, 717, 


691, 654 (m), 643, 632, 618, 590 (w), 566, 536 (s)  cm-1. GC-MS (EI, 70 eV): m/z (%) = 426 
([(M+H), 81Br, 35Cl]+, 100), 424 ([M+H), 79Br, 35Cl]+, 77), 267 (16), 239 (37). HRMS (EI, 70 
eV): calcd for C22H14BrClO2 [M, 81Br, 35Cl]+, '#'9% )34, '#!% 7/74 )
C22H14BrClO2 [M, 79Br, 35Cl]+: 423.'# !%)34,.98530. 
Synthesis of unsymmetrical 2,3,5-triaryl-1H-inden-ones 18a-c and 19a,b:  
2,5-Bis(4-tert-butylphenyl)-3-(4-methoxyphenyl)-1H-inden-1-one (18a): Starting with 15g (78 
mg, 0.199 mmol), Pd(PPh3)4 (11 mg, 5 mol%), 1,4-
dioxane (5 mL), K2CO3 (2 M, 1 mL) and 4-tert-
butylphenylboronic acid 3c (82 mg, 0.43 mmol), 
following the general procedure A, 18a was isolated as 
a brownish yellow solid (77 mg, 78%). reaction 
temperature: 70°C for 6 h. Mp.188-190°C. 1H NMR 
(300MHz, CDCl3): δ = 1.22 (s, 9H, 3CH3), 1.27 (s, 9H, 3CH3), 3.77 (s, 3H, OCH3), 6.85 (d, 2H, 
J = 8.61 Hz, ArH), 7.15-7.23 (m, 4H, ArH), 7.29-7.44 (m, 8H, ArH), 7.52 (d, 1H, J = 8.54 Hz, 
ArH). 13C NMR (62.9 MHz, CDCl3): δ = 30.2, 30.3 (CH3), 33.5, 33.6 (C), 54.3 (OCH3), 114.3, 
120.3, 123.1 (CH), 123.1 (C), 125.1, 125.8, 126.9, 127.0 (CH), 128.0 (C), 129.6, 130.2 (CH), 
132.2, 137.6, 146.2, 146.3, 149.5, 150.4, 153.0, 159.3 (C), 195.4 (CO). IR (KBr): v = 3033, 
2958, 2923, 2855 (w), 1700, 1597 (s), 1510, 1499, 1463 (m), 1493, 1405, 1392 (w), 1352 (m), 
1332, 1307, 1290, 1266 (w), 1248, 1175 (s), 1111, 1092, 1070 (m), 1040 (w), 1023 (s), 958, 948, 
941, 931, 908, 896, 867, 856 (w), 821 (s), 808, 784, 740, 729, 690, 649 (m), 638, 629, 610 (w), 
573, 543, 534 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 500 ([M]+, 100), 485 (70), 235 (21). 
HRMS (EI, 70 eV): calcd for C36H36O2 [M]+,!!9!'#%)34,!!9
3-(4-Chlorophenyl)-2,5-bis(4-ethylphenyl)-1H-inden-1-one (18b): Starting with 13 (100 mg, 
0.27 mmol), Pd(PPh3)4 (15 mg, 5 mol%), 1,4-dioxane (5 
mL), K3PO4 (262 mg, 1.23 mmol), 4-chlorophenylboronic 
acid 3f (43 mg, 0.27 mmol) and 4-ethylphenylboronic 
acid 3b (89 mg,  0.59 mmol) following the general 
procedure B, 18b was isolated as a brownish yellow solid 
(99 mg, 81%). reaction temperature: at 45°C for 9h, at 
70°C for 6 h. Mp.133-134°C. 1H NMR (300 MHz, CDCl3): δ = 1.15 (t, 3H, J = 7.62 Hz, CH3), 
1.19 (t, 3H, J = 7.62 Hz, CH3), 2.55 (q, 2H, J = 7.59 Hz, CH2), 2.61 (q, 2H, J = 7.59 Hz, CH2), 
	
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7.04 (d, 2H, J = 8.25 Hz, ArH), 7.12 (d, 2H, J = 8.28 Hz, ArH), 7.17-7.21 (m, 3H, ArH), 7.26-
7.34 (m, 4H, ArH), 7.37-7.41 (m, 3H, ArH), 7.54 (d, 1H, J = 7.44 Hz, ArH). 13C NMR (75.5 
MHz, CDCl3): δ = 14.2, 14.5 (CH3), 27.5, 27.6 (CH2), 119.0, 122.5, 126.1, 126.2 (CH), 126.6 
(C), 126.7, 127.4 (CH), 128.1 (C), 128.2, 128.8, 129.0 (CH), 130.4, 132.5, 134.0, 136.6, 143.2, 
143.7, 144.9, 145.8, 151.6 (C), 195.0 (CO). IR (KBr): v = 3391, 3024, 2961, 2926, 2870, 1907, 
1789 (w), 1706, 1595 (s) 1515 (w), 1485, 1462, 1455 (m), 1410, 1373 (w), 1351 (m), 1260 (w), 
1181, 1142 (m), 1087 (s), 1069, 1049 (m), 1012 (s), 963, 948, 935, 894, 862, 850 (w), 819 (s), 
784, 741, 717 (m), 700, 670, 654, 638, 621, 571 (w) cm-1. GC-MS (EI, 70 eV): m/z (%) = 448 
([M]+, 100), 433 (18), 419 (16). HRMS (EI, 70 eV): calcd for C31H25ClO [M]+, ###%
found: 448.15899. 
3-(4-Chlorophenyl)-2,5-bis(4-methoxyphenyl)-1H-inden-1-one (18c): Starting with 13 (100 
mg, 0.27 mmol), Pd(PPh3)4 (15 mg, 5 mol%), 1,4-dioxane 
(5 mL), K3PO4 (262 mg, 1.23 mmol), 4-
chlorophenylboronic acid 3f (42 mg, 0.27 mmol) and 4-
ethylphenylboronic acid 3b (90 mg, 0.59 mmol) following 
the general procedure B, 18c was isolated as a brownish 
yellow solid (104 mg, 84%). reaction temperature: at 45°C 
for 9h, at 70°C for 6 h. Mp.201-203°C. 1H NMR (250 MHz, CDCl3): δ = 3.81 (s, 3H, OCH3), 
3.85 (s, 3H, OCH3), 6.74 (d, 2H, J = 8.80 Hz, ArH), 6.88 (d, 2H, J = 8.72 Hz, ArH), 7.13-7.18 
(m, 3H, ArH), 7.26-7.36 (m, 5H, ArH), 7.42 (d, 2H, J = 8.70 Hz, ArH), 7.52 (d, 1H, J = 7.47 Hz, 
ArH). 13C NMR (62.9 MHz, CDCl3): δ = 55.2 (OCH3), 55.4 (OCH3), 113.8, 114.3, 119.5 (CH), 
122.8 (C), 123.5, 126.6, 128.3 (CH), 128.7 (C), 129.3, 130.0, 131.3 (CH), 131.5, 132.7, 133.0, 
135.0, 146.1, 146.4, 151.7, 159.4, 160.0 (C), 196.2 (CO). IR (KBr): v = 3377, 3057, 3042, 3010, 
2951, 2925, 2835 (w), 1697 (s), 1608 (w), 1591 (s), 1516 , 1486, 1462, 1455, 1442 (m), 1413, 
1398, 1348, 1331, 1307 (w), 1286 (m), 1246, 1173 (s), 1141, 1087, 1071, 1039, 1013 (m), 936, 
893, 850 (w), 836 (m), 822 (s), 811, 797, 786, 744, 738, 727, 718 (m), 699, 655, 621(w), 571, 
562 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 452 ([M, 35Cl]+, 100), 226 (12). HRMS (EI, 70 
eV): calcd for C29H21ClO3 [M, 35Cl]+,99%)34,#!
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2,3-Bis(4-fluorophenyl)-5-(3-methoxyphenyl)-1H-inden-1-one (19a): Starting with 16d (79 
mg, 0.20 mmol), Pd(PPh3)4 (8 mg, 3 mol%), 1,4-dioxane (5 mL), 
K2CO3 (2 M, 1 mL) and 3-methoxyphenylboronic acid 3o (33 mg, 
0.22 mmol), following the general procedure A, 21a was isolated as 
a yellow solid (74 mg, 88%). reaction temperature: 70°C for 6 h. 
Mp.175-177°C. 1H NMR (300 MHz, CDCl3): δ = 3.78 (s, 3H, 
OCH3), 6.84-6.94 (m, 3H, ArH), 6.99-7.10 (m, 4H, ArH), 7.14-7.21 
(m, 3H, ArH), 7.26-7.35 (m, 3H, ArH), 7.41 (dd, 1H, J = 1.41, 7.44 Hz, ArH), 7.56 (d, 1H, J = 
7.47 Hz, ArH). 19F NMR (282.4 MHz, CDCl3): δ = -112.9, -110.4. 13C NMR (62.9 MHz, 
CDCl3): δ = 55.4 (OCH3), 113.2, 113.3 (CH), 115.3 (d, JF,C= 21.5 Hz, CH), 116.3 (d, JF,C = 21.7 
Hz, CH), 119.7, 120.4, 123.5 (CH), 126.5 (d, JF,C = 3.50 Hz, C), 127.7 (CH), 128.5 (d, JF,C = 3.53 
Hz, C), 129.4 (C), 130.0 (CH), 130.5 (d, JF,C = 8.26 Hz, CH), 131.7 (d, JF,C = 8.11 Hz, CH), 
132.3, 141.7, 145.7, 146.8, 153.6, 160.0 (C), 162.4 (d, JF,C = 248.6 Hz, C), 163.2 (d, JF,C = 250.3 
Hz, C), 195.7 (CO). IR (KBr): v = 3393, 3066, 3034, 2919, 2850 (w), 1704, 1596 (s), 1738, 1731 
(w), 1704 (s), 1667, 1651, 1644, 1633 (w), 1596 (s), 1575 (m), 1510, 1538 (w), 1510, 1495, 1463 
(m), 1437, 1417, 1406 (w), 1351 (m), 1316, 1298, 1279, 1263, 1248 (w), 1223, 1211(s), 1186, 
1171, 1160, 1154 (m), 1101, 1080, 1071, 1049, 1023, 965, 951, 944, 877(w), 849 (s), 838 (m), 
816 (s), 800, 793 (w), 772 (s), 747, 736, 712, 696, 676 (m), 666, 629, 608 , 581(w), 568 (m), 
548, 536 (s) cm-1. GC-MS (EI, 70 eV): m/z (%) = 424 ([M]+, 100). HRMS (EI, 70 eV): calcd for 
C28H18F2O2 [M]+, '%)34, '
5-(4-Methoxyphenyl)-2,3-bis(4-(trifluoromethyl)phenyl)-1H-inden-1-one (19b): Starting 
with 13 (100 mg, 0.27 mmol), Pd(PPh3)4 (15 mg, 5 mol%),   
1,4-dioxane (5 mL), K3PO4 (172 mg, 0.81 mmol), 4-
(trifluoromethyl)phenylboronic acid 3q (102 mg, 0.54 
mmol) and 4-methoxyphenylboronic acid 3h (42 mg, 0.27 
mmol) following the general procedure B, 19b was isolated 
as a yellow solid (124 mg, 86%). reaction temperature: at 
60°C for 9h, at 70°C for 6 h. Mp.200-201°C. 1H NMR (300 MHz, CDCl3): δ = 3.77 (s, 3H, 
OCH3), 6.89 (d, 2H, J = 8.76 Hz, ArH), 7.17 (s, 1H, ArH), 7.28 (d, 2H, J = 8.10 Hz, ArH), 7.41-
7.48 (m, 7H, ArH), 7.59 (d, 1H, J = 7.50 Hz, ArH), 7.65 (d, 2H, J = 8.13 Hz, ArH). 19F NMR 
(282.4 MHz, CDCl3): δ = -62.8, -62.7. 13C NMR (62.9 MHz, CDCl3): δ = 55.4 (OCH3), 114.4, 
120.2 (CH), 123.6 (q, JF,C = 272.6 Hz, CF3), 123.8 (q, JF,C = 270.3 Hz, CF3), 124.1 (CH), 125.2 
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(q, JF,C = 3.83 Hz, CH), 126.2 (q, JF,C = 3.75 Hz, CH), 127.4 (CH), 128.2 (C), 128.3, 128.9 (CH), 
130.0 (q, JF,C = 31.5 Hz, C-CF3), 130.2 (CH), 131.5 (q, JF,C = 33.0 Hz, C-CF3), 132.3, 132.7, 
133.9, 136.0, 145.2, 146.9, 154.4, 160.2 (C), 194.8 (CO). IR (KBr): v = 3078, 2999, 2962, 2918, 
2849, 2837 (w), 1699 (s), 1667, 1660, 1651, 1613 (w), 1593(s), 1574 (m), 1557, 1539 (w), 1520, 
1471(m), 1463, 1455, 1435, 1416, 1410, 1354 (w), 1418, 1410 (m), 1318, 1280 (s), 1264 (m), 
1244, 1160 (s), 1148 (m), 1120, 1112, 1068, 1058 (s), 1033 (m), 1016 (s), 964, 937, 916, 987, 
867, 856 (m), 819 (s), 799, 781 (m), 766, 756 (w), 730, 719, 709, 698, 618, 601, 554 (m) cm-1. 
GC-MS (EI, 70 eV): m/z (%) = 524 ([M]+, 100). HRMS (EI, 70 eV): calcd for C30H18F6O2 [M]+: 
!%)34,!9'
Site-Selective Synthesis of Arylated-1-methyl-1H-indole by Suzuki–Miyaura Cross-
Coupling Reactions of 2,3,6-tribromo-1-methyl-1H-indole 
Synthesis of 2,3,6-tribromo-1-methyl-1H-indole (21): To a THF solution (50 mL) of N-
methylindole 20 (0.96 g, 7.34 mmol) was portion wise added NBS (4.40 g, 
24.9 mmol) at -78°C and the solution was stirred at this temperature for 4 
h and then at 20°C for 14 h. To the solution was added water (25 mL). The 
organic and the aqueous layer were separated and the latter was extracted 
with CH2Cl2 (3 x 30 mL). The combined organic layers were washed with a saturated aqueous 
solution of NaHCO3, dried (Na2SO4), filtered and concentrated in vacuo. The residue was 
purified by flash silica column chromatography (pure heptanes) to yield 21 as a yellowish solid 
(1.85 g, 69.5%), Mp.94-96°C. 1H NMR (300 MHz, CDCl3): δ = 3.57 (s, 3H, NCH3), 7.12 (dd, 
1H, J = 1.56, 8.49 Hz, ArH), 7.17-7.20 (m, 1H, ArH), 7.25 (d, 1H, J = 1.26 Hz, ArH). 13C NMR 
(62.9 MHz, CDCl3): δ = 32.4 (NCH3), 92.9 (C), 112.5 (CH), 115.6, 116.6 (C), 120.0, 124.0 
(CH), 125.7, 136.7 (C). IR (KBr): v = 3207, 3105, 3069, 2935, 2860, 2817, 2679 (w), 1494 (m), 
1452 (s), 1410 (m), 1359 (w), 1321, 1314 (s), 1287 (m), 1226 (s), 1195, 1182, 1132 (w), 1112 
(m), 1081 (w), 1048 (m), 946 (s), 847, 839 (w), 829, 790 (s), 731 (m), 666 (w), 649 (m), 597 (w), 
582 (s), 562 (m) cm−1. GC-MS (EI, 70 eV): m/z (%): 369 ([(M+H), 79Br, 81Br, 81Br]+, 97), 367 
([(M+H), 79Br, 79Br, 81Br]+, 100), 365 ([(M+H), 79Br, 79Br, 79Br]+ 34), 354 (18), 352 (19). HRMS 
(EI, 70 eV): calcd for C9H6Br3N [M, 79Br, 81Br, 81Br]+, ##!!!% )34 ##!!, calcd for 
C9H6Br3N [M, 79Br, 79Br, 81Br]+,   #!% )34   #!, calcd for C9H6Br3N [M, 79Br, 
79Br, 79Br]+: 364.80449;  found 364.80426.  
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General procedure (A) for Suzuki cross-coupling reactions of brominated N-methylindole 
(21): The reaction was carried out in a pressure tube. To a 1,4-dioxane or a mixture solvent (for 
mono cross-coupling reactions) of toluene/1,4-dioxane (4:1) (3-5 mL) suspension of the 
brominated -N-methylindole, Pd(PPh3)4 (3-5 mol%) and of the arylboronic acid (1.1 per cross 
coupling),  K3PO4 (1.5 equiv. per cross coupling) or an aqueous solution of K2CO3 (2 M, 1 mL) 
was added. The mixture was heated at the indicated temperature (65-110°C) under Argon 
atmosphere for the indicated period of time (8 h). The reaction mixture was diluted with water 
and extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were dried (Na2SO4), 
filtered and the filtrate was concentrated in vacuo. The residue was purified by flash 
chromatography (silica gel, EtOAc/ heptanes). 
Synthesis of 2,3,6-triaryl-1-methyl-1H-indole 22a-i: 
2,3,6-Tris(4-methoxyphenyl)-1-methyl-1H-indole (22a): Starting with 21 (100 mg, 0.27 
mmol), 4-methoxyphenylboronic acid 3h (142 mg, 
0.93 mmol), Pd(PPh3)4 (16 mg, 5 mol%), K2CO3 (2 M, 
1 mL) and 1,4-dioxane (5 mL), 22a was isolated as a 
?$. 2)4 
!9 0: #9@% reaction temperature: 
110°C for 8 h, Mp.124-126°C. 1H NMR (300 MHz, 
CDCl3): δ = 3.67 (s, 3H, NCH3), 3.72 (s, 3H, OCH3), 
3.75 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 6.68 (d, 1H, J = 2.94 Hz, ArH), 6.75-6.94 (m, 6H, 
ArH), 7.14-7.16 (m, 3H, ArH), 7.30 (dd, 1H, J = 1.50, 8.28 Hz, ArH), 7.44 (d, 1H, J = 0.99 Hz, 
ArH), 7.55 (d, 2H, J = 8.76 Hz, ArH), 7.68 (d, 1H, J = 8.25 Hz, ArH). 13C NMR (62.9 MHz, 
CDCl3): δ = 30.9 (NCH3), 55.2, 55.3, 55.4 (OCH3), 107.6, 113.8, 114.2 (CH), 114.3 (C), 114.8, 
116.0, 119.6 (CH), 124.2, 126.1, 127.8 (C), 128.4, 130.8, 132.3 (CH), 135.2, 137.6, 137.7, 149.5, 
157.5, 158.7, 159.3 (C). IR (KBr):  v = 3053, 3037, 2994, 2961, 2928, 2838, 1607, 1573, 1551 
(w), 1515 (m), 1478 (w), 1466, 1455, 1440 (m), 1426, 1392, 1370, 1338, 1303 (w), 1286 (m), 
1239, 1173 (s), 1148, 1107, 1089 (m), 1036, 1026 (s), 961, 944, 932, 856 (w), 838 (m), 820, 809, 
795 (s), 755 (m), 729, 721 (w), 688 (m), 646, 640, 628, 625 (w), 611 (s), 586, 576 (m), 556 (w), 
537 (m) cm−1. GC-MS (EI, 70 eV): m/z (%): 449 (M]+, 100), 435 (11), 434 (36). HRMS (EI, 70 
eV): calcd for C30H27O3N [M]+: ''#%)34,'''





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2,3,6-Tris(4-(tert-butyl)phenyl)-1-methyl-1H-indole (22b): Starting with 21 (100 mg, 0.27 
mmol), 4-tert-butylphenylboronic acid 3c (166 mg, 0.93 
mmol), Pd(PPh3)4 (16 mg, 5 mol%), K2CO3 (2 M, 1 
mL) and 1,4-dioxane (5 mL), 22b was isolated as a 
?$.2)4
0:#@%reaction temperature: 110°C 
for 8 h, Mp.116-117°C. 1H NMR (300 MHz, CDCl3): δ
= 1.24 (s, 9H, 3CH3), 1.28 (s, 9H, 3CH3), 1.30 (s, 9H, 
3CH3), 3.60 (s, 3H, NCH3), 6.16-7.21(m, 5H, ArH), 
7.30-7.37 (m, 3H, ArH), 7.39 (d, 3H, J = 3.54 Hz, ArH), 7.49 (d, 1H, J = 1.05 Hz, ArH), 7.57 
(d, 2H, J = 8.49 Hz, ArH), 7.76 (d, 1H, J = 8.04 Hz, ArH). 13C NMR (75.5 MHz, CDCl3): 
δ = 31.0 (NCH3), 31.3, 31.4, 31.5 (CH3), 34.4, 34.5, 34.7 (C), 107.9 (CH), 114.7 (C), 119.8, 
119.9, 125.4, 125.5, 125.7 (CH), 126.4 (C), 127.1 (CH), 128.9 (C), 129.3, 130.8 (CH), 132.2, 
135.4, 137.8, 138.2, 139.7, 148.0, 149.5, 150.9 (C). IR (KBr): v = 3029 (w), 2956 (s), 2902, 2865 
(m), 1911, 1673, 1604, 1548, 1519 (w), 1461 (s), 1426, 1392 (w), 1361 (s), 1335, 1318, 1307 
(w), 1267 (m), 1201, 1181, 1166 (w), 1108 (m), 1086, 1047 (w), 1014, 947 (m), 921, 907 (w), 
860 (m), 835, 809 (s), 769, 756 (w), 732 (m), 711, 699, 672, 651 (w), 623, 599 (m), 554 (s) cm−1. 
GC-MS (EI, 70 eV): m/z (%) : 528 ([M+H]+, 38), 527 ([M]+, 100), 513 (11), 512 (26), 471 (12), 
249 (9). HRMS (EI, 70 eV): calcd for C39H45N [M]+: 9 %)34,9 
2,3,6-Tris(4-ethylphenyl)-1-methyl-1H-indole (22c): Starting with 21 (100 mg, 0.27 mmol),      
4-ethylphenylboronic acid 3b (140 mg, 0.93 mmol), 
Pd(PPh3)4 (16 mg, 5 mol%), K2CO3 (2 M, 1 mL) and 
1,4-dioxane (5 mL), 22c was isolated as a white solid 

'' 0: #@% reaction temperature: 110°C for 8 h, 
Mp.116-117°C. 1H NMR (300 MHz, CDCl3): δ = 1.14-
1.24 (m, 9H, 3CH3), 2.52-2.66 (m, 6H, 3CH2), 3.60 (s, 
3H, NCH3), 7.03 (d, 2H, J = 8.31 Hz, ArH), 7.14-7.23 (m, 8H, ArH), 7.34 (dd, 1H, J = 1.56, 
8.28 Hz, ArH), 7.48 (d, 1H, J = 1.02 Hz, ArH), 7.55 (d, 2H, J = 8.19 Hz, ArH), 7.74 (d, 1H, J = 
8.28 Hz, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 15.3, 15.4, 15.7 (CH3), 28.5, 28.6, 28.7 (CH2), 
31.0 (NCH3), 107.9 (CH), 114.8 (C), 119.8, 119.9 (CH), 126.4 (C), 127.7, 127.9, 128.0, 128.2 
(CH), 128.3 (C), 129.3, 130.2 (CH), 132.6, 135.6, 137.9, 138.3, 140.0, 141.2, 142.7, 144.1 (C). 
IR (KBr): v = 3020, 2963, 2929, 2872 (w), 1608, 1566, 1546 (w), 1517, 1463 (m), 1428, 1409, 


1392 (w), 1373 (m), 1341, 1317, 1256, 1229, 1182, 1147, 1118 (w), 1087 (m), 1059, 1047, 1014, 
961 (w), 944 (m), 908, 855 (w), 830, 822, 806 (s), 753, 730, 700, 688, 664, 646, 640, 629 (w), 
611 (m), 583, 564 (w), 535 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) : 444 ([M+H]+, 37), 443 
([M]+, 100). HRMS (ESI, 70 eV): calcd for C33H34N [M+H]+:  ##%)34, #
1-Methyl-2,3,6-tri-p-tolyl-1H-indole (22d): Starting with 21 (100 mg, 0.27 mmol),                      
4-methylphenylboronic acid 3e (126 mg, 0.93 mmol), 
Pd(PPh3)4 (16 mg, 5 mol%), K2CO3 (2 M, 1 mL) and 
1,4-dioxane (5 mL), 22d was isolated as a white solid 

'  0: #9@% reaction temperature: 110°C for 8 h, 
Mp.174-177°C. 1H NMR (300 MHz, CDCl3): δ = 2.23 
(s, 3H, CH3), 2.30 (s, 3H, CH3), 2.31 (s, 3H, CH3), 3.58 
(s, 3H, NCH3), 6.99 (d, 2H, J = 7.86 Hz, ArH), 7.07-7.18 (m, 8H, ArH), 7.32 (dd, 1H, J = 1.53, 
8.28 Hz, ArH), 7.46 (d, 1H, J = 1.02 Hz, ArH), 7.51 (d, 2H, J = 8.10 Hz, ArH), 7.71 (d, 1H, J = 
8.31 Hz, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 21.1, 21.2, 21.4 (CH3), 31.0 (NCH3), 107.9 
(CH), 114.8 (C), 119.8, 119.9 (CH), 126.4 (C), 127.3, 129.0, 129.2 (CH), 129.3 (C), 129.5, 
129.7, 131.0 (CH), 132.4, 135.0, 135.6, 136.3, 137.8, 137.9, 138.3, 139.8 (C). IR (KBr): v
= 3018, 2917, 2860, 2733, 1610, 1567, 1548 (w), 1518, 1468 (m), 1449, 1428, 1403, 1391 (w), 
1373 (m), 1337, 1319, 1304, 1256, 1229, 1212, 1185, 1147, 1112 (w), 1087 (m), 1039, 1015, 
971, 962 (w), 944, 852 (m), 840, 820, 810, 801 (s), 777, 755, 726 (m), 698, 689, 642, 633 (w), 
612 (m), 577, 567, 539 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) : 402 ([M+H]+, 33), 401 ([M]+, 
100), 371 (6). HRMS (ESI, 70 eV): calcd for C30H28N [M+H]+: 402 %)34,!
2,3,6-Tris(4-chlorophenyl)-1-methyl-1H-indole (22e): Starting with 21 (100 mg, 0.27 mmol),   
4-chlorophenylboronic acid 3f (145 mg, 0.93 mmol), 
Pd(PPh3)4 (16 mg, 5 mol%), K2CO3 (2 M, 1 mL) and 1,4-
dioxane (5 mL), 22e was isolated as a white solid (108 
0:#@%reaction temperature: 110°C for 8 h, Mp.218-
222°C. 1H NMR (300 MHz, CDCl3): δ = 3.60 (s, 3H, 
NCH3), 7.10-7.21 (m, 6H, ArH), 7.29-7.37 (m, 5H, ArH), 
7.47 (d, 1H, J = 1.02 Hz, ArH), 7.54 (d, 2H, J = 8.58 Hz, ArH), 7.68 (d, 1H, J = 8.22 Hz, ArH). 
13C NMR (62.9 MHz, CDCl3): δ = 30.0 (NCH3), 107.1 (CH), 113.4 (C), 118.8, 119.1 (CH), 
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125.2 (C), 127.5, 127.6, 127.8, 127.9 (CH), 128.8 (C), 129.9 (CH), 130.7 (C), 131.2 (CH), 131.8, 
132.2, 133.5, 133.9, 136.3, 136.9, 139.6 (C). IR (KBr): v = 3078, 3031, 2923, 2852, 1899, 1614, 
1598, 1568, 1543 (w), 1495 (m), 1461 (s), 1426, 1396 (w), 1370, 1334 (m), 1315, 1299 (w), 
1254 (m), 1233, 1176, 1164 (w), 1088, 1013 (s), 957 (w), 946, 904 (m), 870 (w), 853 (s), 831, 
821 (m), 811 (s), 760 (w), 746 (m), 732 (s), 720, 706 (m), 661, 644, 633, 625 (w), 614, 583 (m), 
563, 541 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) : 464 ([M+H], 35Cl, 35Cl, 37Cl)+, 29), 463 ([M,
35Cl, 35Cl, 37Cl]+, 99), 462 ([(M+H), 35Cl, 35Cl, 35Cl]+, 31), 461 ([M, 35Cl, 35Cl, 35Cl]+,  100). 
HRMS (EI, 70 eV): calcd for C27H18Cl3N [M, 35Cl, 35Cl, 37Cl]+: 463.04698; found: 463.04719, 
calcd for C27H18Cl3N [M, 35Cl, 35Cl, 35Cl]+: 461.04993; found: 461.04975. 
2,3,6-Tris(3-chlorophenyl)-1-methyl-1H-indole (22f): Starting with 21 (100 mg, 0.27 mmol),   
3-chlorophenylboronic acid 3n (145 mg, 0.93 mmol), 
Pd(PPh3)4 (16 mg, 5 mol%), K2CO3 (2 M, 1 mL) and 1,4-
dioxane (5 mL), 22f was isolated as a white solid (101 mg, 
#!@% reaction temperature: 110°C for 8 h, Mp.120-123°C. 
1H NMR (300 MHz, CDCl3): δ = 3.63 (s, 3H, NCH3), 6.99-
7.02 (m, 1H, ArH), 7.09-7.11 (m, 3H, ArH), 7.21-7.35 (m, 7H, ArH), 7.46-7.49 (m, 2H, ArH), 
7.59-7.60 (m, 1H, ArH), 7.70 (d, 1H, J = 8.13 Hz, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 30.1 
(NCH3), 107.3 (CH), 113.4 (C), 118.9, 119.3, 124.5, 125.0 (CH), 125.3 (C), 125.8, 126.4, 126.9, 
127.7, 128.3, 128.5, 128.6, 128.9, 129.0, 129.7 (CH), 132.1, 133.1, 133.4, 133.6, 133.8, 135.4, 
136.3, 136.8, 143.0 (C). IR (KBr): v = 3066, 2917, 2849 (w), 1592 (s), 1564 (w), 1550 (m), 1485 
(w), 1467 (s), 1455 (m), 1427, 1410, 1397 (w), 1373 (s), 1334 (m), 1308, 1296 (w), 1256 (m), 
1165, 1140 (w), 1099, 1088, 1077 (m), 1050, 1034, 995 (w), 963 (m), 910 (w), 894, 866, 856 
(m), 825, 787, 781, 771, 758, 717, 700, 688, 676 (s), 661 (w), 646 (s), 603, 583, 557, 551, 541 
(w) cm−1. GC-MS (EI, 70 eV): m/z (%) : 464 [(M+H), 35Cl, 35Cl, 37Cl]+, 29), 463 ([M, 35Cl, 35Cl,
37Cl]+, 98), 462 ([(M+H), 35Cl, 35Cl, 35Cl]+, 29), 461 ([M, 35Cl, 35Cl, 35Cl]+, 100). HRMS (EI, 70 
eV): calcd for C27H18Cl3N [M, 35Cl, 35Cl, 37Cl]+: 463.04698; found: 463.04738, calcd for 
C27H18Cl3N [M, 35Cl, 35Cl, 35Cl]+: 461.04993; found: 461.05006.  
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
2,3,6-Tris(4-fluorophenyl)-1-methyl-1H-indole (22g): Starting with 21 (100 mg, 0.27 mmol),    
4-fluorophenylboronic acid 3j (130 mg, 0.93 mmol), 
Pd(PPh3)4 (16 mg, 5 mol%), K2CO3 (2 M, 1 mL) and 1,4-
dioxane (5 mL), 22g was isolated as a white solid (95 mg, 
#@%reaction temperature: 110°C for 8 h, Mp.178-180°C. 
1H NMR (300 MHz, CDCl3): δ = 3.62 (s, 3H, NCH3), 6.87-
6.93 (m, 2H, ArH), 6.98-7.10 (m, 4H, ArH), 7.12-7.24 (m, 
4H, ArH), 7.30 (dd, 1H,  J = 1.56, 8.28 Hz, ArH), 7.45 (d, 1H, J = 1.02 Hz, ArH), 7.53-7.59 (m, 
2H, ArH), 7.67 (d, 1H, J = 8.28 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):  = -116.8, -116.6, -
112.7. 13C NMR (75.5 MHz, CDCl3): δ = 29.9 (NCH3), 107.0 (CH), 113.3 (C), 114.2 (d, JF,C 
= 21.2 Hz, CH), 114.6 (d, JF,C = 21.4 Hz, CH), 114.7 (d, JF,C = 21.6 Hz, CH), 118.6, 119.1 (CH), 
125.2 (C), 126.5 (d, JF,C =3.54 Hz, C), 127.9 (d, JF,C = 8.00 Hz, CH), 129.7 (d, JF,C = 3.28 Hz, C), 
130.2 (d, JF,C = 7.76 Hz, CH), 131.8 (d, JF,C = 8.20 Hz, CH), 134.1, 136.3, 136.7 (C), 137.4 (d, 
JF,C = 3.19 Hz, C), 160.2 (d, JF,C = 245.1 Hz, C-F), 160.7 (d, JF,C = 246.1 Hz, C-F), 161.6 (d, JF,C 
= 248.1 Hz, C-F). IR (KBr): v = 3068, 3043, 2961, 2853, 1907, 1891 (w), 1601, 1593, 1556 (m), 
1513 (s), 1493 (m), 1463 (s), 1425, 1403 (w), 1367, 1335 (m), 1315, 1299 (w), 1258 (m), 1219, 
1156, 1087, 1014 (s), 946 (m), 907 (w), 860, 837 (m), 819, 811, 800, 794 (s), 762 (w), 730 (m), 
724, 686, 643, 628 (w), 608 (s), 576 (w), 566 (m), 538 (w) cm−1. GC-MS (EI, 70 eV): m/z (%): 
414 ([M+H]+, 30), 413 ([M]+, 100), 397 (9). HRMS (EI, 70 eV): calcd for C27H18F3N [M]+: 
413.13859; found: 413.13909. 
1-Methyl-2,3,6-tris(4-(trifluoromethyl)phenyl)-1H-indole (22h): Starting with 21 (100 mg, 
0.27 mmol), 4-(trifluoromethyl)phenylboronic acid 3q
(177 mg, 0.93 mmol), Pd(PPh3)4 (16 mg, 5 mol%), 
K2CO3 (2 M, 1 mL) and 1,4-dioxane (5 mL), 22h was 
2)/.4 /2 / ?$. 2)4 
9 0: #@% reaction 
temperature: 110°C for 8 h,Mp.200-202°C. 1H NMR 
(300 MHz, CDCl3): δ = 3.67 (s, 3H, NCH3), 7.30 (d, 
2H, J = 1.56 Hz, ArH), 7.36-7.42 (m, 3H, ArH), 7.47 (d, 2H, J = 8.13 Hz, ArH), 7.56 (d, 1H, J 
= 0.84 Hz, ArH), 7.59-7.65 (m, 4H, ArH), 7.71-7.76 (m, 3H, ArH). 19F NMR (282.4 MHz, 
CDCl3):  = -62.7, -62.3, -62.3. 13C NMR (62.9 MHz, CDCl3): δ = 30.2 (NCH3), 107.7 (CH), 
113.8 (C), 119.0, 119.7 (CH), 122.9 (q, JF,C = 273.3 Hz, CF3), 123.5 (q, JF,C = 272.7 Hz, CF3), 
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123.7 (q, JF,C = 272.0 Hz, CF3), 124.4 (q, JF,C = 3.74 Hz, CH), 124.6 (q, JF,C = 3.79 Hz, CH), 
124.9 (q, JF,C = 3.56 Hz, CH), 125.5 (C), 126.6 (CH), 127.0 (q, JF,C = 32.4 Hz, C-CF3), 127.9 (q, 
JF,C = 32.4 Hz, C-CF3), 128.8 (CH), 129.6 (q, JF,C = 32.6 Hz, C-CF3), 130.3 (CH), 133.9, 134.0, 
136.6, 137.1, 137.3, 144.5 (C). IR (KBr): v = 3051, 2957, 2923, 2852, 2640 (w), 1613 (m), 1574, 
1553, 1520, 1494 (w), 1465 (m), 1431, 1416, 1407, 1397, 1369 (w), 1321 (s), 1257 (m), 1187 
(w), 1160 (m), 1105, 1089, 1163, 1012 (s), 960, 946 (w), 858, 841 (m), 828, 807 (s), 779, 771, 
761, 742, 712 (w), 696 (m), 675, 654, 650 (w), 634, 614, 599 (m), 576 (w) cm−1. GC-MS (EI, 
70 eV): m/z (%): 564 ([M+H]+, 39), 563 ([M]+, 100), 97 (10), 84 (13), 71 (18), 69 (27), 57 (28). 
HRMS (EI, 70 eV): calcd for C30H18F9N [M]+: 563.12900; found: 563.12941. 
1-Methyl-2,3,6-tris(3-(trifluoromethyl)phenyl)-1H-indole (22i): Starting with 21 (100 mg, 
0.27 mmol), 3-(trifluoromethyl)phenylboronic acid 3g
(177 mg, 0.93 mmol), Pd(PPh3)4 (16 mg, 5 mol%), K2CO3
(2 M, 1 mL) and 1,4-dioxane (5 mL), 22i was isolated as a 
?$. 2)4 
!0: 9#@% reaction temperature: 110°C 
for 8 h,Mp.158-160°C. 1H NMR (300 MHz, CDCl3): δ = 
3.66 (s, 3H, NCH3), 7.28-7.46 (m, 8H, ArH), 7.48-7.58 (m, 4H, ArH), 7.71 (d, 1H, J = 8.34 Hz, 
ArH), 7.76-7.78 (m, 1H, ArH), 7.85 (brs, 1H, ArH). 19F NMR (282.4 MHz, CDCl3):  = -62.9, -
62.8, -62.5. 13C NMR (75.5 MHz, CDCl3): δ = 30.1 (NCH3), 107.5 (CH), 113.7 (C), 118.9, 119.5 
(CH), 121.6 (q, JF,C = 3.74 Hz, CH), 122.5 (q, JF,C = 3.75 Hz, CH), 122.7 (q, JF,C = 272.5 Hz, 
CF3), 123.0 (q, JF,C = 272.5 Hz, CF3), 123.1 (q, JF,C = 3.79 Hz, CH), 123.3 (q, JF,C = 272.5 Hz, 
CF3), 124.2 (q , JF,C = 3.67 Hz, CH), 125.4 (q, JF,C = 3.76 Hz, CH), 126.7 (q, JF,C = 3.72 Hz, CH), 
127.9, 128.2, 128.3, 129.7 (CH), 129.8 (q, JF,C = 25.3 Hz, C-CF3), 130.1 (q, JF,C = 27.4 Hz, C-
CF3), 130.2 (q, JF,C = 30.7 Hz, C-CF3), 130.9 (C), 131.8, 133.3 (CH), 134.0, 134.2, 136.4, 137.1, 
141.8 (C). IR (KBr): v = 3073, 3046, 2960, 2924, 2853, 1610, 1590, 1551, 1494, 1465, 1439, 
1424, 1411, 1375 (w), 1334, 1326, 1308 (s), 1270 (w), 1251, 1159, 1112, 1094, 1071 (s), 1049, 
1034 (m), 1000, 986, 964 (w), 912 (s), 879, 862, 829, 809 (m), 795 (s), 783 (m), 764 (w), 724 
(m), 698 (s), 677 (w), 670 (s), 644, 622, 612, 595, 571, 528 (w) cm−1. GC-MS (EI, 70 eV): m/z 
(%): 564 ([M+H]+, 27), 563 ([M]+, 100), 547 (15), 69 (19). HRMS (ESI, 70 eV): calcd for 
C30H19F9N [M+H]+: 564.13683; found: 564.13740. 
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Synthesis of 2,6-diaryl-3-bromo-1-methyl-1H-indole 23a-e:
3-Bromo-2,6-bis(4-methoxyphenyl)-1-methyl-1H-indole (23a): Starting with 21 (100 mg, 0.27 
mmol), 4-methoxyphenylboronic acid 3h (86 mg, 
0.57 mmol), Pd(PPh3)4 (16 mg, 5 mol%), K3PO4
(172 mg, 0.81 mmol) and 1,4-dioxane (5 mL), 23a
?/22)/.4/2/?$.2)4
' 0:#@%reaction 
temperature: 90°C for 8 h, Mp.163-165°C (CH2Cl2/EtOH 1:1). 1H NMR (300 MHz, CDCl3): δ = 
3.58 (s, 3H, NCH3), 3.77 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 6.87-6.98 (m, 4H, ArH), 7.31-7.37 
(m, 4H, ArH), 7.49-7.54 (m, 3H, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 30.6 (NCH3), 54.3, 
54.4 (OCH3), 88.8 (C), 106.7, 112.9, 113.2, 118.3, 119.1 (CH), 121.5, 125.2 (C), 127.4, 130.9 
(CH), 133.7, 134.9, 136.2, 137.3, 157.8, 158.8 (C). IR (KBr): v = 3033, 2998, 2961, 2932, 2833 
(w), 1606 (m), 1573, 1562, 1542 (w), 1518, 1489, 1461, 1443, 1424 (m), 1372 (w), 1345, 1305, 
1288, 1274 (m), 1246, 1175 (s), 1105, 1035 (m), 1019 (s), 950 (m), 864 (w), 845, 832 (m), 815, 
804, 781 (s), 747, 732, 704, 687, 668, 643, 629 (w), 621, 600, 576 (m), 556 (w) cm−1. GC-MS 
(EI, 70 eV): m/z (%): 424 ([(M+H), 81Br]+, 25), 423 ([M, 81Br]+, 99), 422 ([(M+H), 79Br]+, 28), 
421 ([M, 79Br]+, 100), 408 (34), 406 (33), 212 (13). HRMS (EI, 70 eV): calcd for C23H20BrNO2
[M, 79Br]+,! 9'% found: 421.06734, calcd for C23H20BrNO2 [M, 81Br]+,! %)34: 
421.06567. 
3-Bromo-2,6-bis(4-ethylphenyl)-1-methyl-1H-indole (23b): Starting with 21 (100 mg, 0.27 
mmol), 4-ethylphenylboronic acid 3b (85 mg, 0.57 mmol), 
Pd(PPh3)4 (16 mg, 5 mol%), K3PO4 (172 mg, 0.81 mmol) 
and 1,4-dioxane (5 mL), 23b was isolated as a white solid 

'!0:9'@%reaction temperature: 90°C for 8 h, Mp.119-
121°C (CH2Cl2/EtOH 1:1). 1H NMR (300 MHz, CDCl3): δ
= 1.19-1.26 (m, 6H, 2CH3), 2.59-2.70 (m, 4H, 2CH2), 3.61 (s, 3H, NCH3), 7.24 (q, 4H, J = 8.31 
Hz, ArH), 7.35 (d, 2H, J = 8.25 Hz, ArH), 7.39 (dd, 1H, J = 1.47, 8.19 Hz, ArH), 7.43 (d, 1H, J 
= 0.75 Hz, ArH), 7.50-7.57 (m, 3H, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 15.3, 15.7 (CH3), 
28.6, 28.8 (CH2), 31.7 (NCH3), 89.9 (C), 108.1, 119.5, 120.4 (CH), 126.5 (C), 127.4 (CH), 127.6 
(C), 127.8, 127.9, 130.6 (CH), 136.4, 137.4, 138.7, 139.6, 143.0, 144.9 (C). IR (KBr): v = 3050, 
3019, 2966, 2930, 2872, 2853,  1517, 1492 (w), 1456 (s), 1423, 1410 (w), 1370, 1342 (m), 1309, 
1272, 1231 (w), 1216 (m), 1182, 1139, 1115 (w), 1101 (m), 1051, 1017, 964 (w), 949 (s), 908, 
	

858 (w), 844, 835 (m), 812 (s), 771, 763 (m), 750, 732, 685, 676, 647, 631 (w), 619, 603 (m), 
562 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) : 419 ([M, 81Br]+, 99), 418 ([(M+H), 79Br]+, 28), 417 
([M, 79Br]+, 100], 404 (27), 402 (26). HRMS (EI, 70 eV): calcd for C25H24BrN [M, 81Br]+: 
'!  %)34: 419.10785, calcd for C25H24BrN [M, 79Br]+: 9!#  %)34,9.10911.  
3-Bromo-1-methyl-2,6-di-p-tolyl-1H-indole (23c): Starting with 21 (100 mg, 0.27 mmol),        
4-methylphenylboronic acid 3e (77 mg, 0.57 mmol), 
Pd(PPh3)4 (16 mg, 5 mol%), K3PO4 (172 mg, 0.82  
mmol) and 1,4-dioxane (5 mL), 23c was isolated as a 
w$. 2)4 
9# 0: 9@% reaction temperature: 90°C 
for 8 h, Mp.135-137°C. 1H NMR (300 MHz, CDCl3): δ = 2.30 (s, 3H, CH3), 2.37 (s, 3H, CH3), 
3.62 (s, 3H, NCH3), 7.06-7.11 (m, 1H, ArH), 7.21-7.27 (m, 3H, ArH), 7.33(d, 2H, J = 8.24 Hz, 
ArH), 7.39 (dd, 1H, J = 1.45, 8.24 Hz, ArH), 7.43 (brs, 1H, ArH), 7.49-7.57 (m, 3H, ArH). 13C 
NMR (62.9 MHz, CDCl3): δ = 21.1, 21.4 (CH3), 31.7 (NCH3), 89.9 (C), 107.9, 119.4, 120.8 
(CH), 120.8, 123.1, 126.4 (C), 127.3, 129.2, 129.5, 130.5 (CH), 136.3, 136.6, 137.3, 138.7, 139.3 
(C). IR (KBr): v = 3022, 2916, 2852, 2729, 1908, 1613, 1556 (w), 1518, 1492 (m), 1455 (s), 
1423 (w), 1368, 1341 (m), 1312, 1299, 1253, 1231 (w), 1218 (m), 1183, 1139 (w), 1105 (m), 
1059, 1039, 1018, 965 (w), 950 (s), 939 (m), 907, 854 (w), 840, 821 (m), 806 (s), 779 (m), 748 
(w), 721 (m), 687, 672, 649, 631 (w), 622, 598 (m), 570, 537 (w) cm−1. GC-MS (EI, 70 eV): m/z 
(%) : 392 ([(M+H), 81Br]+, 24), 391 ([M, 81Br]+, 100), 390 [(M+H), 79Br]+, 31), 389 ([M, 79Br]+, 
100), 295 (11), 294 (14). HRMS (EI, 70 eV): calcd for C23H20BrN [M, 81Br]+: 391.07532; found: 
391.07571, calcd for C23H20BrN [M, 79Br]+: #'!99 %)34, 389.07745. 
3-Bromo-2,6-bis(4-chlorophenyl)-1-methyl-1H-indole (23d): Starting with 21 (100 mg, 0.27 
mmol), 4-chlorophenylboronic acid 3f (89 mg, 0.57 
mmol), Pd(PPh3)4 (16 mg, 5 mol%), K3PO4 (172 mg, 
0.81 mmol) and 1,4-dioxane (5 mL), 23d was isolated as 
/?$. 2)4 
'0:#!@% reaction temperature: 90°C 
for 8 h, Mp.173-175°C. 1H NMR (300 MHz, CDCl3): δ = 3.61 (s, 3H, NCH3), 7.31-7.44 (m, 8H, 
ArH), 7.49-7.58 (m, 3H, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 30.7 (NCH3), 88.5 (C), 107.1, 
118.8, 119.4 (CH), 125.8 (C), 127.6, 127.8, 127.9, 130.9 (CH), 131.2, 132.0, 134.0, 134.4, 136.4, 
136.5, 139.4 (C) . IR (KBr): v = 3069, 3054, 3013, 2961, 2924, 2872, 2851, 1598, 1557, 1542, 
1498 (w), 1478, 1463 (m), 1426, 1399, 1367, 1340, 1306, 1296 (w), 1258 (m), 1236, 1213, 1180, 
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1124 (w), 1104 (m), 1089 (s), 1056 (m), 1009 (s), 950, 939 (m), 907, 861 (w), 838 (s), 823, 813 
(m), 797 (s), 742, 733 (w), 725 (m), 715, 698, 673, 666, 648, 639, 626 (w), 609 (m), 592, 582, 
538 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) : 431 ([(M+H), 81Br, 35Cl]+, 100), 430 ([M, 81Br,
35Cl]+, 15),  429 ([(M+H), 79Br, 35Cl]+, 63), 393 (8), 314 (10), 139 (16). HRMS (EI, 70 eV): calcd 
for C21H14BrCl2N [M, 81Br, 35Cl]+: 430.96607; found: 430.96755, calcd for C21H14BrCl2N [M,
79Br, 35Cl]+: 428.96812; found: 428.96935. 
3-Bromo-2,6-bis(4-fluorophenyl)-1-methyl-1H-indole (23e): Starting with 21 (100 mg, 0.27 
mmol), 4-fluorophenylboronic acid 3j (79 mg, 0.57 mmol), 
Pd(PPh3)4 (16 mg, 5 mol%), K3PO4 (172 mg, 0.81 mmol) 
and 1,4-dioxane (5 mL), 23e was isolated as a white solid 

'!0:#@%reaction temperature: 90°C for 8 h,Mp.115-
117°C. 1H NMR (300 MHz, CDCl3): δ = 3.60 (s, 3H, NCH3), 7.06 (t, 2H, J = 5.22 Hz, ArH), 
7.14 (t, 2H, J = 5.22 Hz, ArH), 7.35 (dd, 1H, J = 0.87, 4.92 Hz, ArH), 7.39-7.42 (m, 3H, ArH), 
7.53-7.57 (m, 3H, ArH). 19F NMR (282.4 MHz, CDCl3):  = -116.3, -111.9. 13C NMR 
(62.9 MHz, CDCl3): δ = 31.7 (NCH3), 90.3 (C), 108.2 (CH), 115.5 (d, JF,C = 6.51 Hz, CH), 117.3 
(d, JF,C = 6.83 Hz, CH), 119.7, 120.5 (CH), 126.2, 126.3 (C), 128.9 (d, JF,C = 7.92 Hz, CH), 132.5 
(d, JF,C = 8.32 Hz, CH), 135.7, 137.3, 137.7, 138.1 (C), 162.3 (d, JF,C = 245.9 Hz, C-F), 162.9 (d, 
JF,C = 249.2 Hz, C-F). IR (KBr): v = 2925, 2852 (w), 1603, 1591 (m), 1574, 1557 (w), 1539 (m), 
1515, 1488 (s), 1456 (m), 1424, 1405, 1371, 1339, 1308, 1298 (w), 1229, 1158, 1100 (s), 1022 
(w), 1010, 951 (m), 860 (w), 846, 834, 824 (w), 794 (s), 726, 718, 686, 667, 644, 629 (w), 619 
(m), 599 (s), 566 (m), 536 (w) cm−1. GC-MS (EI, 70 eV): m/z (%): 399 ([M, 81Br]+, 100), 398 
([(M+H), 79Br]+, 25), 397 ([M, 79Br]+, 99), 317 (11), 316 (15), 303 (14). HRMS (EI, 70 eV): 
calcd for C21H14F2BrN [M, 81Br]+: 399.02517; found: 399.02549, calcd for C21H14F2BrN [M, 
79Br]+: 397.02722 found: 397.02732. 
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Synthesis of 3,6-dibromo-2-aryl-1-methyl-1H-indole 24a-e: 
3,6-Dibromo-2-(4-(tert-butyl)phenyl)-1-methyl-1H-indole (24a): Starting with 21 (100 mg, 
0.27 mmol), 4-tert-butylphenylboronic acid 3c (52 mg, 0.29 
mmol), Pd(PPh3)4 (10 mg, 3 mol%), K3PO4 (86 mg, 0.40 mmol) 
and toluene/1,4-dioxane (4:1) (5 mL), 24a was isolated as a 
?$. 2)4 
'90: #@% reaction temperature: 65°C for 8 h, 
Mp.156-158°C. 1H NMR (300 MHz, CDCl3): δ = 1.31 (s, 9H, 3CH3), 3.55 (s, 3H, NCH3), 7.23 
(dd, 1H, J = 1.92, 10.11 Hz, ArH), 7.31-7.46 (m, 6H, ArH). 13C NMR (62.9 MHz, CDCl3): 
δ = 31.3 (CH3), 31.8 (NCH3), 33.2, 90.0 (C), 112.7 (CH), 116.2 (C), 120.5, 123.7, 125.5 (CH), 
126.2, 126.8 (C), 130.2 (CH), 137.5, 138.8, 151.9 (C). IR (KBr): v = 3026 (w), 2959 (m), 2901, 
2865, 2707, 1920, 1868, 1731, 1681, 1599, 1563, 1556 (w), 1491, 1461, 1451, 1416 (m), 1405, 
1390 (w), 1360 (m), 1336 (s), 1289, 1267 (w), 1217 (m), 1199, 1131 (w), 1109, 1053, 1014 (m), 
968 (w), 945, 842, 800 (s), 738, 723, 689 (w), 654 (m), 628 (w), 615 (s), 589 (m), 576, 553, 543 
(w) cm−1.GC-MS (EI, 70 eV): m/z (%): 421 ([(M+H), 79Br, 81Br]+, 100), 420 ([M, 79Br, 81Br]+, 
11), 419 (52), 408 (23), 406 (45), 404 (23), 378 (8). HRMS (EI, 70 eV): calcd for C19H19Br2N 
[M, 79Br, 81Br]+: 420.98583; found: 420.98605. 
3,6-Dibromo-2-(4-ethylphenyl)-1-methyl-1H-indole (24b): Starting with 21 (100 mg, 0.27 
mmol), 4-ethylphenylboronic acid 24c (44 mg, 0.29 mmol), 
Pd(PPh3)4 (10 mg, 3 mol%), K3PO4 (86 mg, 0.40 mmol) and 
toluene/1,4-dioxane (4:1) (5 mL), 24b was isolated as a white 
2)4 
##0: #@% reaction temperature: 65°C for 8 h, Mp.94-
96°C. 1H NMR (300 MHz, CDCl3): δ = 1.24 (t, 3H, CH3), 2.67 (q, 2H, J = 7.59, CH2), 3.56 (s, 
3H, NCH3), 7.20-7.26 (m, 2H, ArH), 7.29 (d, 3H, J = 8.40 Hz, ArH), 7.33-7.39(m, 1H, ArH), 
7.42 (d, 1H, J = 1.41 Hz, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 15.3 (CH3), 28.7 (CH2), 31.7 
(NCH3), 90.1 (C), 112.7 (CH), 116.2 (C), 120.5, 123.7 (CH), 126.2, 127.1 (C), 128.0, 130.5 
(CH), 137.5, 138.8, 145.1 (C). IR (KBr): v = 3070, 3022, 2960, 2868 (w), 1492, 1463, 1448 (m), 
1414, 1371 (w), 1338 (m), 1305, 1289, 1231 (w), 1214 (m), 1183, 1130, 1117 (w), 1109, 1054 
(m), 1040, 1015, 966 (w), 943, 934, 843, 837, 829 (s), 811 (w), 800 (s), 765, 734, 677 (w), 659 
(m), 632 (w), 617 (m), 587 (s), 560 (w) cm−1. GC-MS (EI, 70 eV): m/z (%): 395 ([(M+H), 
81Br]+, 49), 394 ([M, 81Br]+, 19), 393 ([(M-H), 81Br]+, 100), 392 ([M, 81Br]+, 11), 391 ([(M+H), 
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79Br]+, 51), 378 (32), 376 (16). HRMS (EI, 70 eV): calcd for C17H15Br2N [M, 81Br]+: 394.95248; 
found: 394.95330, calcd for C17H15Br2N [M, 79Br]+: 390.95658; found: 390.95765. 
3,6-Dibromo-1-methyl-2-(p-tolyl)-1H-indole (24c): Starting with 21 (100 mg, 0.27 mmol),       
4-methylphenylboronic acid 3e (40 mg, 0.29 mmol), Pd(PPh3)4
(10 mg, 3 mol%), K3PO4 (86 mg, 0.40 mmol) and toluene/1,4-
dioxane (4:1) (5 mL), 24c was isolated as a white solid (79 mg, 
77%), reaction temperature: 65°C for 8 h. 1H NMR (300 MHz, 
CDCl3): δ = 2.37 (s, 3H, CH3), 3.54 (s, 3H, NCH3), 7.21-7.32 (m, 5H, ArH), 7.35-7.39 (m, 1H, 
ArH), 7.42 (d, 1H, J = 1.77 Hz, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 21.4 (CH3), 31.7 
(NCH3), 90.1 (C), 112.7 (CH), 116.2 (C), 120.5, 123.7 (CH), 126.2, 126.9 (C), 129.3, 130.4 
(CH), 137.5, 138.8, 139.0 (C). IR (KBr): v = 3206, 3070, 3021 (w), 2918 (m), 2866, 2584, 2550, 
2417, 2357, 2326, 2142, 1965, 1910, 1869, 1801, 1732, 1673, 1604, 1562 (w), 1492 (m), 1462, 
1450 (s), 1419, 1370 (m), 1336 (s), 1289, 1217, 1182 (m), 1131 (w), 1110, 1054 (m), 1040 (w), 
1018 (m), 964 (w), 943 (s), 830, 797 (s), 781 (m), 759, 736 (w), 720 (m), 677, 658, 633 (w), 620, 
586 (s), 549 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) : 381 ([(M+H), 81Br]+, 49), 380 ([M, 81Br]+, 
19), 379 ([(M+H), 79Br, 81Br]+, 100), 377 ([(M+H), 79Br]+, 50), 218 (11), 204 (13). HRMS (EI, 
70 eV): calcd for C16H13Br2N [M, 81Br]+: 380.93683; found: 380.93821, calcd for C16H13Br2N 
[M, 79Br, 81Br]+: 378.93888; found: 378.93905, calcd for C16H13Br2N [M, 79Br]+: 376.94093; 
found: 376.94069. 
3,6-Dibromo-2-(4-chlorophenyl)-1-methyl-1H-indole (24d): Starting with 21 (100 mg, 0.27 
mmol), 4-chlorophenylboronic acid 3f (46 mg, 0.29 mmol), 
Pd(PPh3)4 (10 mg, 3 mol%), K3PO4 (86 mg, 0.40 mmol) and 
toluene/1,4-dioxane (4:1) (5 mL), 24d was isolated as a white 
solid (86 mg, 79%), reaction temperature: 65°C for 8 h. 1H NMR 
(300 MHz, CDCl3): δ = 3.54 (s, 3H, NCH3), 7.23-7.26 (m, 1H, ArH), 7.32-7.36 (m, 3H, ArH), 
7.39-7.44 (m, 3H, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 31.8 (NCH3), 90.7 (C), 112.8 (CH), 
116.7 (C), 120.8, 124.0 (CH), 126.1, 128.4 (C), 128.9, 131.9 (CH), 135.2, 137.4, 137.6 (C). IR 
(KBr): v = 3079, 3064, 2925, 2854, 1915, 1872, 1728, 1692, 1599, 1562, 1536, 1503, 1478 (w), 
1461, 1454 (m), 1418, 1400, 1361 (w), 1336 (m), 1288, 1268, 1232, 1212, 1179, 1129, 1104 (w), 
1088 (m), 1051, 1036 (w), 1011 (m), 966 (w), 944, 939 (m), 835 (s), 803 (m), 795 (s), 737 (w), 
724 (m), 674, 648, 625 (w), 607 (m), 589 (s), 570 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) : 399 
([(M+H), 79Br, 81Br, 35Cl]+, 100), 398 ([M, 79Br, 81Br, 35Cl]+, 8), 397 ([(M+H), 79Br, 79Br, 35Cl]+, 
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45), 204 (11). HRMS (EI, 70 eV): calcd for C15H10Br2ClN [M, 79Br, 81Br, 35Cl]+: 398.88426; 
found: 398.88410, calcd for C15H10Br2ClN [M, 79Br, 79Br, 35Cl]+: 396.88630; found: 396.88615. 
General procedure (B) for Suzuki cross-coupling Reactions of brominated N-methylindole
(21): The reaction was carried out in a pressure tube. To a mixture solvent of toluene/dioxane 
(4:1) (5 mL) suspension of the brominated -N-methylindole, Pd(PPh3)4 (5 mol%) and of the 
Ar1B(OH)2 (1.1 equiv.), K3PO4 (1.5 equiv.) was added also. The mixture was heated at the 
indicated temperature (65°C) under Argon atmosphere for the indicated period of time (8 h) and 
cooled to room temperature. Then Ar2B(OH)2 (2.1 equiv.), K2CO3 (2 M, 1 mL) and 1,4-dioxane 
(3 mL) was added. The reaction mixture was further heated for 8 h at 110°C. The reaction 
mixture was again cooled to room temperature and diluted with water and extracted with CH2Cl2
(3 x 25 mL). The combined organic layers were dried (Na2SO4), filtered and the filtrate was 
concentrated in vacuo. The residue was purified by flash chromatography (silica gel, EtOAc/ 
heptanes). 
Synthesis of unsymmetrical 2,3,6-triaryl-1-methyl-1H-indoles 25a-d: 
3,6-Bis(4-(tert-butyl)phenyl)-2-(4-fluorophenyl)-1-methyl-1H-indole (25a): Starting with 21 
(100 mg, 0.27 mmol), 4-flourophenylboronic acid 3j (41 
mg, 0.29 mmol), Pd(PPh3)4 (16 mg, 5 mol%), K3PO4 (86 
mg, 0.40 mmol) and toluene/ 1,4-dioxane (4:1) (5 mL), 4-
tert-butylphenylboronic acid 3c (99 mg, 0.57 mmol), 
K2CO3 (2 M, 1 mL) and 1,4-dioxane (3 mL), following the 
general procedure B, 25a was isolated as a yellowish solid 

'' 0: 9@% reaction temperature: at 65°C for 8 h, at 
110°C for 8 h, Mp.148-150°C. 1H NMR (300 MHz, CDCl3): δ = 1.22(s, 9H, 3CH3), 1.29 (s, 9H, 
3CH3), 3.56 (s, 3H, NCH3), 6.97 (t, 2H, J = 8.64 Hz, ArH), 7.10-7.25 (m, 6H, ArH), 7.34 (dd, 
1H, J = 1.35, 8.31 Hz, ArH), 7.40 (d, 2H, J = 8.34 Hz, ArH), 7.47 (d, 1H, J = 0.90 Hz, ArH), 
7.56 (d, 2H, J = 8.31 Hz, ArH), 7.75 (d, 1H, J = 8.31 Hz, ArH). 19F NMR (282.4 MHz, CDCl3):
 = -113.2. 13C NMR (62.9 MHz, CDCl3): δ = 30.9 (NCH3), 31.4, 31.5 (CH3), 34.4, 34.5 (C), 
107.9 (CH), 115.2 (C), 115.6 (d, JF,C = 21.5 Hz, CH), 120.1, 125.2, 125.7 (CH), 126.3 (C), 127.1 
(CH), 128.1 (d, JF,C = 3.49 Hz, CH), 129.3 (CH), 131.9 (C), 132.4 (d, JF,C = 8.15 Hz, CH), 135.8, 
136.9, 137.9, 139.6, 148.4, 149.7 (C), 162.6 (d, JF,C = 247.9 Hz, C-F). IR (KBr): v = 3030 (w), 
2957 (m), 2902, 2865, 2244, 1900, 1605, 1593, 1563, 1549 (w), 1516 (m), 1491 (w), 1462 (s), 
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1426, 1404, 1392 (w), 1363 (m), 1334, 1319, 1307, 1296 (w), 1267 (m), 1221 (s), 1202 (w), 
1156 (m), 1108, 1093, 1086, 1045, 1014 (w), 947 (m), 906 (s), 860 (m), 836, 823, 810, 802 (s), 
761, 750 (w), 729 (s), 694, 672, 649 (w), 624, 604 (m), 561 (s), 538 (w)  cm−1. GC-MS (EI, 
70 eV): m/z (%): 490 ([M+H]+, 61), 489 ([M]+, 100), 474 (38), 444 (8), 229 (23), 215 (36), 201 
(96), 189 (16), 183 (15), 134 (14). HRMS (EI, 70 eV): calcd for C35H36FN [M]+: 489.28263; 
found: 489.28253. 
2-(4-(Tert-butyl)phenyl)-3,6-bis(4-methoxyphenyl)-1-methyl-1H-indole (25b): Starting with 
24a (71 mg, 0.17 mmol), 4-methoxyphenylboronic 
acid 3h (53 mg, 0.35 mmol), Pd(PPh3)4 (10 mg, 5 
mol%), K2CO3 (2 M, 1 mL) and 1,4-dioxane (3 mL), 
following the general procedure A, 25b was isolated as
a ye)?2$2)4
 0:#@%reaction temperature: 
at 90°C for 8 h, Mp.184-186°C. 1H NMR (300 MHz, 
CDCl3): δ = 1.27 (s, 9H, 3CH3), 3.62 (s, 3H, NCH3), 3.72 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 
6.76 (d, 2H, J = 8.76 Hz, ArH), 6.92 (d, 2H, J = 8.73 Hz, ArH), 7.16-7.18 (m, 4H, ArH), 7.31 
(d, 3H, J = 8.28 Hz, ArH), 7.44 (d, 1H, J = 0.84 Hz, ArH), 7.56 (d, 2H, J = 8.70 Hz, ArH), 7.68 
(d, 1H, J = 8.22 Hz, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 31.0 (NCH3), 31.3 (CH3), 34.7 
(C), 55.2, 55.4 (OCH3), 107.6, 113.7, 114.2 (CH), 114.5 (C), 119.7, 125.3 (CH), 122.1, 127.8 
(C), 127.4, 128.7 (CH), 128.9 (C), 130.7, 130.9 (CH), 135.3, 137.8, 138.0, 150.9, 157.6, 158.7 
(C). IR (KBr): v = 3033, 2996, 2953, 2902, 2866, 2832, 2248, 2059, 1886, 1714, 1650 (w), 1607 
(m), 1573, 1548 (w), 1514 (s), 1492 (w), 1461 (s), 1440 (m), 1426, 1407, 1393 (w), 1363 (m), 
1334, 1316, 1302 (w), 1278 (m), 1240, 1174 (s), 1108, 1089 (w), 1035 (s), 946, 906, 858 (m), 
832, 807, 794 (s), 783, 760 (w), 727 (s), 688 (m), 648, 624 (w), 607 (s), 582, 558 (w), 531 (m) 
cm−1. GC-MS (EI, 70 eV): m/z (%): 476 ([M+H]+, 36), 475 ([M]+, 100), 460 (12). HRMS (ESI, 
70 eV): calcd for C33H33NO2 [M+H]+: 476.25841; found: 476.25779. 
2-(4-Chlorophenyl)-3,6-bis(4-methoxyphenyl)-1-methyl-1H-indole (25c): Starting with  24d 
(67 mg, 0.17 mmol), 4-methoxyphenylboronic acid 3h
(54 mg, 0.35 mmol), Pd(PPh3)4 (10 mg, 5 mol%), 
K2CO3 (2 M, 1 mL) and 1,4-dioxane (3 mL), following 
the general procedure A, 25c was isolated as a yellowish 
2)4
 0: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%reaction temperature: at 90°C for 8 
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h, Mp.105-107°C. 1H NMR (300 MHz, CDCl3): δ = 3.60 (s, 3H, NCH3), 3.72 (s, 3H, OCH3), 
3.78 (s, 3H, OCH3), 6.77 (d, 2H, J = 8.79 Hz, ArH), 6.92 (d, 2H, J = 8.79 Hz, ArH), 7.12-7.19 
(m, 4H, ArH), 7.26-7.35 (m, 3H, ArH), 7.44 (brs, 1H, ArH), 7.55 (d, 2H, J = 8.67 Hz, ArH), 
7.67 (d, 1H, J = 8.36 Hz, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 30.0 (NCH3), 54.2, 54.4 
(OCH3), 106.6, 112.8, 113.2, 118.8 (CH), 125.1, 126.1 (C), 127.4, 127.7 (CH), 127.8, 129.4 (C), 
129.8, 131.3 (CH), 133.0, 134.0, 134.7, 135.3, 137.0, 156.8, 157.8 (C). IR (KBr): v = 3033, 
2999, 2958, 2920, 2836 (w), 1606 (m), 1572, 1546 (w), 1510, 1462 (s), 1441 (m), 1426, 1395 
(w), 1368 (m), 1333, 1316, 1302 (w), 1279 (m), 1242, 1174, 1087, 1033, 1013 (s), 945 (m), 907, 
887, 873 (w), 856, 826 (m), 815, 804, 794 (s), 760 (w), 725 (m), 698, 684, 649, 637, 618 (w), 
603 (s), 578, 568 (w), 534 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) : 454 ([M+H]+, 27), 453 
([M]+, 100), 438 (25). HRMS (EI, 70 eV): calcd for C29H24ClO2N [M]+: 453.14901; found: 
453.14838. 
2-(4-(Tert-butyl)phenyl)-3,6-bis(2-methoxyphenyl)-1-methyl-1H-indole (25d): Starting with 
24a (71 mg, 0.17 mmol), 2-methoxyphenylboronic acid 3a  
(54 mg, 0.36 mmol), Pd(PPh3)4 (10 mg, 5 mol%), K2CO3 (2 
M, 1 mL) and 1,4-dioxane (3 mL), following the general 
procedure A, 25d was isolated as a yellowish solid (58 mg, 
9@%reaction temperature: at 90°C for 8 h, Mp.175-177°C.
1H NMR (300 MHz, CDCl3): δ = 1.24 (s, 9H, 3CH3), 3.38 (s, 3H, NCH3), 3.67 (s, 3H, OCH3), 
3.74 (s, 3H, OCH3), 6.77-6.86 (m, 2H, ArH), 6.92-7.00 (m, 2H, ArH), 7.12-7.17 (m, 3H, ArH), 
7.19-7.28 (m, 5H, ArH), 7.33-7.36 (m, 1H, ArH), 7.43-7.46 (m, 2H, ArH). 13C NMR (75.5 MHz, 
CDCl3): δ = 30.2 (NCH3), 30.3 (CH3), 33.6 (C), 53.8, 54.7 (OCH3), 109.5, 109.9 (CH), 110.1 
(C), 110.4 (CH), 118.3, 119.3, 119.8, 120.9 (CH), 123.4 (C), 123.9 (CH), 125.8 (C), 126.4, 126.9 
(CH), 128.7 (C), 129.0, 130.0 (CH), 131.2, 131.4 (C), 131.7 (CH), 136.3, 138.0, 149.3, 155.7, 
156.2 (C). IR (KBr): v = 3050 (w), 2954, 2924 (m), 2854, 1716, 1699, 1683, 1669, 1652, 1635, 
1615, 1597, 1578, 1558, 1501 (w), 1457 (s), 1432 (m), 1406, 1394 (w), 1363 (m), 1333, 1313, 
1289 (w), 1252, 1239 (s), 1178, 1160 (w), 1117, 1083, 1050 (m), 1025 (s), 947 (m), 932, 856, 
838 (w), 825, 813, 792 (m), 749 (s), 699, 654 (m), 638 (w), 628 (m), 611, 592, 560, 544 (w) 
cm−1. GC-MS (EI, 70 eV): m/z (%) : 476 ([M+H]+, 36), 475 ([M]+, 100). HRMS (EI, 70 eV): 
calcd for C33H33NO2 [M]+: 475.25058; found: 475.25047. 
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Synthesis of Functionalized Anthraquinones by Domino Twofold Heck–6π-
Electrocyclization Reactions of 2,3-Dibromonaphthoquinone 
General procedure for the synthesis of mono- and disubstituted anthraquinones: 
    In a pressure tube (glass bomb) a suspension of Pd(OAc)2 (11 mg, 5 mol%) and XPhos (48 
mg, 10 mol%) in DMF (5 mL) was purged with argon and stirred at 20°C to give a yellowish or 
brownish clear solution. To the stirred solution were added 26 (316 mg, 1.0 mmol), NEt3 (1.1 
mL, 8.0 mmol) and the alkene 27a-j (2.5 equiv.). The reaction mixture was stirred at 90°C 
(Method 1) or 110°C (Method 2) for 8 h. The solution was cooled to 20°C, poured into H2O and 
CH2Cl2 (25 mL each), and the organic and the aqueous layer were separated. The latter was 
extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were washed with H2O (3 x 20 
mL), dried (Na2SO4), concentrated in vacuo and the residue was purified by chromatography 
(flash silica gel, heptanes/ EtOAc) to give 28 or 29.
2,3-Bis(4-chlorophenyl)anthracene-9,10-dione (28a): Starting with 26 (316 mg, 1.0 mmol), 4-
chlorostyrene 27a (346 mg, 2.5 mmol), Pd(OAc)2 (11 mg, 5 
mol%), XPhos (48 mg, 10 mol%), 28a was isolated as a yellowish 
solid (325 mg, 76%), reaction temperature: at 90°C for 8 h, Mp. 
221-223°C. 1H NMR (300 MHz, CDCl3): δ = 7.05 (d, 4H, J = 
7.05 Hz, ArH), 7.20 (d, 4H, J = 8.52 Hz, ArH), 7.72-7.77 (m, 2H, 
ArH), 8.21 (s, 2H, ArH), 8.23-8.26 (m, 2H, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 126.3, 
127.7, 128.5, 129.9 (2CH), 131.5, 132.5, 133.1 (2C), 133.2 (2CH), 136.7, 143.9 (2C), 181.6 
(2CO). IR (KBr): v = 3316, 3073, 3054, 3028, 2961, 2924, 2851 (w), 1671, 1661, 1586 (s), 1565 
(m), 1519, 1500 (w), 1490, 1477 (m), 1455, 1413, 1387 (w), 1329 (s), 1302, 1284 (m), 1258 (s), 
1180, 1170, 1126 (w), 1087 (s), 1044 (w), 1011 (s), 969, 957 (w), 945 (s), 905 (w), 825, 796 (s), 
762 (w), 748, 739, 728 (m), 712 (s), 688, 665, 644, 635, 586 (w), 560 (m), 534 (w) cm−1. GC-MS 
(EI, 70 eV): m/z (%) : 431 ([(M+H), 35Cl, 37Cl]+, 17), 430 ([M, 35Cl, 37Cl]+, 69), 429 
([(M+H),35Cl, 35Cl]+, 30), 428 ([M, 35Cl, 35Cl]+, 100), 393 (59), 358 (21), 330 (11), 300 (31), 150 
(25). HRMS (EI, 70 eV): calcd for C26H14Cl2O2 [M, 35Cl, 37Cl]+: 430.03359; found: 430.03367, 
calcd for C26H14Cl2O2 [M, 35Cl, 35Cl]+: 428.03654; found: 428.03595.  




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2,3-Bis(3-chlorophenyl)anthracene-9,10-dione (28b): Starting with 26 (316 mg, 1.0 mmol), 3-
chlorostyrene 27b (346 mg, 2.5 mmol), Pd(OAc)2 (11 mg, 5 
mol%), XPhos (48 mg, 10 mol%), 28b was isolated as a 
yellowish solid (303 mg, 71%), reaction temperature: at 90°C for 
8 h, Mp.150-152°C. 1H NMR (300 MHz, CDCl3): δ = 6.93 (d, 
2H, J = 7.85 Hz, ArH), 7.10-7.22 (m, 5H, ArH), 7.35-7.53 (m, 1H, ArH), 7.72-7.78 (m, 2H, 
ArH), 8.23 (s, 2H, ArH), 8.24 (m, 2H, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 126.3, 126.8, 
127.1, 128.4, 128.5, 128.6 (2CH), 131.6, 132.5 (2C), 133.3 (2CH), 133.4, 139.9, 143.8 (2C), 
181.6 (2CO). IR (KBr): v = 3321, 3055, 3014, 2957, 2919, 2851, 1953, 1875, 1770, 1698 (w), 
1670, 1584 (s), 1564 (m), 1477, 1469, 1463, 1418, 1395 (w), 1327, 1316 (s), 1286 (m), 1266, 
1248 (s), 1167, 1129, 1097, 1078, 1052, 998, 977 (w), 952 (m), 928, 900, 884, 857 (w), 792, 784 
(m), 755, 738 (w), 711, 702, 688 (s), 666 (m), 641, 621, 684, 656, 532 (w) cm−1. GC-MS (EI, 
70 eV): m/z (%) : 431 ([(M+H), 35Cl, 37Cl]+, 19), 430 ([M, 35Cl, 37Cl]+, 66), 429 ([(M+H), 35Cl, 
35Cl]+, 30), 428 ([M, 35Cl, 35Cl]+, 100), 393 (84), 358 (24), 330 (12), 300 (36), 150 (32). HRMS 
(EI, 70 eV): calcd for C26H14Cl2O2 [M, 35Cl, 37Cl]+: 430.03359; found: 430.03421, calcd for 
C26H14Cl2O2 [M, 35Cl,  35Cl]+: 428.03654; found: 428.03696. 
2,3-Bis(4-(tert-butyl)phenyl)anthracene-9,10-dione (28c): Starting with 26 (316 mg, 1.0 
mmol), 4-tert-butylstyrene 27c (400 mg, 2.5 mmol), Pd(OAc)2
(11 mg, 5 mol%), XPhos (48 mg, 10 mol%), 28c was isolated as a 
yellowish solid (377 mg, 80%), reaction temperature: at 90°C for 
8 h, Mp.166-168°C. 1H NMR (300 MHz, CDCl3): δ = 1.24 (s, 
9H, 3CH3), 1.24 (s, 9H, 3CH3), 7.08 (d, 4H, J = 8.61 Hz, ArH), 
7.21 (d, 4H, J = 8.58 Hz, ArH), 7.71-7.76 (m, 2H, ArH), 8.24-8.27 (m, 2H, ArH), 8.29 (s, 2H, 
ArH). 13C NMR (62.9 MHz, CDCl3): δ = 31.3 (2CH3), 34.5 (2C), 125.0, 127.2, 129.3, 129.6 
(2CH), 132.0, 133.8 (2C), 134.0 (2CH), 136.8, 146.4, 150.7 (2C), 183.1 (2CO). IR (KBr): v
= 3325, 3063, 3033, 2959, 2923, 2853, 1737 (w), 1672 (s), 1610 (w), 1587 (s), 1513, 1493, 1475, 
1462, 1414, 1390, 1361 (w), 1329 (s), 1310, 1290 (m), 1259 (s), 1201, 1186, 1168 (w), 1109, 
1080 (m), 1022 (w), 1013 (m), 971, 960 (w), 946 (m), 929, 896, 851 (w), 832, 800, 791 (m), 752, 
734 (w), 713 (s), 690, 666, 647 (w), 588 (m), 561, 529 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) : 
473 ([M+H]+, 21), 472 ([M]+, 69), 457 ([M]+, 100), 359 (13), 221 (16), 193 (23). HRMS (EI, 70 
eV): calcd for C34H32O2 [M]+: 472.23968; found: 472.24008. 
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2,3-Di-p-tolylanthracene-9,10-dione (28d): Starting with 26 (316 mg, 1.0 mmol), 4-
methylstyrene 27d (295 mg, 2.5 mmol), Pd(OAc)2 (11 mg, 5 
mol%), XPhos (48 mg, 10 mol%), 28d was isolated as a 
yellowish solid (302 mg, 78%), reaction temperature: at 90°C 
for 8 h, Mp.140-142°C. 1H NMR (250 MHz, CDCl3): δ = 
2.24 (s, 3H, CH3), 2.24 (s, 3H, CH3), 6.97-6.99 (m, 7H, ArH), 
7.66-7.69 (m, 2H, ArH), 8.18-8.22 (m, 5H, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 21.2 
(2CH3), 127.2, 128.9, 129.5, 129.6 (2CH), 132.0, 133.7 (2C), 134.0 (2CH), 136.8, 137.4, 146.3 
(2C), 182.9 (2CO). IR (KBr): v = 3324, 3015, 2914, 2857 (w), 1671 (m), 1609 (w), 1586 (m), 
1513, 1478, 1453, 1391 (w), 1327 (s), 1309, 1287, 1271, 1255 (m), 1208, 1184, 1169 (w), 1127, 
1113 (m), 1039 (w), 1017 (m), 971 (w), 946 (m), 923, 906, 863, 850, 841 (w), 820 (s), 794 (m), 
758 (w), 727 (m), 710 (s), 670, 665, 642, 636, 605, 589, 565 (w), 547 (m) cm−1.GC-MS (EI, 
70 eV): m/z (%) : 389 ([M+H]+, 31), 388 ([M]+, 100), 373 (67), 187 (14). HRMS (EI, 70 eV): 
calcd for C28H20O2 [M]+: 388.14578; found: 388.14581. 
2,3-Bis(4-fluorophenyl)anthracene-9,10-dione (28e): Starting with 26 (316 mg, 1.0 mmol), 4-
fluorostyrene 27e (305 mg, 2.5 mmol), Pd(OAc)2 (11 mg, 5 
mol%), XPhos (48 mg, 10 mol%), 28e was isolated as a yellowish 
solid (285 mg, 72%), reaction temperature: at 90°C for 8 h, 
Mp.164-166°C. 1H NMR (300 MHz, CDCl3): δ = 6.90 (t, 4H, J = 
8.70 Hz, ArH), 7.05-7.11 (m, 4H, ArH), 7.69-7.76 (m, 2H, ArH), 8.21 (s, 2H, ArH), 8.23-8.26 
(m, 2H, ArH).19F NMR (282.4 MHz, CDCl3):  = -113.7, -112.8. 13C NMR (75.5 MHz, CDCl3): 
δ = 115.5 (d, JF,C = 21.6 Hz, 2CH), 127.3, 129.5 (2CH), 131.3 (d, JF,C = 8.21 Hz, 2CH), 132.4, 
133.6 (2C), 134.2 (2CH), 135.4 (d, JF,C = 3.37 Hz, 2C), 145.3 (2C), 162.4 (d, JF,C = 248.6 Hz, 
2C-F), 182.8 (2CO). IR (KBr): v = 3319, 3182, 3058, 2923, 2853 (w), 1670 (s), 1600 (m), 1583, 
1509 (s), 1477 (m), 1434, 1392 (w), 1327 (s), 1301, 1273, 1256 (m), 1221, 1157 (s), 1128, 1097 
(m), 1044 (w), 1014 (m), 976 (w), 949, 924 (m), 864 (w), 834 (s), 816, 803, 792 (m), 760 (w), 
730 (m), 710 (s), 666 (m), 638, 606, 588, 581, 565 (w), 546 (m) cm−1. GC-MS (EI, 70 eV): m/z 
(%) : 397 ([M+H]+, 29), 396 ([M]+, 100),  338 (22), 318 (8). HRMS (EI, 70 eV): calcd for 
C26H14F2O2 [M]+: 396.09564; found: 396.09500. 
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Diethyl 9,10-dioxo-9,10-dihydroanthracene-2,3-dicarboxylate (28g): Starting with 26 (316 
mg, 1.0 mmol), ethylacrylate 27g (250 mg, 2.5 mmol), Pd(OAc)2 (11 
mg, 5 mol%), XPhos (48 mg, 10 mol%), 28g was isolated as a 
yellowish solid (278 mg, 79%), reaction temperature: at 90°C for 8 
h, Mp.136-138°C. 1H NMR(300 MHz, CDCl3): δ = 1.36 (t, 3H, J = 
7.14Hz, CH3), 1.36 (t, 3H, J = 7.14 Hz, CH3), 4.38 (q, 2H, J = 7.14 Hz, CH2), 4.38 (q, 2H, J = 
7.14 Hz, CH2), 7.78-7.80 (m, 2H, ArH), 8.27-8.29 (m, 2H, ArH), 8.56 (s, 2H, ArH). 13C NMR 
(75.5 MHz, CDCl3): δ = 28.7 (2CH3), 61.4 (2OCH2), 126.6, 127.1 (2CH), 132.3, 133.6 (2C), 
133.7 (2CH), 135.9 (2C), 165.1 (2CO), 180.7 (2CO). IR (KBr): v = 3072, 2957, 2926, 2856 (w), 
1725 (s), 1627, 1666 (m), 1650, 1597 (w), 1462 (m), 1379, 1328 (w), 1272 (s), 1122, 1071 (m), 
1039, 1017, 960, 862, 795, 768, 741, 704, 651, 610, 573, 553 (w) cm−1. GC-MS (EI, 70 eV): m/z 
(%) : 352 ([M]+, 6), 307 (19), 279 (100), 235 (11). HRMS (EI, 70 eV): calcd for C20H16O6 [M]+: 
352.09414; found: 352.09347. 
Di-tert-butyl 9,10-dioxo-9,10-dihydroanthracene-2,3-dicarboxylate (28h): Starting with 26
(316 mg, 1.0 mmol), 4-tert-butylacrylate 27h (320 mg, 2.5 mmol), 
Pd(OAc)2 (11 mg, 5 mol%), XPhos (48 mg, 10 mol%), 28h was 
isolated as a yellowish solid (334 mg, 82%), reaction temperature: at 
90°C for 8 h, Mp.172-174°C. 1H NMR (300 MHz, CDCl3): δ = 1.56 
(s, 9H, 3CH3), 1.56 (s, 9H, 3CH3), 7.73-7.80 (m, 2H, ArH), 8.23-8.29 (m, 2H, ArH), 8.44 (s, 2H, 
ArH). 13C NMR (75.5 MHz, CDCl3): δ = 28.2 (2CH3), 83.3 (2C), 127.5, 127.9 (2CH), 132.3, 
133.4 (2C), 134.6 (2CH), 138.5 (2C), 165.3 (2CO), 181.9 (2CO). IR (KBr): v = 3075, 3002, 
2978, 2924, 2853 (w), 1724 (m), 1713, 1679 (s), 1630, 1613 (w), 1590 (m), 1522, 1478, 1456, 
1404 (w), 1391, 1367, 1340 (m), 1254, 1151, 1135, 1123 (s), 1042 (w), 1021, 961, 936 (m), 927 
(w), 842, 792 (m), 776, 750, 741, 719 (w), 707 (s), 691 (m), 656, 641, 605 (w), 566 (m) 
cm−1.GC-MS (EI, 70 eV): m/z (%) : 409 ([M+H]+, 31), 408 ([M]+, 100), 297 (20), 234 (23), 150 
(13). HRMS (ESI, 70 eV): calcd for C24H24O6Na [M+Na]+: 431.14651; found: 431.14654. 
2-(4-Chlorophenyl)anthracene-9,10-dione (29a): Starting with 26 (316 mg, 1.0 mmol), 4-
chlorostyrene 27a (346 mg, 2.5 mmol), Pd(OAc)2 (11 mg, 5 
mol%), XPhos (48 mg, 10 mol%), 29a was isolated as a yellowish 
solid (140 mg, 44%), reaction temperature: at 110°C for 8 h, 
Mp.180-182°C. 1H NMR (300 MHz, CDCl3): δ = 7.06 (d, 2H, J = 
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8.52 Hz, ArH), 7.21 (d, 2H, J = 8.52 Hz, ArH), 7.41 (d, 1H, J = 8.58 Hz, ArH ), 7.58 (d, 1H, J = 
8.58 Hz, ArH ), 7.70-7.95 (m, 2H, ArH), 8.23 (s, 1H, ArH), 8.24-8.41 (m, 2H, ArH). 13C NMR 
(75.5 MHz, CDCl3): δ = 125.4, 127.3, 128.6, 128.7, 129.4, 129.5, 130.9, 132.1 (CH), 132.5, 
133.6, 134.1 (C), 134.3 (CH), 137.7, 145.0, 145.5 (C), 182.7, 183.1 (CO). IR (KBr): v = 3320, 
3056, 3031, 2955, 2919, 2850 (w), 1671, 1587 (s), 1491, 1477 (m), 1455, 1419, 1390 (w), 1329, 
1307, 1299, 1272, 1254 (s), 1210, 1184, 1174, 1157, 1127, 1106 (w), 1090 (s), 1045 (w), 1011 
(s), 968 (w), 947, 931 (m), 906, 864 (w), 822 (s), 796 (m), 762, 748, 740 (w), 729 (m), 707 (s), 
666, 644, 635 (m), 607, 586 (w), 562 (m), 534 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) : 319 
([M+H]+, 22), 318 ([M]+, 100), 290 (18), 262 (12), 226 (33).  HRMS (EI, 70 eV): calcd for 
C20H11ClO2 [M]+: 318.04421; found: 318.04467. 
2-(4-(Tert-butoxy)phenyl)anthracene-9,10-dione (29f): Starting with 26 (316 mg, 1.0 mmol), 
4-tert-butoxystyrene 27f (440 mg, 2.5 mmol), Pd(OAc)2 (11 
mg, 5 mol%), XPhos (48 mg, 10 mol%), 29f was isolated as a 
yellowish solid (210 mg, 59%), reaction temperature: at 110°C 
for 8 h, Mp.100-111°C. 1H NMR (300 MHz, CDCl3): δ =1.34 
(s, 9H, 3CH3), 7.04 (d, 2H, J = 8.70 Hz, ArH), 7.56 (d, 2H, J = 8.70 Hz, ArH), 7.69-7.72 (m, 2H, 
ArH), 7.89 (dd, 1H, J = 1.98, 8.13 Hz, ArH), 8.21-8.26 (m, 3H, ArH), 8.41 (d, 1H, J = 1.83 Hz, 
ArH). 13C NMR (75.5 MHz, CDCl3): δ = 28.9 (CH3), 79.1(C), 124.3, 125.1, 127.1, 127.2, 127.9, 
128.0 (CH), 131.7 (C), 131.9 (CH), 133.5, 133.6, 133.7, 133.9 (C), 134.0, 134.1 (CH), 146.4 (C), 
156.6 (CO), 182.8, 183.3 (CO). IR (KBr): v = 3310, 3063, 3034, 2973, 2922, 2850 (w), 1673, 
1589 (s), 1513 (m), 1480, 1456, 1425, 1388 (w), 1364, 1326, 1299, 1278, 1250, 1239 (m), 1156 
(s), 1108, 1029, 1011, 971 (w), 954, 932 (m), 923 (w), 892 (s), 872 (w), 850 (s), 791 (w), 722 
(m), 705 (s), 670, 636, 618, 569 (w), 535 (m) cm−1.GC-MS (EI, 70 eV): m/z (%) : 356 ([M]+, 
20), 300 (100), 272 (17), 244 (14), 215 (21). HRMS (ESI, 70 eV): calcd for C24H20O3 [M]+: 
356.14070; found: 356.14105. 
Ethyl 9,10-dioxo-9,10-dihydroanthracene-2-carboxylate (29g): Starting with 26 (316 mg, 1.0 
mmol), ethylacrylate 27g (250 mg, 2.5 mmol), Pd(OAc)2 (11 mg, 5 
mol%), XPhos (48 mg, 10 mol%),  29g was isolated as a yellowish 
solid (104 mg, 37%+28g), reaction temperature: at 110°C for 8 h, 
Mp.143-145°C. 1H NMR (300 MHz, CDCl3): δ = 1.38 (t, 3H, J = 

 
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7.14 Hz, CH3), 4.39 (q, 2H, J = 7.14 Hz, CH2), 7.72-7.80 (m, 2H, ArH), 8.20-8.28 (m, 2H, ArH), 
8.30 (s, 1H, ArH), 8.35 (dd, 1H, J = 1.68, 8.07 Hz, ArH), 8.84 (d, 1H, J = 1.29 Hz, ArH). 13C 
NMR (62.9 MHz, CDCl3): δ = 30.9 (CH3), 61.9 (OCH2), 127.3, 127.4, 127.5, 128.5 (CH), 133.3, 
133.4, 133.5 (C), 134.3, 134.4, 134.5 (CH), 135.5, 136.0 (C), 165.0 (CO), 182.3, 182.5 (CO). IR 
(KBr): v = 3419, 3325, 3099, 3076, 3041, 2991, 2964, 2915, 2852 (w), 1717, 1674, 1588 (s), 
1481, 1453, 1411, 1392, 1371 (w), 1330, 1316, 1292 (m), 1264, 1240 (s), 1162, 1108, 1083, 
1025, 1015, 971, 928 (m), 908 (w), 869 (m), 818 (w), 797, 764 (m), 702 (s), 651 (w), 631 (m) 
cm−1. GC-MS (EI, 70 eV): m/z (%) : 280 ([M]+, 34), 252 (49), 235 (100), 207 (26), 151 (41). 
HRMS (EI, 70 eV): calcd for C17H12O4 [M]+: 280.07301; found: 280.07294. 
Tert-butyl 9,10-dioxo-9,10-dihydroanthracene-2-carboxylate (29h): Starting with 26 (316 mg, 
1.0 mmol), 4-tert-butylacrylate 27h (320 mg, 2.5 mmol), 
Pd(OAc)2 (11 mg, 5 mol%), XPhos (48 mg, 10 mol%), 29h was 
isolated as a yellowish solid (184 mg, 60%+28h), reaction 
temperature: at 110°C for 8 h, Mp.119-121°C. 1H NMR (300 
MHz, CDCl3): δ = 1.57 (s, 9H, 3CH3), 7.71-7.77 (m, 2H, ArH), 8.19-8.30 (m, 4H, ArH), 8.76-
8.77 (m, 1H, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 28.2 (CH3), 82.5 (C), 127.3, 127.4, 128.4 
(CH), 133.4, 133.5 (C), 134.2, 134.4, 134.5 (CH), 135.7, 138.0 (C), 164.1 (CO), 182.4, 182.6 
(CO). IR (KBr): v = 3410, 3327, 2996, 2976, 2923, 2874, 2853 (w), 1712, 1674 (s), 1590 (m), 
1483, 1476, 1462, 1391 (w), 1368, 1332 (m), 1274, 1246 (s), 1183 (w), 1154 (s), 1124, 1093 
(m), 1036, 977, 968 (w), 930 (m), 894 (w), 865, 846, 793 (m), 764, 751 (w), 700 (s), 634 (m) 
cm−1.GC-MS (EI, 70 eV): m/z (%) : 308 ([M]+, 21), 253 (100), 235 (86), 208 (59), 151 (51). 
HRMS (ESI, 70 eV): calcd for C19H16O4 [2M+Na]+: 639.19844; found: 639.19859. 
Octadecyl 9,10-dioxo-9,10-dihydroanthracene-2-carboxylate (29i): Starting with 26 (316 mg, 
1.0 mmol), octadecylacrylate 
27i (325 mg, 2.5 mmol), 
Pd(OAc)2 (11 mg, 5 mol%), 
XPhos (48 mg, 10 mol%), 
29i was isolated as a yellowish solid (231 mg, 46%), reaction temperature: at 110°C for 8 h, 
Mp.103-105°C.1H NMR (300 MHz, CDCl3): δ = 1.16-1.19 [m, 35H, 16(CH2)CH3], 4.32 (q, 2H, 
J = 6.75 Hz, CH2), 7.73-7.75 (m, 2H, ArH), 8.21-8.29 (m, 2H, ArH), 8.30 (s, 1H, ArH), 8.35 (dd, 
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1H, J = 1.65, 8.10 Hz, ArH), 8.85 (d, 1H, J = 1.26 Hz, ArH).13C NMR (62.9 MHz, CDCl3): 
δ = 14.1 (CH3), 22.7, 26.0, 28.6, 29.2, 29.3, 29.5, 29.6, 29.6, 29.7 (CH2), 66.1 (OCH2), 127.3, 
127.4, 127.5, 128.5 (CH), 133.3, 133.4, 133.5 (C), 134.3, 134.4, 134.5 (CH), 135.6, 136.0 (C), 
165.1 (CO), 182.3, 182.5 (CO). IR (KBr): v = 2958 (w), 2915, 2848, 1720, 1670 (m), 1606 (w), 
1589, 1472 (m), 1406, 1392, 1365, 1332, 1326, 1300 (w), 1265, 1242 (s), 1165 (m), 1126, 1097, 
1050, 1027, 1018, 995, 980 (w), 947 (m), 928, 906, 867, 843, 818 (w), 799 (m), 763, 751, 741 
(w), 717 (m), 706 (s), 646, 634, 567, 540 (w) cm−1. GC-MS (EI, 70 eV): m/z (%) : 505 ([M+H]+, 
30), 504 ([M]+, 100), 254 (69), 253 (30), 235 (12). HRMS (EI, 70 eV): calcd for C33H44O4 [M]+: 
504.32341; found: 504.32231. 
2-Methoxyethyl 9,10-dioxo-9,10-dihydroanthracene-2-carboxylate (29j): Starting with 26
(316 mg, 1.0 mmol), ethylene glycol methyl ether acrylate 
27j (325 mg, 2.5 mmol), Pd(OAc)2 (11 mg, 5 mol%), XPhos 
(48 mg, 10 mol%), 29j was isolated as a yellowish solid 
(220 mg, 71%), reaction temperature: at 110°C for 8 h, 
Mp.125°C. 1H NMR (300 MHz, CDCl3): δ = 3.38 (s, 3H, OCH3), 3.69-3.73 (m, 2H, CH2), 4.47-
4.50 (m, 2H, OCH2), 7.72-7.79 (m, 2H, ArH), 8.24-8.30 (m, 2H, ArH), 8.32 (brs, 1H, ArH), 8.38 
(dd, 1H, J = 1.71, 8.10 Hz, ArH), 8.88-8.89 (m, 1H, ArH). 13C NMR (75.5 MHz, CDCl3): 
δ = 59.1 (OCH3), 64.9 (CH2), 70.3 (OCH2), 127.4, 127.5, 127.5, 128.8 (CH), 133.4, 133.5, 133.6 
(C), 134.4, 134.5, 134.7 (CH), 135.1, 136.1 (C), 165.1 (CO), 182.3, 182.6 (CO). IR (KBr): v
= 3428, 3326, 3099, 3079, 3046, 2960, 2925, 2889, 2850, 2828, 2815, 1999, 1871 (w), 1717, 
1674 (s), 1588 (m), 1477, 1463, 1440, 1416, 1404, 1373 (w), 1330, 1294 (m), 1266, 1242 (s), 
1204, 1162 (m), 1115, 1106 (s), 1077 (m), 1021 (s), 979, 966 (w), 930 (m), 880, 874 (w), 862 
(m), 824 (w), 795 (m), 775, 764 (w), 700 (s), 650 (w), 635 (m), 541 (w) cm−1. GC-MS (EI, 
70 eV): m/z (%) : 310 ([M]+, 21), 278 (11), 235 (100), 207 (25), 179 (8), 151 (60), 58 (58). 
HRMS (EI, 70 eV): calcd for C18H14O5[M]+: 310.08358; found: 310.08340. 
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X-ray Crystal Data 
Data for compound 5b 
Identification code                                             dz-t16 
Empirical formula                                              C22H15F3O4S2
Formula weight                                                  464.46 
Temperature                                                       173 (2) K 
Wavelength                                                         0.71073 Å 
Crystal system                                                    Monoclinic 
Space group (H.-M.)                                           P21/c 
Space group (Hall)                                             -P 2ybc 
Unit cell dimensions                                           a = 5.2396 (2) Å                  = = 90.00° 
                                                                            b = 19.5582 (9) Å                P = 96.074 (2)° 
                                                                            c = 19.2611 (8) Å                Q = 90.00° 
Volume                                                               1962.74 (14) Å3 
Z                                                                          4 
Density (calculated)                                            1.572 Mg /m3 
Absorption coefficient                                        0.33 mm−1 
F (000)                                                                952 
Crystal size                                                         0.99 × 0.18 × 0.05 mm3
R range for data collection                                                4.7–59.8° 
Reflections collected                                          21304 
Independent reflections                                      5620 
Absorption correction                                         multi-scan  
Max. and Min. transmission                               0.984 and 0.737 
Refinement method                                            full-matrix 
Goodness-of-fit F2                                             1.046 
Final R indices [I >2S (I)]                                   R1 = 0.0393, wR2 = 0.0942 
R indices (all data)                                              R1 = 0.0646, wR2 = 0.1056 
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Data for compound 5c 
Identification code                                             dz-t7 
Empirical formula                                              C24H19F3O4S2
Formula weight                                                  492.51 
Temperature                                                       173 (2) K 
Wavelength                                                        0.71073 Å 
Crystal system                                                    Monoclinic 
Space group (H.-M.)                                           P21/c
Space group (Hall)                                             -P 2ybc 
Unit cell dimensions                                           a = 5.4456 (3) Å                   = = 90.00° 
                                                                            b = 30.3961 (18) Å               P = 93.177 (4)° 
                                                                            c = 12.9846 (8) Å                 Q = 90.00° 
Volume                                                               2146.0 (2) Å3 
Z                                                                          4 
Density (calculated)                                            1.524 Mg /m3 
Absorption coefficient                                        0.31 mm−1 
F (000)                                                                 1016 
Crystal size                                                          0.87 × 0.06 × 0.04 mm3
R range for data collection                                                 5.1–47.5° 
Reflections collected                                           21642 
Independent reflections                                       5175 
Absorption correction                                          multi-scan  
Max. and Min. transmission                                0.988 and 0.777 
Refinement method                                             full-matrix 
Goodness-of-fit F2                                              0.932 
Final R indices [I >2S (I)]                                   R1 = 0.0481, wR2 = 0.0919 
R indices (all data)                                              R1 = 0.1235, wR2 = 0.1070 
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Data for compound 6b 
Identification code                                             dz-t21 
Empirical formula                                              C30H26O2S 
Formula weight                                                  450.57 
Temperature                                                       173 (2) K 
Wavelength                                                         0.71073 Å 
Crystal system                                                    Monoclinic 
Space group (H.-M.)                                           P21/c 
Space group (Hall)                                             -P 2ybc 
Unit cell dimensions                                           a = 5.6852 (4) Å                  = = 90.00° 
                                                                            b = 22.4121 (14) Å              P = 91.156 (2)° 
                                                                            c = 17.7991 (11) Å              Q = 90.00° 
Volume                                                               2267.5 (3) Å3 
Z                                                                         4 
Density (calculated)                                            1.320 Mg /m3 
Absorption coefficient                                        0.17 mm−1 
F (000)                                                                952 
Crystal size                                                         0.98 × 0.31 × 0.07 mm3
R range for data collection                                              5.9–62.7° 
Reflections collected                                           29126 
Independent reflections                                       7236 
Absorption correction                                         multi-scan  
Max. and Min. transmission                               0.988 and 0.852 
Refinement method                                             full-matrix 
Goodness-of-fit F2                                              1.057 
Final R indices [I >2S (I)]                                    R1 = 0.0432, wR2 = 0.1123 
R indices (all data)                                               R1 = 0.0594, wR2 = 0.1207 
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Data for compound 10a
Identification code                                              dz-ppa6 
Empirical formula                                               C22H15F3O4S2
Formula weight                                                   464.46 
Temperature                                                        173 (2) K 
Wavelength                                                         0.71073 Å 
Crystal system                                                     Tetragonal 
Space group (H.-M.)                                            I 41/a 
Space group (Hall)                                               -I 4ad 
Unit cell dimensions                                        a = 29.1670 (5) Å               = = 90 ° 
                                                                        b = 29.1670 (5) Å               P = 90 ° 
                                                                        c = 9.5537 (2) Å                 Q = 90 ° 
Volume                                                                 8127.5 (3) Å3 
Z                                                                            16 
Density (calculated)                                              1.518 Mg /m3
Absorption coefficient                                           0.32 mm−1 
F (000)                                                                   3808   
Crystal size                                                             0.39 × 0.28 × 0.25 mm3
R range for data collection                                                    5.3–59.3° 
Reflections collected                                              21080 
Independent reflections                                          5857 
Absorption correction                                             multi-scan  
Max. and Min. transmission                                   0.925 and 0.886 
Refinement method                                                full-matrix 
Goodness-of-fit F2                                                  1.048 
Final R indices [I >2S (I)]                                        R1 = 0.0377, wR2 = 0.0946 
R indices (all data)                                                   R1 = 0.0515, wR2 = 0.0994 
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Data for compound 15b 
Identification code                                              dz-41 
Empirical formula                                               C16H7Br2F3O 
Formula weight                                                   432.04 
Temperature                                                        173 (2) K 
Wavelength                                                         0.71073 Å 
Crystal system                                                     Monoclinic 
Space group (H.-M.)                                            P21/c
Space group (Hall)                                               -P 2ybc 
Unit cell dimensions                                             a = 13.3098 (6) Å               = = 90.00 ° 
                                                                               b = 14.9723 (7) Å               P = 92.189 (3) ° 
                                                                               c = 7.4196 (3) Å                 Q = 90.00 ° 
Volume                                                                  1477.49 (11) Å3 
Z                                                                             4 
Density (calculated)                                               1.942 Mg /m3 
Absorption coefficient                                           5.52 mm−1 
F (000)                                                                   832   
Crystal size                                                            0.99 × 0.07 × 0.06 mm3
R range for data collection                                                    5.4–57.7° 
Reflections collected                                              16758 
Independent reflections                                          4304 
Absorption correction                                             multi-scan  
Max. and Min. transmission                                    0.733 and 0.074 
Refinement method                                                 full-matrix 
Goodness-of-fit F2                                                  1.011 
Final R indices [I >2S (I)]                                        R1 = 0.0318, wR2 = 0.0626 
R indices (all data)                                                   R1 = 0.0580, wR2 = 0.0675 
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
Data for compound 16g 
Identification code                                              dz-62a 
Empirical formula                                               C21H11BrCl2O 
Formula weight                                                   430.11 
Temperature                                                        173 (2) K 
Wavelength                                                          0.71073 Å 
Crystal system                                                     Triclinic, P
Space group (H.-M.)                                            P  -1  
Space group (Hall)                                               -P 1 
Unit cell dimensions                                            a = 5.9376 (2) Å               = = 68.331 (2)° 
                                                                             b = 11.9185 (5) Å              P = 80.137 (2)° 
                                                                             c = 13.6971 (5) Å               Q = 82.890 (2)° 
Volume                                                                885.55 (6) Å3 
Z                                                                           2 
Density (calculated)                                             1.613 Mg /m3 
Absorption coefficient                                         2.63 mm−1 
Crystal size                                                           0.33 × 0.10 × 0.05 mm3
R range for data collection                                                   5.7–56.8° 
Reflections collected                                             16383 
Independent reflections                                         4656 
Absorption correction                                           multi-scan  
Max. and Min. transmission                                 0.880 and 0.478 
Refinement method                                              full-matrix 
Goodness-of-fit F2                                               1.090 
Final R indices [I >2S (I)]                                     R1 = 0.0433, wR2 = 0.0812 
R indices (all data)                                                R1 = 0.0632, wR2 = 0.0877 
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
Data for compound 19b 
Identification code                                              dz-72b 
Empirical formula                                               C30H18F6O2
Formula weight                                                   524.44 
Temperature                                                        173 (2) K 
Wavelength                                                          0.71073 Å 
Crystal system                                                     Triclinic, P
Space group (H.-M.)                                            P  -1  
Space group (Hall)                                              -P 1 
Unit cell dimensions                                           a = 7.2654 (3) Å              = = 111.919 (2)° 
                                                                            b = 11.9138 (5) Å              P = 96.065 (2)° 
                                                                            c = 14.8483 (6) Å              Q = 92.612 (2)° 
Volume                                                               1180.62 (8) Å3 
Z                                                                           2 
Density (calculated)                                             1.475 Mg /m3 
Absorption coefficient                                         0.12 mm−1 
F (000)                                                                 536 
Crystal size                                                           0.45 × 0.44 × 0.37 mm3
R range for data collection                                                  5.6–60.0° 
Reflections collected                                            23250 
Independent reflections                                        6224 
Absorption correction                                           multi-scan  
Max. and Min. transmission                                 0.956 and 0.946 
Refinement method                                              full-matrix 
Goodness-of-fit F2                                               1.095 
Final R indices [I >2S (I)]                                     R1 = 0.0389, wR2 = 0.1063 
R indices (all data)                                                R1 = 0.0467, wR2 = 0.1109 
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
Data for compound 23a 
Identification code                                              dz-tri-15R1a 
Empirical formula                                               C23H20BrNO2
Formula weight                                                   422.31 
Temperature                                                        173 (2) K 
Wavelength                                                         0.71073 Å 
Crystal system                                                     Monoclinic 
Space group (H.-M.)                                           P21/c 
Space group (Hall)                                             -P 2ybc 
Unit cell dimensions                                           a = 14.3331 (10) Å               = = 90.00° 
                                                                            b = 10.0572 (7) Å                  P = 97.808 (3)° 
                                                                            c = 26.376 (2) Å                    Q = 90.00° 
Volume                                                               3766.9 (5) Å3 
Z                                                                          8 
Density (calculated)                                            1.489   Mg /m3 
Absorption coefficient                                        2.20  mm−1 
F (000)                                                                1728 
Crystal size                                                          0.78 × 0.45 × 0.02 mm3
R range for data collection                                                 5.1–50.6° 
Reflections collected                                           39122 
Independent reflections                                       9979 
Absorption correction                                          multi-scan  
Max. and Min. transmission                                0.957 and 0.279 
Refinement method                                             full-matrix 
Goodness-of-fit F2                                              1.043 
Final R indices [I >2S (I)]                                    R1 = 0.0530, wR2 = 0.1280 
R indices (all data)                                               R1 = 0.1032, wR2 = 0.1168 
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
Data for compound 23b
Identification code                                             dz-tri-10R2 
Empirical formula                                              C25H24BrN 
Formula weight                                                  418.36 
Temperature                                                       173 (2) K 
Wavelength                                                         0.71073 Å 
Crystal system                                                    Monoclinic 
Space group (H.-M.)                                           P21/c 
Space group (Hall)                                             -P 2ybc 
Unit cell dimensions                                           a = 13.0806 (7) Å              = = 90.00° 
                                                                            b = 21.4854 (12) Å            P = 100.020 (3)° 
                                                                            c = 7.3970 (5) Å                Q = 90.00° 
Volume                                                                2047.2 (2) Å3 
Z                                                                          4 
Density (calculated)                                            1.357  Mg /m3 
Absorption coefficient                                        2.02  mm−1 
F (000)                                                                864 
Crystal size                                                         0.97 × 0.15 × 0.03 mm3
R range for data collection                                                 6.3–44.5° 
Reflections collected                                          18092 
Independent reflections                                      4896 
Absorption correction                                         multi-scan  
Max. and Min. transmission                               0.942 and 0.245 
Refinement method                                            full-matrix 
Goodness-of-fit F2                                             1.057 
Final R indices [I >2S (I)]                                   R1 = 0.0443, wR2 = 0.0856 
R indices (all data)                                              R1 = 0.0915, wR2 = 0.0950 
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
Data for compound 28 c 
Identification code                                                 dz-3b2 
Empirical formula                                                  C34H32O2
Formula weight                                                      472.60 
Temperature                                                           173 (2) K 
Wavelength                                                             0.71073 Å 
Crystal system                                                         Triclinic 
Space group (H.-M.)                                                P -1 
Space group (Hall)                                                   -P 1 
Unit cell dimensions                                                 a = 11.767 (9) Å                = = 94.95 (2)° 
                                                                                  b = 15.173 (10) Å              P = 99.729 (13)° 
                                                                                  c = 15.251 (11) Å               Q = 97.545 (16)° 
Volume                                                                     2644 (3) Å3 
Z                                                                               4 
Density (calculated)                                                  1.187 Mg/ m3    
Absorption coefficient                                              0.07 mm−1 
F (000)                                                                      1008   
Crystal size                                                                0.58 × 0.14 × 0.10 mm3 
R range for data collection                                                       6.5 - 59.1° 
Reflections collected                                                 50656 
Independent reflections                                             13767 
Absorption correction                                               multi-scan  
Max. and Min. transmission                                     0.959 and 0.993  
Refinement method                                                   full-matrix 
Goodness-of-fit F2                                                    1.0436 
Final R indices [I >2S (I)]                                         R1 = 0.0512, wR2 = 0.1291 
R indices (all data)                                                    R1 = 0.0904, wR2 = 0.1427 
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